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"It's the possibility of having a dream come true 
that makes life interesting" 
(Paulo Coelho, 
The Alchemist) 
Abstract 
Genetic defects occurring in the sedlin gene, a conserved component of 
TRAPP complex, cause Spondyloepiphyseal Dysplasia Tarda (SEDT), a 
rare progressive condition characterised by impaired chondrogenesis 
resulting in short stature, flattening of the vertebrae, and premature 
osteoarthritis. The role of sedlin in the pathogenesis of SEDT disease so far 
is still unknown. Prompted by the consideration that sedlin is ubiquitously 
expressed but that sedlin mutations cause cartilaginous-restricted 
dysfunctions, I hypothesized that sedlin might exert a role in membrane 
trafficking generally but in particular in the transport of chondrocyte-
specific cargoes, such as type II procollagen (PCII). This hypothesis was 
reinforced by the fact that mutations in PCII give rise to autosomal 
dominant forms of spondyloepiphiseal dysplasia. I tested this hypothesis by 
analyzing the involvement of sedlin in the transport of different classes of 
secretory cargoes and found that sedlin is selectively required for PCII to 
exit the ER, while it is not essential for ER exit of small soluble and 
membrane-associated cargoes. I have also identified the molecular 
mechanism underlying this role of sedlin in its ability to bind the GTPase 
SarI and to control the membrane-cytosol cycle of SarI itself and of the 
COPII coat complex at the level of the ER exit sites. Sedlin depletion 
and/or mutation in SEDT patients slows down the SarI cycle and prolongs 
the membrane association of Sarl-GTP at the ER exit sites, thus inducing 
constriction and premature fission of nascent carriers which fail to 
incorporate the large PC protofibrils but are still competent for smaller 
secretory cargoes. All together these findings provide new insights not only 
into understanding the role of sed lin but also shed new light on the 
molecular mechanisms underlying the onset of the SEDT disease. 
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Chapter 1 
Introduction 
Newly synthesised proteins destined to enter the secretory pathway are 
translated at the level of the rough endoplasmic reticulum (ER) and 
translocated into the ER lumen or ER membrane. Here, secretory proteins 
undergo folding, assembly and post-translational modifications. 
Proper folded and assembled proteins are then separated from ER resident 
proteins and transported to the Golgi complex (GC) for further processing, 
modifications and transport to their fmal destination. 
The transport of newly synthesized proteins from one organelle to another 
(such as from the ER to the Golgi complex) or through a single organelle 
(such as transport through the Golgi stacks: intra-Golgi transport) is tightly 
regulated so that a large amount of cargo can flow through the secretory 
pathway without compromising the integrity and steady-state composition 
of the constituent organelles (Figure 1.1). 
1 
Figure 1.1 The secretory pathway. Schematic representation of the intracellular 
transport pathway. The scheme depicts the compartments of the secretory, 
lysosomal/vacuolar, and endocytic pathways. Transport steps are indicated by arrows. 
Colors indicate the known or presumed locations of COPII (blue), COP! (red), and 
clathrin (orange). Adapted from Bonifacino and Glick, 2004 . 
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Although the protein subunits of the different machineries acting along the 
secretory pathway are largely known (as in the case of COPII subunits that 
mediate the formation of carriers at the ER-exit sites (ERES) and the 
SNARE proteins that are involved in membrane fusion), a number of 
important aspects and questions remain to be resolved. 
One open question is whether different proteins that differ in size and 
composition are incorporated into the same or different carriers. Moreover, 
the debate about the shapes and sizes of these transpost carriers (i.e. 60-80 
nm vesicles or large pleiomorphic tubular carriers: Mironov et al. 2003; 
Fromme and Schekman, 2005) also remains an important open question, 
with some proteins thought to be transported in distinct carriers (such as 
vesicles) while others are thought to move via large carriers that are formed 
by "en-bloc protrusions" from the ER (Mironov et aI., 2003). 
Indeed, beyond the recruitment of nascent cargo for delivery to downstream 
compartments, other transport components must be integrated with the 
recruitment of nascent cargo, such as targeting and fusion proteins, 
including the tethering and SNARE complexes that direct COPII vesicles to 
the Golgi complex. 
In the following sections, I will briefly describe and discuss what is known 
about protein transport and the machineries that are involved, with 
particular reference to the questions that remain to be answered. 
3 
1.1COPII 
1.1.1 COP!! coat recruitment and assembly 
The ER-to-Golgi transport step is thought to occur via membrane-bound 
transport carrier intermediates, which are formed by the assembly of the 
coat protein complex II, the COPII coat, on the ER membranes. 
COPII (coatomer protein II) has been shown to be involved in the direct 
capture of cargo molecules and in the physical deformation of the ER 
membranes that drives the formation of the so-called COPII carriers or 
transport intermediates in ER-to-Golgi anterograde trafficking. 
The COPII proteins directly participate in the selection of the cargo that is 
incorporated, either by recognizing sorting signals that are present in the 
cytosolic domains of the transmembrane cargo proteins, or indirectly, via 
specific cargo receptors in the case of soluble cargoes and some 
transmembrane cargoes (Bonifacino and Glick, 2004). 
Protein export by COPII vesicles from the ER represents the default ER-to-
Golgi route in yeasts and mammals. Cargo proteins that are destined for the 
GC not only include newly synthesised biosynthetic cargo molecules, but 
also a variety of other machinery proteins that constantly cycle between the 
ER and the GC. 
4 
The molecular mechanistic details of COPII vesicle formation and cargo 
delivery to the GC have been defined through yeast genetics and in vitro 
reconstitution. 
The components of the COPII machinery identified using the yeast model 
Saccharomyces cerevisiae as being necessary for ER exit include: SarI 
(Nakano and Maramtsu, 1989), Sec23/24 (Hicke et aI., 1992), Sec 13/31 
(Salama et al., 1993) and the SarI regulator Sec12 (Nakano et aI., 1988). 
Only few years after the original discovery of these proteins, their physical 
interaction and their capability to generate COPII vesicles in vitro were 
demonstrated (Barlowe et aI., 1994). 
A wealth of biochemical and genetic experiments led to a general consensus 
that COPII vesicles were formed through a precise sequence of events 
(Figure 1.2). 
1.1.1.1 SarI and SecJ 2 
COPII coat assembly is initiated by the exchange of GDP for GTP on the 
small GTPase SarI, a process catalyzed by the ER-Iocalized guanine 
nucleotide exchange factor (GEF) Sec12. As a small Ras-like GTPase, SarI 
needs to be activated by a guanine nucleotide exchange factor (GEF). 
Activation from the GDP- to the GTP-bound form occurs thanks to the GEF 
Sec 12p first identified in the yeast S. cerevisiae (Barlowe et aI., 1993). 
Sec12p is a type II transmembrane ER glycoprotein composed of a 40-kDa 
cytoplasmic domain and 10-kDa luminal domain. The cytosolic domain has 
been reported to function independently of membranes as a Sar I-specific 
5 
CytOSOl 
Serlp·GDP 
l_ 
Sec24 p Sec23p 
c.-go 
Prot';n. 
Secl 3p ·Sec3 1p 
Figure 1.2 Assembly of the COPII machinery and cargo sorting/packaging. SarI is 
activated to Sarl-GTP by the ER-Iocalized exchange protein Secl2. Sarl-GTP assembles 
into the Sarl-Sec23/Sec24-cargo pre-budding complex that is successively clustered by 
the outer layer Sec 13-Sec31 protein complex. Adapted from Bonifacino and Glick, 2004. 
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GEF (Nakano et ai., 1988; D'Enfert et ai., 1991). Since Sec12 is strictly 
localised to the ER membranes by static retention (Sato et aI., 1996), SarI 
activation is restricted to the ER membranes. 
Activation of Sari by Sec12 at the ERES in mammalian cells (Aridor et aI., 
2001), leads to the recruitment of cargo to "prebudding" complexes (Aridor 
et al., 1998; Kuhen et aI., 1998) and assembly of the COPII cytosolic coat 
complexes Sec23/24 and Sec 13/31, directing vesicle budding from the ER. 
In its GTP-bound state, SarI interacts with the ER membranes by the 
exposure of the N-terminal ampbipathic a-helix (Huang et ai., 2001; Bi et 
al., 2002) and recruits the Sec23/Sec24 heterodimeric complex, and this 
Sar I-Sec23/Sec24 complex then recruits the Sec 13/Sec31 proteins. 
Together with Sec23/Sec24, SarI forms the layer of the coat that is 
proximal to the membrane, the inner layer, while Sec13/Sec31 form a 
second, more distal, outer or membrane layer. 
In addition to its established role in recruiting the Sec23/Sec24 complex, 
Sar 1 also appears to facilitate membrane bending and to contribute also to 
membrane-bound carrier fission (Lee et aI., 2005; Long et aI., 2010). SarI 
with bound GTP (or non-hydrolyzable GTP analogs) has been shown to 
generate curvature and tubulation in vitro from liposomes with lipid 
composition mimicking that of the ER (Lee et aI., 2005; Bielli et aI., 2005, 
Bacia et aI., 2011). The incubation of Sarl-GTP with ER membranes in the 
absence of the Sec23/Sec24 and Sec 13/Sec31 proteins leads to the 
formation of tubules at the ERES, and these tubules can be resolved into 
functional transport carriers by the addition of the missing Sec23/Sec24 and 
7 
Sec 13/Sec31 components, indicating that Sar 1 can control membrane 
curvature and has an important role in the generation of the ERES (Aridor et 
aI., 2001; Long et aI., 2010). 
This tubulation is dependent on the SarI N-terminal amphipathic a-helix 
(possessing a hydrophobic face and a hydrophilic face; Lee et aI., 2005; 
Long et al., 2010), formed by 23 amino acids that are exposed when the 
protein is GTP-bound, allowing the hydrophobic hemicylinder to insert into 
the lipid bilayer (Matsuoka et aI., 1998). By contrast, Sarl-GDP binds 
membranes with lower affinity. 
The expression of a GTP-restricted mutant form of SarI has differential 
effects on the segregation of cargo during export from the ER, blocking the 
transport of these cargoes to the Golgi complex (Stephens and Pepperkok, 
2004). In addition, the microinjection of a GDP-restricted form of Sarlp 
inhibits the ER exit of both large molecules, such as procollagen type-I 
(-300 run in size), and small proteins, such as the viral protein VSV-G, 
suggesting that, despite their differences in size, ER exit is COPII-
dependent for both large and small cargoes (Aridor et al., 2001; Mironov et 
al.,2003). 
X-ray crystallography studies revealed details of the SarI structure. It 
consists of four distinct domains: a guanine nucleotide binding pocket, 
switch I domain, switch II domain, and N-terminal amphipathic a-helix, 
each of which plays a specific role in SarI function (Rao et al., 2006; Bi et 
al., 2002; Huang et aI., 2001). Six p sheets compose the core of the protein 
that forms the guanine nucleotide binding pocket (the G domain) typical of 
8 
the Ras superfamily (Huang et aI., 2001). Ihis G domain is essential for 
SarI function: mutation ofThr39 to Asn creates a GDP-restricted dominant-
negative mutant by interfering with the association to its guanine nucleotide 
exchange factor, Sec12 (Weissman et aI., 2001). Another position important 
in regulating SarI GTPase activity is His79 in the switch II region which, if 
mutated, results in a loss of ability of SarI to hydrolyze GIP thus inhibiting 
the disassembly of the COPII complex (Huang et aI., 2001). 
SarI has a very slow intrinsic rate of GIP hydrolysis because, like other 
Ras-like small GIPases, it lacks key catalytic residues (Bi et aI., 2002; 
Vetter and Wittinghofer, 2001). As mentioned above, SarI-GTP recruits the 
Sec23/24 heterodimer by binding Sec23 to form the so-called "pre budding 
complex" (Kuehn et aI., 1998). Sec23 acts as a GTPase-activating protein 
(GAP) for SarI (Yoshihisa et al., 1993), and it binds to SarI-GIP on the 
side opposite to the SarI membrane anchor. 
Therefore, Sec23 stimulates Sar I GTP hydrolysis upon binding to Sar I, an 
event that leads to the loss of SarI from membranes (Antonny et aI., 2001). 
However, the presence of Secl2, which continuously provides "fresh" Sarl-
GIP guarantees a constant presence of Sarl-GIP, and hence the full 
assembly of the COPII coat at the ERES (Futai et aI., 2004). 
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1.1.1.2 Sec23/Sec24 
The Sec23/24 heterodimer is responsible for binding cargo molecules and 
accelerating the SarI GTPase activity (Yoshihisa et aI., 1993). The crystal 
structure of the Sec23/24 heterodimer revealed a general bow tie shape 
(Lederkremer et al., 2001) with a concave inner face that closely matches 
the arc of the 60 nm cages, likely favouring deformation of the membrane 
(Bi et aI., 2002). Interestingly, the two structures of Sec23 and Sec24 are 
very similar, albeit they share only 14% sequence identity (Bi et aI., 2002). 
The two structures share common features: they both possess a P barrel, a 
zinc fmger, an a-helical region and a trunk domain (Figure 1.3). The trunk 
domain plays an important role in the binding of Sar 1 and is responsible for 
the binding between Sec23 and Sec24. 
The carboxyl-terminal gelsolin-like domain of Sec23 is responsible for the 
activation of the GTPase activity of SarI. The mechanism by which Sec23 
acts as a GAP to accelerate the GTP hydrolysis of SarI involves the 
insertion of an arginine side chain, Arg722, into the active site to form 
bonds with the phosphates via its guanidinum group (Bi et al., 2002). 
This type of mechanism, involving an "arginine-finger" residue that 
neutralizes negative charge in the GTPase transition state is a common 
feature of Ras-like GTPases (Vetter and Wittinghofer, 2001). 
The lifetime of the Sarl-Sec23/Sec24 prebudding complex is believed to be 
sufficiently long to allow its lateral diffusion on the ER membrane and 
cargo capture. The subsequent recruitment of Sec 13/Sec31 accelerates the 
Sec23-mediated GAP activity on SarI by an order of magnitude (Antonny 
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A B 
D 
Figure 1.3 The structure of the COPIl components. Upper panel : Sec23/24 . (A) 
Superposition of Sec23 and Sec24 shows the high degree of homology between the two 
proteins. (B) Sec23/24 domains: the trunk (green), Zn-finger (orange), p-barrel (red), helical 
(yellow), and gelsolin-like (blue) . Lower panel: Secl3/Sec3!. (A) Sec 13/Sec31 structure 
derived from cryo-EM. (B) WD domains mediate the formation of the vertices of the cage. (C) 
Sec 13/sec31 structure with Sec23/24 (D) 13 angle of 90°C dictates the 600 A diameter 
structure, while 13 angle of 108 dictates the formation of a larger structure of 1000 A in 
diameter. Adapted from Russell and Stagg, 20 I O. 
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et aI., 2001). Sec31 binds as an extended polypeptide (heterotetramer) 
across the Sec23 and SarI molecules, and inserts amino-acid side chains in 
the proximity of the SarI active site, thus accelerating GTP hydrolysis in 
combination with Sec23 (Bi et aI., 2007). 
Sec24 functions as the primary cargo adaptor element of the COPII coat, as 
it is generally responsible for the direct interaction with cargo molecules 
(Miller et aI., 2003). 
Basically, the selective capture is driven by export signals located within the 
cytoplasmically exposed regions of transmembrane proteins, but some of 
these transmembrane proteins and the majority of soluble cargo proteins 
need specific transmembrane receptors/adaptors to mediate the interaction 
with the COPII coat. 
Although a universal ER-export signal has not yet been described, a number 
of different signals appear to regulate the interaction with the COPII coat, 
including di-acidic motifs and hydrophobic/aromatic motifs (Bonifacino and 
Glick, 2004). Sec24 was initially studied in yeast and at least three 
interaction domains have been identified on its membrane-facing surface: 
the A, B and C sites that control which cargo is selected (Mossessova et al., 
2003; Miller et al., 2003). The Sec24 A site is the binding site for the NPF 
motif, the dominant signal for ER exit of the Syntaxin SNARE protein SedS 
(Mossessova et al. 2003; Miller et al. 2005). The B site on Sec24 binds to 
the LxxLE-class signals that are present on the SNAREs Bet! and SedS, as 
well as to the DxE transport signal that directs the ER exit of VSV -G and 
yeast Syslp (Nishimura et al. 1999; Votsmeier and Gallwitz 2001). The C 
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site was defined through the mutagenesis of Sec24, and it is specific for 
packaging the SNARE Sec22. 
The presence of multiple binding sites allows for diversity in the number of 
exit codes that Sec24 can bind, and multiple Sec24 isoforms (four isoforms, 
A, B, C and D, have been identified in mammals) expand the range and 
specificity of Sec24-cargo interactions. 
Intriguingly, distinct Sec24 family members, by interacting with Sec23, are 
able to recognize export signals different from those bound by Sec24 alone 
(Pagano et aI., 1999; Miller et aI., 2003), thus expanding the cargo 
multiplicity captured by COPII coat. 
1.1.1.3 Secl3/Sec31 
After the "prebudding complex" is formed, the subsequent recruitment of 
Sec 13/Sec3I accelerates the Sec23-mediated GAP activity. The GAP 
activity associated with these components of the COPII complex makes the 
complex unstable in principle, and raises the question of how sufficient 
stability for cargo capture and carrier formation is achieved. 
Notably, Sec31 cannot act alone on Sari because it only binds to the Sec23-
Sari complex (Bi et aI., 2007). In this scenario, the sequential binding 
reaction confers a two-gear mechanism for GTP hydrolysis on Sari 
(Antonny et aI., 2001), whereby hydrolysis is initiated upon Sec23/24 
binding and is accelerated further upon recruitment of Sec 13/31. Thus, GTP 
hydrolysis is programmed into the COPII system upon assembly, since the 
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slow rate of reaction on Sar 1-Sec23124 may provide the pre budding 
complex the opportunity to gather cargo and SNARE molecules prior to 
Sec13/31 binding (Antonny et aI., 2001). 
However, some cell types have to secrete extremely large macromolecular 
cargoes, such as the lipoprotein chylomicrons (-400 nm in diameter) and 
the procollagen molecules that assemble into a triple helical molecule of 
>300 nm in length (see below). These types of cargo exceed the regular 
COPII size and they are clearly too large to fit into these conventional 60-80 
nm vesicles that bud from the ER. New insights came from the full 
determination of the crystal structure of COPII machinery that has revealed 
new rules in COPII formation (Stagg et al., 2008). 
A conventional model of coat assembly suggested the possibility that each 
Sarl-Sec23/24-cargo ternary prebudding complex (Aridor et aI., 1999; 
Supek et al., 2002) will recruit a Sec13/31 heterotetramer that will 
subsequently assemble a vertex. But new detailed structural information led 
to a different model: Sec23/24 first form an oligomer to define a site for 
Sec 13/31 recruitment (Stagg et aI., 2008). While other permutations are 
possible, such a pathway based on assembly of Sec23/24 tetramer clusters 
could establish the polarity and geometry of the observed vertices as well as 
facilitate regulation by cargo. The formation of a vertex depends on two 
angles: a and p. a is invariant for all the COPII structures observed. p, 
varies between 90° and 108°, and this is what allows COPII cages to form 
with different diameters. 
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The COPII structures observed should be capable of recruiting a huge 
variety of molecules of several classes that differ in term of size and 
dimensions including single and multi-membrane spanning proteins. If 
COPII cages are to incorporate cargo molecules larger than those that can be 
accommodated by the 1000 A coat, ~ must be capable of assuming angles 
greater than 108°. If 1000 A is the largest coat that can be formed, then 
large cargo such as procollagen and chylomicrons (up to 3,000 A or 10,000 
A respectively) would have to be transported by some other means, perhaps 
a non-canonical COPII vesicle that lacks Sec 13/31. 
In another scenario, ~ angles larger than 108° (up to 120°) would make it 
possible to assemble any kind of structures from planar polygonal sheets to 
helical tubes. Thus, if ~ could take on different angles it would support the 
hypothesis that the COP II machinery possesses the capacity to 
accommodate large cargo molecules; however such structures have not been 
observed in vitro as yet (Russell and Stagg, 2010). 
How such cargoes are packaged into transport carriers and how they are 
subsequently transported to and through the Golgi complex still remain an 
open question (Fromme and Schekman, 2005). 
1.1.2 Maintenance and regulation ofERES 
The molecular mechanisms controlling the positioning, biogenesis and 
maintenance of ERES have remained elusive. Recent evidence suggests a 
function for Sec16 in the homoeostasis of ERES (Watson et al., 2006; 
Bhattacharyya and Glick, 2007; Iinuma et al., 2007; Fahran et al., 2008; 
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Hughes and Stephens, 2009). Sec16 is a large peripheral membrane protein 
of 250 kDa. It is a highly evolutionarily conserved protein that associates 
with ERES and is thought to form a scaffold for the assembly of COPlI 
(Gimeno et al., 1996). Sec 16 is also an essential gene in S. cerevisiae and 
Pichia pastoris (Espenshade et aI., 1995; Connerly et aI., 2005). In vitro 
COPlI binding reactions performed with isolated ER membranes stripped of 
Sec16 showed less efficient vesicle formation (Gimeno et aI., 1996; Supek 
et aI., 2002). Sec16 has then been shown to act as a protein scaffold to direct 
the assembly of the COPII coat through its binding to Sari (Ivan et aI., 
2008), to Sec23 (Bhattacharyya and Glick, 2007), and to Sec 13 (Hughes and 
Stephens, 2009). 
COPlI turnover at a single ERES has been analyzed in living cells, and the 
half-lives for SarI, Sec23 and Sec24 were determined as 1.1, 3.7 and 3.9 
sec, respectively (Forster et al., 2006). Moreover, decreasing the amount of 
transport-competent cargo in the ER has been shown to accelerate the 
turnover of the Sec23/24p and to slow down that of Sar 1. The combination 
of several experimental in vivo FRAP kinetic studies, the mathematical 
model of membrane turnover by COPII, and existing in vitro data predicts 
that Sec23/24p remains membrane associated even after GTP is hydrolysed 
by SarI, for a duration that is strongly increased by the presence of cargo. 
Thus the cargo retains the COPlI complex on membranes even after the 
release of SarI, and prevents the premature disassembly of COPlI during 
cargo sorting and transport-carrier formation (Forster et al., 2006). 
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Indeed, Guo and Linstedt showed the importance of cargo in the recruitment 
of COPII (Guo and Linstedt, 2006). Quantification of COPII assembly 
during de novo biogenesis of the Golgi complex during wash-out of 
brefeldin A (BFA, a fungal toxin that induces a reversible redistribution of 
the Golgi complex into the ER), showed that a dramatic up-regulation of 
COPII at the ERES was driven by increased levels of cargo (i.e. Golgi 
proteins) in the ER (Guo and Linstedt, 2006). 
This up-regulation of COPII assembly occurred in the absence of GTP 
hydrolysis and any cytosolic factors, other than the COPII prebudding 
complex of Sarl-Sec23/Sec24. These findings suggest that the interaction 
between the cargo (Le. Golgi proteins exiting the ER) and COPII 
components regulates ER exit (Guo and Linstedt, 2006). Moreover, an acute 
increase in cargo load causes fusion of ERES leading to an increase in 
ERES size (Farhan et al., 2008). This response was dependent on a limiting 
amount of either PI4-kinase III a (PI4K-Illa) or Sec16. By contrast, a 
chronic increase in cargo load resulted in the neo-formation of additional 
ERES. This response was in turn independent of PI4K-IIIa but required 
Sec16. The chronic increase in cargo load induced the expression of COPII 
and Sec16 through the unfolded protein response (UPR). These results 
suggest that acute and chronic cargo loads are handled in a different 
mechanistic way at the level ofERES (Farhan et al., 2008). 
ERES align along microtubules in several cell lines (Ralston et al., 2001) 
ERES undergo predominantly short- but also long-range movements in 
mammalian cells that are completely inhibited following depolymerization 
of microtubules. In metazoans, ER-to-Golgi transport carriers are 
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transported along microtubules in a dyne in motor-dependent manner 
(Presley et aI., 1997). Moreover a subunit of the dynactin complex, which is 
essential for dynein function, has been shown to directly interact with the 
human Sec23A paralog (Watson et aI., 2005). This interaction paired with 
observation of both dynactin and Sec23A at the plus-end of growing 
microtubules in living cells, corresponding to ER exit sites. Interfering with 
the Sec23A-dynactin interaction resulted in an increased turnover rate of 
COPII components at ER exit sites, coupled with a decrease in the kinetics 
of ER export, but it did not affect the velocity of ER-to-Golgi transport 
carriers (Watson et al., 2005). 
Dynactin is important for an early stage of ER exit, but not for microtubule 
transport. A subsequent study found that microtubule plus-end localization 
of dynactin was dependent upon EBI (End-Binding protein 1) and CLIP-
170 (Cytoplasmic Linker Protein 170; Watson et al., 2006). EBI and CLIP-
170 mediate the microtubule plus-end loading of p150 (Glued) (Watson et 
al., 2006). Disruption of the plus-end localization of dynactin did not affect 
ER-to-Golgi transport, implying that dynein-based transport is not 
dependent upon localization to plus-ends. This work suggests the hypothesis 
that the COPII coat functions as the link between the vesicle membrane and 
the microtubule motor. 
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1.2 Procollagens 
A central question is whether the huge variety of cargoes leaving the ER use 
different types of carriers. Studies in yeast have shown that different carriers 
forming in a COPII-dependent manner at the ER membrane have 
differential molecular requirements (Castillon et ai., 2009; Morsomme and 
Riezman, 2002; Morsomme et ai., 2003). A number of approaches have 
been undertaken to address this question in mammals but a definitive 
answer is still missing (Stephens and Pepperkok, 2002; Mironov et ai., 
2003). This issue is particularly relevant for cargoes that are considered 
special because of their size, as is the case for types I and II procollagen 
(PCI and PCII), which form large 300 nm rigid triple helices whose size 
greatly exceeds the size of a "regular" COPII carrier vesicle (60-80nm). 
Collagen is a very abundant structural protein in all animals. In humans, 
collagen comprises one third of the total protein and is the most prevalent 
component of the extracellular matrix (ECM). So far, twenty-eight different 
types of collagen composed of at least 46 distinct polypeptide chains have 
been identified in vertebrates (Veit et aI., 2006; Brinkman et al., 2005; 
Figure 1.4). 
Xaa-Yaa-Gly is the amino-acid motif responsible for the assembly of the 
triple helix of all collagen types, where Xaa and Yaa can be any amino acid. 
The amino acids in the Xaa and Yaa positions of collagen are often (2S)-
proline (Pro, 28%) and (2S, 4R)- 4-hydroxyproline (Hyp, 38%), 
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Figure 1.4 Collagens structure and classification. (A) Overview of the collagen triple 
helix. (B) List of all identified collagens. Adapted from Shoulders and Raines, 2009. 
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respectively. The most common triplet found in collagen is ProHypGly 
(10.5%, Ramshaw et aI., 2009). 
Collagens consist of three polypeptide (a) chains, displaying an extended 
polyproline-II conformation, a right-handed supercoiled triple helix and a 
one-residue stagger between adjacent chains (Brodsky and Persikov, 2005). 
Collagens can be heterotrimeric, i.e. type I collagen, which contains two 
identical a chains and a different third chain [(11 (l)h(12(I). However, the 
majority of collagens are homotrimers, like collagen II that contains three 
identical a chains [al(II)13. 
Vertebrate collagens are classified by function and domain homology into 
different classes (Figure 1.4): classical fibril forming collagens, network-
forming collagens, fibril-associated collagens with interrupted triple helices 
(FACITs), transmembrane collagens, membrane associated (MACITs), 
multiple triple-helix domains and interruptions (MUL TIPLEXINs). 
Collagen types, their distribution, composition, and associated pathologies 
are listed in Figure 1.4. 
Fibril-forming collagens occur as 67-nm D-periodic fibrils that constitute 
the principal source of tensile strength in animal tissues (Kadler et aI., 
1996). The periodic structure of the fibril is due to regular staggering of 
triple helical collagen molecules. Mammals have 11 fibrillar collagen genes, 
which cluster phylogenetically into three distinct subclasses (Huxley-Jones 
et aI., 2007). Collagen type I and collagen type II belong to this family. 
Interestingly, the X-Y-Gly domain of fibril-forming collagens contains 
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-1000 residues and is usually uninterrupted, with the notable exception of 
collagen XXIV and collagen XXVII. Newly synthesised fibril-forming 
collagens are initially produced as pro-collagens containing N- and C-
propeptides at each end of the triple helical domain. Cleavage of the C-
propeptides is required for fibrillogenesis. 
Collagen type II is found predominantly, but not exclusively, in hyaline 
cartilage where it accounts for 90% of the total cartilage collagen (Mayne 
1989). Together with smaller amounts of other collagens (types IX and XI), 
type II collagen forms a three-dimensional fibrillar network which is 
fundamental for the tensile stiffness and strength of cartilage, providing the 
architecture of the tissue (Eyre et aI., 1991). 
Mutations occurring in the Col2 gene are responsible for the onset of 
Spondyloepiphyseal dysplasia congenita (see 1.7.4 section). 
Collagen fibrils formed from type I collagen (all fibrous tissues except 
cartilage) and fibrils formed largely from type II collagen ( cartilage) have 
slightly different structures, but they share a rod-like structures of 300-400 
nm. 
1.3 copn and genetic diseases 
While there has been important progress recently in identifying receptors 
such as T ANGOIMIA3 that can guide the soluble PCs into COPII transport 
vesicles (Saito et aI., 2009; Wilson et al., 2011), the issue of sterie 
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incompatibility between cargo (300 nm triple helices) and containers (80 nm 
vesicles) remains a puzzle. In this regard, studies of genetic diseases 
involving genes that encode components of the early secretory pathway 
have been illuminating. Though ubiquitous, these components turn out to be 
rate limiting only for selected tissues/cells, presumably because these 
tissues/cells have specific requirements in terms of efficiency, loads and/or 
types of cargo. 
1.3.1 Sar1B: Anderson's disease (AD) and Chylomicron Retention Disease 
(CMRD) 
Anderson' disease (AD; OMIM 246700) or Chylomicron Retention Disease 
(CMRD) is a disorder characterized by hypobetalipoproteinemia with 
selective absence of apo B-48 in the post-prandial state (Bonavent et aI., 
1997; Jones et aI., 2003; Peretti et aI., 2010). 
Chylomicrons, the principal carriers of dietary lipids, are triglyceride (TG)-
rich lipoproteins secreted exclusively from enterocytes. These large 
lipoproteins (700 to 6000 A) contain a single molecule of apolipoprotein 
(apo) B-48, which is essential for chy lomicron structure cohesion 
(Mansbach et al., 2010; Kindel et aI., 2010). Apo B-100 is found within 
very-low-density lipoproteins (VLDL) secreted by the liver and in low-
density lipoprotein (LDL), a catabolic product ofVLDL. 
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It is a very rare recessive disease with less than 50 cases reported in the 
literature. Subjects with this disorder exhibit the clinical manifestations 
initially described by Anderson and her colleagues in 1961, which consist of 
a malabsorption syndrome with steatorrhea and failure to thrive (Anderson 
et aI., 1961). 
When the SarlB gene is mutated, the pre-chylomicron transport vesicle 
delivered by the ER cannot fuse with the Golgi apparatus, which then 
induces an accumulation of pre-chylomicron transport vesicles in the 
cytoplasm of the enterocytes (Siddiqi et aI., 2003). To date, 15 mutations in 
the SarI B gene (induding frameshifts, missense, or deletions) have been 
identified in patients with AD/CMRD. Interestingly, the SarIA gene located 
on chromosome 10 encodes a second human isoform of Sar 1, Sar 1 A. Sar 1 A 
is very similar to SariB (90,5 % of sequence identity), but so far no 
mutation in the SariA gene has been described in patients with AD/CMRD. 
In AD/CMRD, the existence of another SarI paralogue- and cargo-specific 
transport could explain the rather modest and tissue specific manifestations 
of the disease. If, in enterocytes, the SarlB paralogue is used specifically in 
pre-chylomicron transport vesicles (PC TV) for the transport of 
chylomicrons, and if the SarlA paralogue is used for the transport of small 
soluble and membrane bound proteins, then mutations in Sar I B would be 
expected to affect primarily or only chylomicron transport. Indeed, it has 
been shown that SarI B has a weaker affinity compared to Sar 1 A for 
Sec13/31A, which could lead to a less constrained structure (Fromme et al., 
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2007). This less constrained structure would be permissive for the formation 
of larger COPII vesicles (which could transport large cargoes such as 
chylomicrons) as compared to those assembled with SarlA (Fromme et aI., 
2008; Fromme et aI., 2005). 
It has been proposed, in fact, that mutated Sar I B protein leads to an absence 
of chylomicronemia in AD because the PCTVs that are produced in the 
absence of SarI do not fuse with the Golgi complex and are retained in the 
cytosol (Siddiqi et aI., 20 10). 
Furthermore, the question arises as to whether AD/CMRD occurs only in 
tissues in which there is insufficient amounts of the second Sar 1 paralogue 
to compensate for the loss of activity of the first paralogue or whether a 
specific cargo (chylomicrons) is strictly dependent on a specific 
paralogue(s) of the secretion machinery. 
Both the SarIA and SarIB genes are expressed in the intestine (Jones et al., 
2003; Su et al., 2004; Gurkan et aI., 2005). In one AD patient, an increase in 
the expression level of SariA was detected, but SariA failed to rescue the 
phenotype (Georges et al., 2011). This increased expression of the SariA 
gene and, presumably, of its encoded protein does not appear to be 
sufficient to compensate the defect in SariB (Georges et al., 2011). This is 
consistent with a Sar I paralogue-specific and cargo-specific transport of 
chylomicrons. 
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1.3.2 Sec23A: Crania-Lenticula-Sutural Dysplasia (CLSD) 
CLSD is an autosomal recessive syndrome characterized by late-closing 
fontanels, sutural cataracts, facial dysmorphisms and skeletal defects 
(Boyadjiev et aI., 2003). CLSD was originally described in five males and 
one female from a large consanguineous Saudi Arabian family of Bedouin 
descent (Boyadjiev et aI., 2003), while the identification of Sec23A as the 
gene responsible for this syndrome came a few years later (Boyadjiev et aI., 
2006). 
The process of endochondral ossification forms most of the skeletal 
elements in mammals where mesenchymally derived chondrocytes compose 
the matrix of future bones. The two exceptions to this rule are the bones of 
the calvaria and the clavicles, formed by the process of intramembranous 
ossification in which the mesenchymal cells bypass the intermediate 
cartilaginous step and differentiate directly into osteoblasts (Karsenty et al., 
2002). One major type of calvarial malformation is failure of the fontanels 
and/or sutures to close, which is the process affected by the loss of Sec23A. 
A frequent missense substitution was identified in the primary sequence of 
Sec23A protein: F382L (Fromme et al., 2007). The molecular properties of 
this Sec23A mutant were analysed and compared to the wild-type Sec23A 
in several in vitro assays. F382L-Sec23A is able to bind to synthetic 
membranes at a level equivalent to the wild-type and retains intrinsic GAP 
activity similar to the wild-type protein (Fromme et al., 2007). However, 
F382L-Sec23A shows reduced recruitment of the Sec 13/Sec31 outer coat 
complex both in vitro and in vivo. 
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Fibroblasts isolated from patients affected by CLDS have a dilated ER and a 
cytoplasmic mislocalization of Sec31, as shown by EM and 
immunofluorescence (Boyadjiev et aI., 2006). Not surprisingly, nonsense 
mutations in Sec23 were also found to have serious developmental 
consequences in worms and fish (Lang et aI., 2006; Roberts et aI., 2003). 
Recently, mutation in position 702 (M702V) was found to be responsible 
for the CLSD (Boyadjiev et aI., 2011). 
Moreover, in zebrafish crusher mutants, chondrocytes accumulate proteins 
in a distended ER, resulting in a severe reduction in the extracellular matrix 
deposits of cartilage, including type II collagen (Lang et aI., 2006). 
1.3.3 Sec23B: Congenital dyserythropoietic anemia type II (CDAII) 
Mutations occurring in the SEC23B gene cause the onset of a rare genetic 
disorder affecting erythropoiesis, Congenital dyserythropoietic anemia type 
II (Schwarz et al., 2009). Congenital dyserythropoietic anemias (CDA) were 
first described in the literature by Heimpel and colleagues in 1968 as a 
condition characterized by a paradoxical association of anemia and 
reticulocytopenia with erythroid hyperplasia of the bone marrow (Heimpel 
et aI., 1968). These pathological conditions are phenotypically and 
genotypically heterogeneous (Heimpel et aI., 1968), but the most frequent 
form of CDAs is the CDA type II (CDAII). 
CDAII is an autosomal recessive condition characterised by moderate to 
severe normocytic or microcytic anemia, by a normal or insufficiently 
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increased reticulocyte count, chronic or intennittent jaundice and 
progressive splenomegaly (Iolascon et aI., 2000). 
In CDAII patients, bi- and multinucleated erythroblasts were found in bone 
marrow, with nuclei of equal size and DNA content, suggesting a 
cytokinesis defect (Queisser et aI., 1971). Other features of the peripheral 
red blood cells are protein and lipid dysglycosylation (and additional 
hypoglycosylation of the band 3) and endoplasmic reticulum double-
membrane remnants (Iolascon et aI., 1996). By contrast, development of 
other hematopoietic lineages is nonnal. Only recently, the gene responsible 
for the development of CDAII was identified as Sec23B (Schwarz et aI., 
2009). Again, Sec23B selective impainnent leads to a very specific 
erythropoietic phenotype. This CDAII phenotype might be caused by tissue-
specific expression of Sec23B versus Sec23A. The hypothesis arose from 
the interesting finding that, while in nonnal dennal cells no gross difference 
was detectable between mRNA expression of the two genes, Sec23B 
mRNA expression increased 5-7 fold over Sec23A mRNA expression 
during in vitro erythroid differentiation of CD34+ blood cells (Schwarz et 
al., 2009). More interestingly, zebrafish Sec23B morphants mimicked the 
erythroid differentiation problems. In parallel, the Sec23A mutant zebrafish 
line, crusher, showed nonnal erythrocyte development (Schwarz et aI., 
2009). 
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1.4 Rab protein 
One of the most important molecular machines operating within the 
secretory pathway is represented by the small GTPases of the Rab family. 
Rab (Ras-related proteins in brain) are highly evolutionarily conserved 
regulators of membrane trafficking. They regulate key steps of the exocytic 
secretory pathway and endocytosis. Rabs take part in all events of 
intracellular transport, as they participate in cargo selection, budding of 
vesicular structures in donor compartments, regulate the transport of these 
membrane-bound structures along cytoskeletal tracks and also control their 
docking and fusion to the target membrane. Moreover, they ensure organelle 
identity, in terms of protein and lipid composition as well as their correct 
position within the cell (Seabra et al., 2002; Grosshans et al., 2006). In 
yeast, 11 Rabs have been described, while more than 70 different Rab-like 
proteins are present in mammals, reflecting the higher complexity of 
transport events in higher eukaryotes (Pereira-Leal and Seabra, 2001; 
Gurkan et al., 2005). 
Rabs function as small monomeric GTPases that cycle between a GDP-
bound inactive state and a GTP-bound active state (Dumas et aI., 1999; 
Pasqualato et aI., 2004). The GTP-bound form is the active state that can 
recruit "effectors", which participate in different steps of membrane 
transport. The inactive form, the GDP-bound form, can be either 
cytoplasmic or membrane-associated (Wittman and Rudolph, 2004). 
Notably, Rabs possess low intrinsic rates of nucleotide exchange and 
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hydrolysis. For this reason, the activity switch function of Rabs is mediated 
by GOP-GTP exchange factors, called GEFs, and GTPase activating 
proteins, the GAPs (Bos et aI., 2007). Hydrolysis of GTP leads to 
inactivation of the Rab and the GOP-bound form can be extracted from the 
membrane by GOI (GOP dissociation inhibitor, Ullrich et aI., 1993). GOI 
delivers cytosolic Rab to the appropriate organelle (Pfeffer and Aivazian, 
2004). When a Rab in its GOP-bound state becomes membrane-associated, 
aRab GEF promotes the GOP exchange with GTP, thus converting the Rab 
to its active form (Bos et aI., 2007; Figure 1.5). 
Each individual GEF has a certain specificity profile for individual members 
of a G-protein family. The Sec2-, Vps9-, and Mss4-like proteins act as 
GEFs for members of the Rab family. In particular, Sec2 is a reversibly 
membrane-associated, multi-domain protein with guanine nucleotide 
exchange activity towards the yeast Rab-protein Sec4 (Itzen et aI., 2007). 
The GEFs with VPS9 domains, like Rabex-5, activate Rab5, Rab21 and 
Rab22 in mammals (Oelprato and Lambright, 2007). 
On the other hand, the Mss4 protein was first identified as a mammalian 
GEF that interacted with several Rabs belonging to the same family, which 
included Rabl, Rab3, Rab8 and RablO, but not Rab2, Rab4, Rab5, Rab6, 
Rab9 and Rabll (Burton al., 1994). 
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Figure 1.5 Schematic representation of the Rab cycle showing membrane 
recruitment and activation. (A) GDP-bound proteins form a cytosolic complex with 
Rab-GDI (GDP Dissociation Inhibitor). (B) Membrane delivery and Rab-GDI 
displacement are mediated by a GDF (GDI Displacement Factor), followed by (C) Rab 
activation through GEF-catalyzed nucleotide exchange. (D) GTP-bound Rab recruits 
effector molecules to the membrane. (E) GAP-mediated GTP hydrolysis returns the Rab 
to its inactive state, resulting in re-extraction from the membrane by GDI (modified from 
Seabra and Wasmeier, 2004). 
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Few years later, the same protein was shown not to be a GEF that mediated 
the activation of Rab, but rather a protein that interacts with the transient 
guanine-nucleotide-free state of the Rabs, acting as a chaperone that assists 
the Rabs that fail to undergo productive interactions with components of the 
transport machinery during guanine nucleotide exchange (Nuoffer et aI., 
1997). 
Recently, the multi subunit tethering complex TRAPP has been shown to act 
as a GEF for the Yptlp and Ypt31132 proteins in yeast (Jones et aI., 2000; 
Sacher et al., 2001; Wang and Ferro-Novick, 2002) and to target ER-derived 
vesicles to the Golgi complex by accelerating the nucleotide exchange on 
Ypt 1 p. A similar function has been first postulated and then demonstrated 
for the mammalian counterpart of the TRAPP complex (Morozova et al., 
2006; Yamasaki et aI., 2009). 
In mammals, two Rabs have been shown so far to be involved in the early 
secretory pathway between the ER and the Golgi complex: Rab 1 and Rab2. 
Rabl exists in two isofonns, RablA and RabiB. Both of these are localized 
in the ER-Golgi compartments (Tisdale et ai. 1992; Saraste et ai. 1995) and 
they also have roles in intra-Golgi transport and in the maintenance of the 
structure of the Golgi complex (Pind et al., 1994; Wilson et al. 1994; 
Alvarez et al. 2003). 
In particular, Rabl mutants with a low affinity for both GDP and GTP 
("inactive fonn") result in the disruption of the Golgi complex, with the 
redistribution of the Golgi enzyme mannosidase II (MannlI) and the Golgi 
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protein Giantin to the ER. Moreover, the transport of the viral protein VSV-
G is blocked, being retained in the ER (Tisdale et aI., 1992). 
In contrast, transient expression of mutants with a low affinity for GTP and 
a normal affinity for GDP leads to the partial disruption of the Golgi 
complex and the relocation of MannII and Giantin into perinuclear 
elements, while their microinjection into cells promotes the disassembly of 
the Golgi stacks (Wilson et al., 1994). The transport of the VSV-G protein 
to the plasma membrane is also blocked in cells expressing these mutants 
(Alvarez et aI., 2003; Tisdale et aI., 1992). Cells expressing wild-type Rabl 
or the mutant "active form" with low GTPase activity have a normal Golgi 
complex, as visualized by the localization of the two Golgi-resident 
proteins, MannII and Giantin (Alvarez et al. 2003). Moreover, the transport 
of VSV -G is normal, as VSV -G is transported to the Golgi complex and to 
the plasma membrane (Alvarez et aI., 2003; Tisdale et al. 1992). 
On the other hand, the Rab2 protein (which shares 40% of identity with 
Rabl) localizes to pre-Golgi intermediates (VTCs; ERGIC) and its mutant 
form Rab2 Q65L that is predominantly in the GTP-bound-activated form 
inhibits the ER-to-Golgi transport of VSV -G (Tisdale et aI., 1992; Tisdale 
1999). However, differently from Rabl mutants, the block of anterograde 
transport of VSV -G in this Rab2 mutant is a consequence of VTC 
fragmentation and a decrease in the membrane association of ~-COP 
(Tisdale, 1999). Indeed, a peptide corresponding to the amino terminus of 
Rab2 (residues 2-14) causes a dramatic change in the distribution of pre-
Golgi intermediates containing P-COP, and causes the persistent recruitment 
of COPI to the pre-Golgi compartment, which arrests protein transport due 
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to the inability of the membranes to uncoat (Tisdale and Balch, 1996; 
Tisdale and Jackson, 1998). 
In addition, in vitro binding assays have demonstrated that the Rab2 Q65L 
mutant does not interfere with ~-COP binding, but instead stimulates the 
release of slowly sedimenting vesicles that contain Rab2, ~-COP and 
ERGIC markers and lack anterograde-directed cargo, suggesting their nature 
as retrograde vesicles (Tisdale, 1999). 
Thus, in presence of Rab2 Q65L, the vesicles that bud from VTCs contain 
the mutant Rab2 protein and increase COP! recruitment. The retrograde 
carriers are therefore unable to uncoat and retrieve the components of the 
trafficking machinery, which would explain the ER -staining pattern of 
VSV -G in the presence of Rab2 Q65L (i.e. a block in retrograde traffic). 
Indeed, since the initial target for newly budded ER transport carriers is 
commonly believed to be the VTCs, in their absence or when they fail to 
reach a critical size, the carriers are stalled in their forward movement 
(Tisdale, 1999). 
The important roles of the Rab proteins in membrane transport are 
supported by different studies that demonstrate that membrane tethering is a 
conserved mechanism that depends on the Rab effectors. A clear example 
comes from studies in yeast. Here the tethering of ER-derived carriers to the 
Golgi depends on the membrane recruitment of U so 1 p (yeast homologue of 
mammalian pI 15) by Yptlp (yeast homologue of mammalian Rabl). Usolp 
is a soluble cytoplasmic protein that shows peripheral association with 
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membranes. Uso1p and p11S share homology in their head domains, but the 
coiled-coil region ofUso1p is at least twice the size of that of pi 15. 
Usolp was initially identified as yeast ER-to-Golgi transport factor by 
showing that the temperature-sensitive mutant, uso}, blocks the transport of 
the secretory protein invertase prior to its delivery to the Golgi complex. 
Moreover, Usol defects can be suppressed by over-expressing the ER-to-
Golgi SNAREs (see below) Betlp, Boslp, Sec22 and Ykt6, and of the GTP-
binding Yptlp, confirming the role of Uso1p in ER-to-Golgi transport. In 
vitro studies have provided direct evidence for a role for U so 1 p in tethering 
COPII vesicles to Golgi membranes. COPII vesicles do not bind to Golgi 
membranes in the absence of functional Usolp, and the addition of 
functional Usolp to the assays reconstituted COPII binding (Lupashin and 
Sztul, 2005). 
However, no direct interactions between Uso1p and Yptlp have been 
shown, while in mammals, p 115 has been shown to bind directly to Rab 1 
(Allan et al., 2000). Moreover, while Rab1 recruits pII5 onto COPII coats 
already at the budding step, in yeast the requirement for Ypt1p appears to be 
only at the level of the target membrane (Cao and Barlowe, 2000). 
The final step in membrane transport is the fusion between the transport 
intermediate and the acceptor compartment. This process is mediated by the 
transmembrane SNARE proteins, which interact in specific combinations to 
bring the membranes of the transport intermediate and acceptor 
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compartment into close proximity and to drive their fusion. Upon membrane 
contact, the SNAREs form the trans-SNARE complexes, also kno~ as the 
"SNAREpins", which catalyzes the apposition and fusion of the two 
membranes (Hong, 2005; Ungermann and Langosch, 2005). 
1.5 SNAREs 
In general, the SNAREs consist of a central "SNARE domain" flanked by a 
variable N-terminal domain and a C-terminal single a-helical 
transmembrane anchor. These transmembrane anchor domains not only 
anchor the SNAREs to the membrane, but also participate in SNARE-
SNARE interactions. Functionally, SNAREs were initially classified as v-
SNAREs, associated with the vesicle/transport intermediate, and t-SNAREs, 
associated with the target compartment. However, the demonstration that t-
SNAREs are also present on vesicles and v-SNAREs are also present on 
target membranes has led to a new classification of these proteins. Based on 
the amino acid sequence of their SNARE domains, the SNAREs are divided 
in the R-SNAREs, with an arginine residue in the centre of their SNARE 
domain, and the Q-SNAREs, with a glutamine (or aspartate) residue. 
In general, most of the previous v-SNAREs are R-SNAREs, while the Q-
SNAREs are further classified into three groups: Qa, Qb and Qc 
(Hong,2005). It is now generally believed that one member of each 
subfamily contributes to the formation of the SNAREpin, which thus 
consists of three Q-SNAREs and one R-SNARE, resulting in a Qa:Qb:Qc:R 
SNARE complex. The formation of this SNARE complex is essential for 
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fusion between two separate membranes (also known as the trans-SNARE 
complex). 
The functions of the SNAREs are under regulation by various factors. N-
ethylmaleimide-sensitive factor (NSF) and soluble NSF-association protein-
a (a-SNAP) represent the most essential regulators of the SNAREs (the 
SNAP receptors), as they promote the disassembly of the SNARE 
complexes. Thus, it is the concerted action of NSF and a-SNAP that causes 
the dissociation of the SNARE complexes that are formed after SNARE-
mediated fusion, which releases the free SNAREs for repeated use (Figure 
1.6). 
a-SNAP is believed to serve as a folding sensor that binds to the assembled 
SNARE complex, mediates the recruitment of NSF, and supports the NSF-
directed disassembly of the SNARE complex. 
Soon after the disassembly, transport-intermediate-associated SNAREs can 
then be recycled to the donor compartment via retrograde transport, while 
the target-compartment-associated SNARE subunits can be re-organized 
into functional SNAREs for the next round of docking and fusion events. 
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Figure 1.6 The SNARE conformational cycle during vesicle fusion . As an example, 
three Q-SNAREs are on the acceptor membrane and one R-SNARE is on the vesicle. Q-
SNARES that are organized in clusters, assemble into acceptor complexes. Acceptor 
complexes interact with the vesicular R-SNAREs through the N-terminal end of the 
SNARE motif to form the four-helical trans SNARE complex. Trans-complexes proceed 
from a loose state to a tight state, and this is followed by the fusion between two 
membranes. Modified from lahan and Scheller, 2006. 
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1.6 The Goigi complex 
The Italian anatomist Camillo Goigi described the "apparato reticulare 
interno" as an extensive perinuclear network that is present in the cytoplasm 
of nerve cells more than one hundred years ago (Camillo Golgi, 1898). With 
the development of EM in the 1950s, the ultrastructure of the Golgi 
complex was first defined, confirming its unique organisation of stacks of 
flattened cisternae that are closely apposed to one another (Dalton and Felix, 
1954). 
Further investigations led to a more detailed description of the Goigi 
complex that together with the ordered stacks of cisternae (from 3 to 11 in 
mammalian cells) also included membranous vesicular/tubular structures 
(Farquhar and Palade, 1981; Rambourg and Clermont, 1990). 
Progress in the morphological characterisation of the Golgi complex was 
accompanied by the discovery of its function. The Goigi complex is 
involved in the intracellular transport and glycosylation of proteins that are 
destined for secretion or for other intracellular organelles. 
Biochemical studies revealed that carbohydrates are progressively added 
during the passage of proteins from the cis to the trans face of the Golgi 
complex. In particular, the enzymes involved in the terminal glycosylation 
steps, i.e. galactosyltransferases and sialyltransferases, reside in the trans-
Golgi elements, confrrming the observation that the Golgi subcompartments 
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(or cisternae) can be recognized by the presence of the enzymes involved in 
the specific steps of glycosylation of proteins and lipids. Indeed, the 
enzymes that process newly synthesised proteins are arranged through the 
Golgi stack in such a manner that the early acting enzymes reside on one 
side of the Golgi stack, while the late-acting enzymes are located at the 
other site. Together with morphological considerations, these observations 
have led to the classification of the Golgi complex into cis-, medial and 
trans-compartments within each single stack (Figure 1.7). 
The architectural features of the Golgi complex were initially investigated in 
various animal, plant and yeast cells using EM analysis of ultrathin sections. 
This has been followed by more sophisticated analyses of EM tilt series 
combined with computer axial tomography, to study the three-dimensional 
structure of this organelle (Kepes et al., 2005). All of these studies revealed 
some common features and some particular differences in the morphology 
of the Golgi complex among plants, animals and yeast. Here the Golgi 
morphology and dynamics in yeast and mammals will be described briefly. 
In mammalian cells, the Golgi complex localised typically around the 
centro somes, where it remains due to a microtubule-dependent mechanism 
(Lippincott-Schwartz, 1998). 
The Golgi complex undergoes fragmentation into hundreds of "islands" 
(known as mini-stacks) when the microtubules are depolymerised by 
specific agents (such as nocodazole). 
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Figure 1.7 The Golgi structure in mammalian cells. Tomographic reconstruction of a 
portion of the Golgi ribbon from a fast frozen , freeze-substitution fixed NRK cells. Two 
serial 4-nm slices extracted from the tomogram are shown in (A) and (8 ). (A) Membranes 
of individual Golgi cisternae (G) are clearly seen. (B) Different cisternae were modelled 
by placing points along the membranes that delimit them. The model viewed in (C) is in 
the same orientation as the tomographic slices (modified from Ladinsky et a\. , 1999). 
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Through conventional or high-voltage EM, the Golgi complex appears as a 
single ribbon-like structure that is composed of a set of flattened parallel 
sacculi (cisternae) arranged into several stacks that are associated with an 
array of small vesicles, as well as with tubules emanating from both sides of 
the stacks (Rambourg and Clermont, 1990). Along its longitudinal axis, the 
Golgi ribbon has structural heterogeneity when examined at higher 
magnifications. Some of its regions are composed of closely apposed and 
poorly fenestrated cisternae; these are described as the "compact" regions 
(or zones). In contrast, other regions consist of highly fenestrated cisternae 
and/or membranous tubules that bridge the adjacent compact zones; these 
are described as the "non-compact" zones (Kepes et al., 2005). The compact 
region of the Golgi ribbon is usually subdivided into three morphologically 
distinct compartments: the cis, medial and trans compartments. 
The cis compartment of the mammalian Golgi complex comprises a tubular 
network that is known as the cis-Golgi network (CGN). It is composed of 
branching tubules that are connected with the highly perforated cis-
cisternae. The CGN receives proteins from the ERGIC, it is involved in the 
retrieval of a subset of proteins back to the ER, and it has a role in the initial 
Golgi-specific addition of carbohydrates to proteins that arrive from the ER. 
In the medial compartment of the mammalian Golgi complex, most of the 
additions of carbohydrate moieties take place. This compartment comprises 
a number of closely apposed, more or less flattened cisternae, which are 
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strictly parallel to each other, and which form the "stacks of cisternae" that 
are characteristic of the mammalian Golgi complex. The number of 
cisternae that form the Golgi stacks varies from one cell type to another 
(three to eight cisternae, in the majority of cases), while the lengths of the 
cisternae frequently depend on the axis of the section. 
The trans compartment and the TGN of the mammalian Golgi complex are 
involved in the terminal glycosylation events of proteins, as well as in cargo 
packaging into the membrane carriers destined for the plasma membrane 
and the endosomal/lysosomal system. The TGN was at fust considered to be 
the trans-most cisternae of the Golgi stack, which is also seen to continue 
into a large anastomosed tubular network. However, different studies have 
indicated the TGN as an entirely independent organelle. Indeed, in some cell 
types, the TGN is positioned at some distance from the trans aspect of the 
Golgi ribbon (Clermont et al., 1995). 
On the other hand, in many cell types, connections between the TGN and 
the stack of cisternae can be easily visualized. Various cargo proteins need 
to be moved within the TGN to the different exit domains where the 
transport carriers are formed. Plasma-membrane-directed proteins leave the 
Golgi complex within Golgi-to-plasma membrane carriers (GPCs), which at 
the EM level have a complex, tubular-saccular morphology (Ladinsky et aI., 
1999). 
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The Golgi complex is the crossroads of many intracellular trafficking 
pathways that is being constantly traversed by huge amounts of proteins and 
membranes, each undergoing its correct processing and following its own 
route, in an amazingly efficient way. In spite of this massive flow of 
material, the typical architecture of the Golgi complex remains almost 
unaltered. How this "highly dynamic" stability is accomplished is largely 
unknown, and thus represents the subject of many studies. 
Indeed, there are conditions in which the Golgi complex loses its 
organisation but not its function. One example is represented by the 
depolymerisation of microtubules with nocodazole, which results in the 
ribbon-breakdown of the Golgi complex in mammalian cells. This does not 
significantly alter Goigi function, since the transport of newly synthesised 
proteins to the plasma membrane continues unperturbed (Cole et al., 1996). 
Microtubules are the major component of the cytoskeleton of mammalian 
cells and they have a vital role in the control of cell morphology and 
function. The microtubules delineate the tracks along which membranes are 
transported during exocytosis and endocytosis, they form the spindle that 
separates the chromosomes during mitosis, and they provide the physical 
strength for maintenance of the shape and internal arrangements of cells. 
Moreover, microtubules have a central role in the perinuclear localization of 
the Golgi complex: agents that alter the distribution of microtubules have 
profound effects on the distribution and integrity of the Golgi complex 
(Thy berg and Moskalewski, 1999). 
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A dramatic example of this is the reversible scattering of the Golgi complex 
during nocodazole-induced microtubule depolymerization, due to the 
binding of nocodazole to the tubulin heterodimers and the successive 
inhibition of their polymerization (Figure 1.8). EM has shown us that these 
fully scattered Golgi fragments are composed of short, stacked cisternae 
that resemble intact Golgi stacks. Notably, the fragmentation of the 
interconnected Golgi stacks and the dispersal of these fragments require 
metabolic energy and continuing membrane trafficking (Turner and 
Tartakoff, 1989). 
As microtubule depolymerisation does not prevent the formation of stacks 
of cisternae, but induces the dispersal of the Goigi complex into "mini-
stacks" in the cytoplasm (Cole et aI., 1996), it might be concluded that these 
Golgi mini-stacks are the minimal requirement for the correct processing 
and transport of cargo proteins. 
Interestingly, the transitional ER sites (tER) redistribute rapidly to form 
clusters next to the Golgi mini-stacks (Hammond and Glick, 2000). 
Another useful tool for the study of the Golgi complex dynamics is the use 
of brefeldin A (BFA). BFA was initially isolated from the fungus 
Penicillium brefeldianum and characterized as an antiviral antibiotic. 
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Figure 1.8 Effect of depolymerizing microtubules on the Golgi apparatus. (A) In this 
endothelial cell, the microtubules are labelled in red, and the Golgi apparatus is labelled in 
green (using an antibody against a Golgi protein) . As long as the system of microtubules 
remains intact, the Golgi is localized near the centrosome, close to the nucleus at the 
center of the cell. (B) After exposure to nocodazole, which cause microtubules to 
depolymerize the Golgi apparatus fragments and is dispersed throughout the cell 
cytoplasm (modified from Alberts et aI. , Molecular Biology of the Cell, fourth edition). 
(C) (Left) In normal cells, tER sites (red) and Goigi structures (green) exchange material 
by microtubule-directed transport (bidirectional arrows). Retrograde transport events 
terminate. This recycling of proteins to the ER causes tER sites to proliferate. (Right) 
When microtubules are disrupted with nocodazole, each Golgi structure receives input 
only from adjacent tER sites, and the number of these sites determines the size and 
stability of the Golgi structure. Conversely, membrane recycling from a given Golgi 
structure induces a localized proliferation of the tER. (adapted from Hammond and Glick, 
2000). 
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BFA gained importance with cell biologists due to the fact that protein 
secretion was inhibited at a very early step in the secretory pathway in BF A-
treated cells. Moreover, the Golgi structure was completely lost by the 
extensive retrograde transport of the Golgi components to the ER, which 
was mediated by the growth of Golgi tubules (Klausner et ai., 1992). 
The mechanism of action of BFA is caused by the inhibition of nucleotide 
exchange on Arf, which prevents the assembly of cytosolic COPI coat 
protein on target membranes. The removal of the coatomer from membranes 
is then followed by the delivery of Golgi enzymes and Golgi proteins to the 
ER (Scheel et al. 1997; Sciaky et al. 1997). 
1.7 The TRAPP complex (Transport Protein Particle) 
1.7.1 Yeast TRAPP complex 
The TRAPP complex was initially characterized in the yeast S. cerevisiae 
by Sacher et al. thirteen years ago (Sacher et aI., 1998, Figure 1.9). Bet3 
was the first member of the TRAPP complex to be identified through its 
genetic interaction with BET1, a gene encoding a SNARE protein that acts 
in ER-to-Golgi transport (Rossi et al., 1995). 
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Figure 1.9 Identification of yeast TRAPPI and TRAPPII. (A) Gel filtration experiment 
showed Trs33p in two high-molecular weight fractions , corresponding to the TRAPP 
complexes (B) Trs65p, Trs 120p and Trs 130p are only found in TRAPP II. Radiolabeled 
Iysates were prepared from an untagged strain (lanes I and 4) and a Bet3p-myc tagged 
strain (lanes 2 and 3), fractionated by gel filtration , and immunoprecipitated using Trs33 p. 
Fractions 9 (lanes 1 and 2) and 13 (lanes 3 and 4) are shown. TRAPP subunits are 
indicated between lanes 2 and 3 (modified from Sacher et aI. , 200 I). 
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Studies using a temperature-sensitive mutant of Bet3 (bet3-i) revealed an 
involvement in the regulation of ER-to-Golgi transport of several cargo 
molecules: invertase, a-factor and carboxypeptidase Y (CPY). These 
cargoes are all soluble proteins that are modified on their passage through 
the different compartments of the secretory pathway. 
Invertase is initially synthesized as a 62-kDa protein that is transformed into 
an 80-kDa form in the lumen of the ER by the addition of oligosaccharide 
units (Moreno et al., 1975). This ER form of invertase accumulates in 
mutants that block trafficking from the ER to the Golgi complex. 
The a-factor is synthesized as a 19-kDa precursor that is subsequently 
converted into a 26-kDa form in the lumen of the ER. The 26-kDa ER form 
is the core-glycosylated molecule that is successively modified inside the 
Goigi complex by the addition of mannose-rich outer chains (Julius et aI., 
1984; Brigance et aI., 2000). Then, a proteolytic process begins in the Golgi 
complex and is completed within the secretory vesicles, after which the 
mature form of the a-factor can be secreted (Julius et al., 1984). 
Finally, CPY is synthesized and translocated into the lumen of the ER (as its 
pI form) before it is transported to and modified in the early (PI' form) and 
late (P2 form) Golgi compartments (Franzusoff and Schekman, 1989; 
Banfield et al., 1995). Proteolytic activation in the vacuole yields the mature 
form (Stevens et al., 1982). 
At 37°C, the bet3-1 mutant accumulated the ER form of invertase (80 kDa), 
the 26-kDa ER form together with a partially glycosylated form of a-factor, 
and finally the pi form of CPY, suggesting a block in ER-to-Golgi transport 
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of these soluble cargo proteins (Rossi et aI., 1995). However, the block of 
ER-to-Golgi transport in this mutant was not complete, since small amounts 
of the pi' CPY form (early Golgi) and small amounts of the Golgi form of 
invertase accumulated inside the cells (Rossi et aI., 1995; Sacher et aI., 
2001), indicating that these proteins proceeded through an initial block 
between the ER and the Golgi complex and were then transported to the 
Goigi. EM analysis of thin sections of the bet3-1 mutant at 37°C revealed 
an accumulation of small and large vesicles and a dilated ER. 
After the identification of the Bet3 protein (Rossi et al., 1995), it emerged 
that it was a member of a large complex (-800) that was named TRAPP 
(Sacher et aI., 1998). Later, gel filtration chromatography revealed the 
presence of two complexes; these were then isolated and identified as 
TRAPP I and TRAPP II (Sacher et al., 2001). Today it is well known that 
TRAPP I is -300 kDa in size and contains six subunits (Trs33p Trs31p, 
Trs23p, Bet3, Trs20p, Bet5p), while TRAPP II is -1,000 kDa and contains 
all of the TRAPP I subunits plus three additional subunits (Trs65p, Trsl20p, 
Trs130p). Additional factors, such as a homolog of Trs20 called Tcal7, may 
also contribute to the formation and functions of TRAPP (Scrivens et al., 
2009; Montpetit et aI., 2009). 
Moreover, recently a third TRAPP complex was identified, the TRAPP III 
complex, involved in the regulation of autophagosome formation (Lynch-
Day et al., 2010). 
Studies on the possible network of interactions between the TRAPP I 
subunits revealed the presence of two subcomplexes (Kim et aI., 2006; 
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Menon et aI., 2006) that according to Kim and co-workers were linked 
together by the TRAPP subunit Trs23 to form a stable six subunit complex 
where the Bet3 subunit is present twice (Kim et aI., 2006). Moreover, 
additional studies have shown the importance of the role of the Bet3 subunit 
in the organization of the TRAPP complex (Kim et aI., 2006; Menon et ai. 
2006). 
TRAPP complex localization was determined by analysis of yeast lysate 
fractions on sucrose density gradients, capable of resolving 
subcompartments of the Golgi complex. TRAPP I and TRAPP II appeared 
to co-fractionate to early Golgi compartments of similar size and density 
(Sacher et al., 2001). Successively, using modified sucrose density gradients 
to better resolve the different compartments of the Golgi complex, it was 
clear that the TRAPP II complex co-fractioned with late Golgilearly 
endosomal markers, indicating the localization of this complex in that 
specific compartment (Cai et al., 2005). 
The first experiments that demonstrated the role of the TRAPP complex in 
vesicle tethering were performed by the Ferro-Novick group (Sacher et aI., 
1998; Barrowman et al., 2000) using an in vitro transport assay (Ruohola et 
al., 1988; Groesch et al., 1990) from permeabilized yeast cells (PYCs) and 
following the glycosylation of a-factor, which in its 26-kDa form marks 
vesicles that bud from the ER. These vesicles, which are formed and 
released from PYCs, are incubated with exogenously added Golgi 
membranes. In the exogenous Golgi, the 26-kDa form of a-factor is 
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converted to a heterogeneous high molecular weight product. This 
conversion of the a-factor can be measured with an antibody (anti-outer 
chain) that specifically recognizes outer chain carbohydrates that are only 
added to the yeast glycoprotein in the Golgi complex. A TP and exogenously 
added cytosol are also required for this assay (Groesch et aI., 1990). Using 
this in vitro assay, they demonstrated that when Bet3-depleted Golgi 
membranes were incubated with vesicles in the presence of Bet3-depleted 
cytosol, the vesicles that formed failed to fuse with the Golgi (Barrowman 
et ai., 2000). Thus, in the absence of Bet3, the budding of the vesicles was 
not blocked, but their tethering to the acceptor membranes did not occur, 
causing a block of vesicle fusion. 
It is of note that reconstitution of the transport activity was possible by 
adding cytosol containing Bet3 (Sacher et al., 1998; Barrowman et al., 
2000). This means that a certain amount of Bet3 is present also in the 
cytosol of the cells and this amount is sufficient to have a partial recovery of 
vesicle docking. In spite of this important fmding, today the yeast TRAPP 
complex is considered to be localized "exclusively" to Golgi membranes 
(Barrowman et al., 2000). 
The concept that the TRAPP complex acted as a tethering factor before 
membrane fusion and thus before SNARE pairing came from the fmding 
that over-expression of SNAREs such as Bosl p, Sec22 (Rossi et al., 1995) 
or Sed5 (Sacher et al., 1998), suppresses the bet3-1 mutant. 
Moreover, the SNARE complex containing the SNAREs Sed5 and Bosl did 
not form in bet3-1 mutant cells (Rossi et al., 1995). These data confirmed 
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that Bet3, and then the TRAPP complex, acts upstream of the SNAREs, i.e. 
during the tethering of the vesicles to the acceptor membranes. More 
precisely, Sacher and co-workers (200 I) demonstrated that TRAPP I 
functions in ER-to-Golgi transport, while TRAPP II functions in intra-Golgi 
trafficking and/or exit from the Golgi (Sacher et aI., 2001). 
Indeed, TRAPPI binds ER-derived COPII vesicles in vitro. As reported by 
Barlowe and co-workers (Barlowe et aI., 1994), when a chemically pure 
TRAPPI was immobilized on IgG-Sepharose beads and COPII vesicles 
were fonned with purified COPII coat components, COPII vesicles bound 
to TRAPPI in a concentration-dependent manner (Sacher et aI., 200 I). The 
finding that this binding was drastically reduced by the addition of GTPyS, 
a non-hydrolyzable analogue of GTP that is known to stabilize the COPII 
coat, led to the suggestion that COPII vesicles must uncoat before TRAPP I 
can bind (Sacher et aI., 2001). 
However, the same group showed subsequently that yeast TRAPPI tethers 
COPII vesicles via an interaction with Sec23, suggesting that vesicle 
tethering precedes vesicle uncoating (Cai et aI., 2007). Indeed, they 
demonstrated that TRAPPI binds efficiently to vesicles fonned in the 
presence of GTPyS. Furthermore, when they stripped vesicles of their 
COPII coat by sedimentation through a sorbitol cushion, TRAPPI loses the 
ability to bind them. Thus, they suggested that ER-derived vesicles 
recognize and bind to their target membrane before uncoating (Cai et aI., 
2007). 
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Recently it has been demonstrated that Bet3 is involved in ensuring the 
sequential directionality of COPII carriers from the ER to the Goigi 
complex (Lord et aI., 2011). Sec23, a component of the inner layer of the 
COPII coat, sequentially interacts with three different binding partners, 
SarI, TRAPPI and Hrr25 , to control the direction of ER-Golgi traffic. 
These interactions should define the three different stages in vesicle traffic: 
budding, tethering and a pre-fusion step (Lord et al., 2011). 
Studies of the components of the TRAPP II complex have shown that a 
trs 130 temperature-sensitive mutant accumulated aberrant Golgi structures 
that had been described in other mutants where the products acted at the 
level of the Goigi complex, like sec-7 and sft I (Sacher et aI., 200 I). 
Moreover, trs130 mutants accumulated Goigi forms of CPY and invertase, 
confirming the role of TRAPP II in late Goigil Goigi exit transport. 
Notably, the trs130 mutant showed synthetic interactions with ret2-1 (a 
mutant with a defect in a COPI subunit), and arflL\ (a mutant that lacks 
Arfl p that is required for COPI vesicle formation), but not with mutants 
defective in COPII subunits, like sec13-I, sec23-1, sec24-1 and sec31-1 
(Sacher et al., 2001). 
Based on these fmding, it was speculated that TRAPP II has a role in the 
binding of retrograde vesicles to the Goigi complex: these vesicles would 
arise from a late Golgi compartment and bind to an earlier Golgi 
compartment (Sacher et al., 2001). Later, mutants in Trs120 were reported 
to mis-localize COPI subunits and a specific, even if weak, interaction 
between TRAPP (purified using the Bet3-tagged subunits that are common 
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to TRAPP I and TRAPP II) and COPI was demonstrated in vitro (Cai et aI., 
2005). However, a mutation in the TRAPP II subunit Trs 120 blocked 
neither invertase secretion nor trafficking of CPY, but showed a defect in 
the recycling of the R-SNARE Snclp (which resides on the plasma 
membrane and moves through the early endosomes before reaching the late 
Golgi), and of the Chs3 enzyme (which has a recycling pathway similar to 
Snclp). Thus, Trs120 appeared to be involved in trafficking from the early 
endosomes to the late Golgi (Cai et aI., 2005). The trafficking of GFP-
Snclp and Chs3-GFP was also defective in trs130 mutants, where, in 
contrast to trs 120 mutants, invertase and CPY transport were also affected. 
Therefore, Trs130 may be required at multiple steps on the secretory and 
endocytic pathways, whereas Trsl20 appears to be required only in the 
endocytic pathway. Given these differences between trsl20 and trs130 
mutants, one possibility is that Trsl20 acts independently of the TRAPP II 
complex. However, the quantitative depletion of Bet3 from lysates was also 
shown to result in the complete depletion of Trs120 and Trs130 (Cai et aI., 
2005), suggesting that Trsl20 is a part of the TRAPP II complex. 
Trs85 is another TRAPP subunit that appears to act independently of the 
TRAPP I and TRAPP II complexes. This subunit is a non-essential 
component of TRAPP, as it is dispensable for yeast growth, and its absence 
does not block the early secretory pathway. Trs85 appears to be required for 
the biogenesis of Cvt vesicles (cytoplasm to vacuole targeting; Meiling-
Wesse et al., 2005). The Cvt pathway was discovered as a variant of 
starvation-induced non-selective autophagy, and in contrast to the 
degradative autophagic pathway, it acts under nutrient-rich conditions as a 
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biosynthetic route that delivers specific cargo proteins to the vacuole. ~trs85 
cells are defective in the biogenesis of Cvt vesicles and in the recruitment of 
the GFP-Atg8 protein (that has an essential role during the formation of Cvt 
vesicles) to the pre-autophagosomal structure (PAS). Moreover, these cells 
show a defect in the organization of the PAS. 
According to the "maturation model" for the formation of the PAS, the 
components of the PAS travel through the ER and Golgi complex and are 
segregated in a specific compartment. This compartment matures into the 
PAS by retrograde transport of specific proteins and lipids back to the donor 
compartment. A block in a retrograde transport step would then result in the 
generation of a premature PAS, which would probably not be able to recruit 
GFP-Atg8 and would thus be unable to fulfil its function (Reggiori et aI., 
2004). This is exactly what occurs in ~trs85 cells, suggesting a role for this 
TRAPP subunit in the retrograde transport step during the generation of the 
PAS (Meiling-Wesse et al., 2005). 
1. 7.2 The Guanine exchange activity o(the TRAPP complex 
The yeast TRAPP complex has been shown to act as a nucleotide exchange 
factor for the YptlRab family of small GTP-binding proteins that cycle 
between their GDP-bound and GTP-bound forms through nucleotide 
exchange and GTP hydrolysis, respectively. It was known previously that 
Yptl, which encodes a small GTP-binding protein that regulates ER-to-
Golgi membrane trafficking, interacted genetically with the Bet3 and BetS 
genes, and its over-expression suppressed the bet3-1 mutation (Rossi et aI., 
1995; Jiang et aI., 1998). Further studies have demonstrated that TRAPP can 
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stimulate guanine nucleotide exchange on Yptlp (the yeast homologue of 
mammalian Rabl), suggesting a role for TRAPP as a GEF for Yptlp (Wang 
et aI., 2000). 
Biochemical analysis confirmed that purified TRAPP can bind to the 
nucleotide-free form of Yptlp and stimulate GDP release (Wang et aI., 
2000). After the characterization of the TRAPP I and TRAPP II complexes, 
it was then shown that both of the TRAPP complexes can stimulate the 
uptake of GTPyS onto Yptlp, and thus both can exchange nucleotides on 
this small GTP-binding protein (Sacher et aI., 2001). 
The architecture of the TRAPP I complex was solved and the minimal 
complex core needed for the exchange factor activity was identified (Kim et 
aI., 2006, Figure 1.10). This minimal unit consists of Bet5-Trs23-Bet3-
Trs31 and is capable of releasing the nucleotide specifically from Ypt 1 p, 
suggesting that TRAPP I is a GEF for Yptlp and not for Ypt31132 (Kim et 
aI.,2006). 
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Figure 1.10 TRAPP complex acts as a guanine exchange factor. (A) Nucleotide 
exchange activity was assayed for recombinant TRAPPI (BetSp-Trs23p-Bet3p-Trs31 p-
Trs20-Trs33, purple line), BetSp-Trs23p-Bet3p-Trs31 p (red line), BetSp-Trs23p (double 
mutant TI36EN I 83D)-Bet3p-Trs31 p (green line), Dss4p (protein with a broad pectrum 
of GEF activity; cyan line), or Yptl p alone (blue line) . Beyond the recombinant TRAPPI 
(I), the minimal unit required for GEF activity is Bet5-Trs23-Bet3-Trs3 l (2). Notably, 
Trs20-sedlin is not required for the minimal GEF activity of the TRAPP complex 
(modified from Kim et aI., 2006). (B) Crystal structure of the mammalian TRAPP 
complex (modified from Cai et aI. , 2008). 
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On the other hand, the TRAPP complex was also identified to act as a 
nucleotide exchanger not only for Yptl p but also for Ypt31132, a functional 
pair of GTPases that are essential for exit from the trans-Golgi (Jones et ai., 
2000). Indeed, TRAPP stimulated both GOP release and GTP uptake by 
Ypt32p, and to a lesser extent, by Ypt31. The ability of the TRAPP complex 
to act as a GEF for Ypt31132 was previously excluded by Wang and co-
workers (Wang et ai., 2000), who successively confirmed that chemically 
pure TRAPP stimulated guanine nucleotide exchange selectively on Yptlp 
but not on Ypt32p (Wang and Ferro-Novick, 2002). The different results 
obtained by these two groups could be due to their different methods of 
TRAPP purification. This issue is still hotly debated. 
Intriguingly, TRAPP III complex has been shown also to act as an exchange 
factor for Yptl during autophagy processes (Lynch-Day et aI., 2010). The 
Trs85 subunit of the TRAPPIII complex directs this Yptl GEF to the 
phagophore assembly site (PAS) that is involved in autophagosome 
formation. Consistent with the observation that a Yptl GEF is directed to 
the PAS, Yptl was found to be essential for autophagy. This finding 
represents the first example of aRab GEF that is specifically required for 
canonical autophagosome formation (Lynch-Day et al., 2010). 
1. 7.3 The mammalian TRAPP complex 
The TRAPP complex in mammalian cells was first isolated in HeLa cells by 
gel filtration analysis as a 670 kDa complex (Sacher et aI., 2001). 
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As mentioned above, S. cerevisiae TRAPP I consists of BetSp, Trs20p, 
Bet3p, Trs23p, Trs31 p, and Trs33p (Sacher et aI., 1998; Sacher et aI., 2000; 
Sacher et aI., 2001), with the mammalian orthologues named TRAPPC}, 
TRAPPC2 (sedlin), TRAPPC3 (Bet3), TRAPPC4 (synbindin), TRAPPCS, 
and TRAPPC6aJb, respectively (Sacher et aI., 2008). 
Together with the so-called "human Bet3 complex", i.e. the human TRAPP 
complex, gel filtration revealed an additional peak with Bet3 and sedlin 
suggesting the presence of a free pool of TRAPP subunits, since the peak-
size was coherent with the monomeric size of Bet3 and sedlin (Sacher et aI., 
2000). This finding was in apparent contrast to what was observed in yeast, 
where no free pool of any of the subunits was detected. One possibility is 
that in higher eukaryotes, TRAPP subunits exert several functions 
independently of the complex. 
However, as in yeast, the mammalian TRAPP complex was resistant to 
extraction by Triton X-lOO, suggesting that it is anchored to a Triton X-lOO-
resistant matrix in the cell (Sacher et al., 2000). Adopting the TAP 
methodology, the other TRAPP subunits were identified (Gavin et al., 
2002). 
All TRAPP subunits except Trs65 are conserved from yeast to mammals 
(Sacher et al., 2008). 
The primary and secondary structures of the two essential TRAPP II 
subunits Trs120 and Trs130 are conserved from yeast to man (Cox et ai. 
2007), whereas the non-essential Trs65 is conserved only among some 
unicellular eukaryotes. Indeed, it has been suggested that TRAPP II, like 
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TRAPP I, is a conserved complex, and that the function of both of their 
TRAPP complexes in their regulation of trafficking through the Golgi 
complex is also conserved (Cox et ai., 2007). The mammalian homologue of 
Trs120 has been identified as the NIBP/TRAPPC9 protein, which is a 
protein that when mutated cause postnatal mental retardation with 
microcephaly (Philippe et ai., 2009; Mochida et ai., 2009), while 
TMEMIIEHOCI (TRAPPClO) has been identified as the Trs130 
orthologue. This protein was previously identified by TAP methodology 
(Gavin et aI., 2002), and it is a candidate for several human disorders, 
including certain types of epilepsy (Cox et al., 2007). 
Recently, a distantly related human sequence C50rf44 (FLJ13611) was 
identified as the human orthologue of Trs65. This sequence was shown to 
interact with a number of known mammalian TRAPP subunits (Choi et aI., 
2011). 
Moreover, two novel TRAPP proteins, C40rf41/Gryzun (now designated 
TRAPPCll) and TIC-15 (now designated TRAPPC12) were identified 
throughout eukarya including diverse fungi, but they are absent in S. 
cerevisiae (Scrivens et aI., 2011). 
However, since the conclusions of Cox and co-workers (2007) were based 
on sequence and predicted secondary structure analyses and are not 
supported by any in vivo evidence, the existence of a mammalian TRAPP II 
remains still remains to be proved. 
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Instead, mammalian TRAPP proteins elute as a single high-molecular-
weight complex, suggesting the absence of a small complex equivalent to 
TRAPP I (Loh et aI., 2005; Scrivens et aI., 2008; Yamasaki et aI., 2009). 
Among the human TRAPP subunits, some have been previously identified 
in other contexts, such as sed lin (human homologue of Trs20) and synbindin 
(human homologue of Trs23). 
Sedlin was previously known as the protein associated with the 
pathogenesis of Spondyloepiphyseal Dysplasia Tarda (or late; SEDT), (see 
below). Synbindin was identified as a protein that is expressed in neuronal 
cells and that co-localizes with the cell-surface heparan sulfate proteoglycan 
Syndecan-2 in the spines of cultured hippocampal neurons (Ethell and 
Yamaguchi, 1999; Ethell et aI., 2000). Its homology with the TRAPP 
subunit Trs23 suggested a role in membrane trafficking for synbindin. 
The most conserved of the TRAPP subunits is Bet3, and its crystal structure 
and possible role in mammalian membrane trafficking have been 
determined. Moreover, the finding that this subunit, and probably the entire 
mammalian TRAPP complex, is mostly localized in the cytosol of 
mammalian cells (Loh et al., 2005), suggests that there are some differences 
in the roles and functions of the mammalian TRAPP complex as compared 
with the yeast TRAPP complex. 
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Although the understanding of mammalian TRAPP (mTRAPP) lags behind 
that of yeast TRAPP (yTRAPP), yTRAPP and mTRAPP have both common 
and distinctive features. Both yTRAPP and mTRAPP are required to 
maintain the organization of the Golgi complex (Barrowman et aI., 2000; 
Yu et al., 2006) and possess guanine nucleotide-exchange (GEF) activity for 
the small GTPases Yptl and Rabl, respectively (Wang et aI., 2000; 
Yamasaki et aI., 2009). In contrast, mTRAPP is implicated in the homotypic 
tethering of ER-derived vesicles (Yu et al., 2006), while yTRAPPI is 
required for the heterotypic tethering of the ER-derived COPII vesicles to 
Golgi membranes (Sacher et al., 2001, Figure 1.11). 
Despite these attempts to describe a possible function of the mammalian 
TRAPP complex, very little data are available to date. Mammalian TRAPP 
is involved in homotypic fusion of COPII carriers (Yu et al., 2006; Cai et 
al., 2007; Lord et aI., 2011), mediates the guanine exchange factor for Rabl 
(Yamaski et aI., 2009) and recently TRAPP has been implicated in 
ciliogenesis (Westlake et al., 2010). 
Indeed, most of the available information regards the mBet3 subunit, the 
most conserved subunit of the TRAPP complex (Loh et al., 2005), while 
little is known about the other mammalian TRAPP subunits. 
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Figurel.)] A model for heterotypic and homotypic COPII vesicle .(Left) In heterotypic 
tethering, yeast TRAPP} acts as a tethering factor on ER-derived vesicles, allowing their fusion 
to the Golgi through via a direct interaction with Sec23p. Coat complexes dissociate from 
vesicles, followed by the formation of trans-SNARE pairs and membrane fusion. (Right) In 
homotypic vesicle tethering, TRAPPI links two COPII-coated vesicles via an interaction 
between mBet3 and mSec23 (modified from Cai et aI., 2007). 
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1. 7.4 Sedlin and Spondyloepiphyseal Dysplasia Tarda (SEDT) 
The mammalian TRAPP complex subunit sed lin (TRAPPC2, human 
homologue of yeast Trs20) was first identified as the protein coded by the 
gene SEDL. This gene appeared to be truncated/mutated in males affected 
by Spondyloepiphyseal Dysplasia Tarda (SEDT) or late (Gedeon et aI., 
1999). 
The term spondyloepiphyseal dysplasia (SED) defines a heterogeneous 
group of disorders, which share typical radiographic defects of the vertebral 
bodies and epiphyseal regions. Frequent additional features are short stature 
and early development of degenerative joint disease. SED has been divided 
into a severe congenita and a more benign tarda form reflecting the broad 
range of clinical severity. The genetic background responsible for its onset 
is variable and it is associated with autosomal dominant, autosomal 
recessive, or X-linked recessive modes of inheritance. Several genes have 
been found to be mutated in patients affected by spondyloepiphyseal 
dysplasia. Collagen type II, the most abundant collagen of cartilage, is 
mutated in autosomal dominant forms of SED (Spranger et aI., 1994) or 
spondylo-epimetaphyseal dysplasia (SEMD) Strudwick type (Tiller et aI., 
1995). Since collagen type II is also a component of the vitreous humor, 
these patients may have additional ophthalmological problems, like severe 
myopia and/or retinal detachment. A rare autosomal recessive form of SED 
associated with insulin-dependent diabetes mellitus (Wolcott-Rallison 
syndrome) has been attributed to mutations in the translation factor 
EIF2AK3 (Delepine et aI., 2000). In another autosomal recessive form of 
SEMD, mutations have been described in the A TPSK2 gene that is involved 
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In sulfate activation (Faiyaz ul Haque et aI., 1998). X-linked 
spondyloepiphyseal dysplasia tarda (SEDT) is a mild variant with 
moderately short stature, barrel chest deformity and minor epiphyseal 
alterations, but characteristic, vertebral body dysplasia comprising 
platyspondyly and a central hump (lceton and Home, 1986; Whyte et aI., 
1999). Degenerative joint disease is common in male patients and often 
makes hip replacement necessary in the fourth or fifth decade. Mutations in 
WISP3 cause progressive pseudorheumatoid dysplasia (PPD; Ehl et aI., 
2004, Hurvitz et aI., 1999), an autosomal recessive form of a 
spondyloepiphyseal dysplasia tarda. Individuals with PPD appear normal at 
birth, have subtle clinical symptoms by 3 years of age, manifest radiologic 
changes of the axial and appendicular skeleton by 5 years of age, and 
develop severe degenerative joint disease necessitating joint replacement 
surgery by their second decade of life. 
Spondyloepiphyseal dysplasia tarda (SEDT, MIM 313400) is a rare 
recessive X-linked osteochondrodysplasia that results in short stature, 
flattening of the vertebrae and premature osteoarthritis, with the absence of 
systemic complications (Gedeon et aI., 1999). 
As outlined by the name, SEDT is a late onset skeletal disorder, which 
manifests in childhood, with the usual age of presentation being after the 
first decade of life. It is caused by mutations in the Sedlin gene (SEDL) 
located on Xp22.12-p22.31 (Gedeon et al., 1999). Carrier females appear to 
be asymptomatic, while the development of SEDT in affected males appears 
normal until just before puberty, when longitudinal growth slows, with the 
appearance of a "barrel chest" deformity. Following malformation of the 
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growing vertebrae, intervertebral disks deteriorate and may appear absent 
later in life. Patients develop joint pain and limited mobility. 
Most of the disease-associated mutations that have been identified 
throughout the SEDL gene are splice alterations, insertions and deletions 
that can lead to premature termination signals and truncated proteins 
(Gedeon et al., 2001), while only four missense mutations have been 
described (Figure 1.12). No apparent correlation between genotype and 
phenotype was detected. 
Five Y -chromosome-linked and another two pseudogenes of SEDL have 
been reported (Gecz et aI., 2000). One of these pseudogenes is SEDLP1, 
located on chromosome 19, which has been described as a transcribed 
pseudogene. More precisely, two different transcripts were identified by 
Northern-blot hybridization (Gedeon et al., 1999): one at approximately 2.8 
kb, encoding the X-linked SEDL, and the other at approximately 0.75 kb, 
encoding the truncated transcript of the chromosome 19 pseudo gene 
(SEDLP1). The two sequences have only six nucleotide differences in the 
ORF, none of which alter the amino-acid sequence. 
SEDL and SEDLPI are expressed in a wide range of tissue/cell types, 
showing their highest expression levels in kidney, heart, skeletal muscle, 
liver and placenta (Mumm et aI., 2001; Figure 1.13). The most striking 
difference between SEDL and SEDLPI is the absence of SEDLPI 
expression in skeletal muscle (Ghosh et al., 2003). 
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Figure 1.12 Sedlin mutations responsible for the onset of SEDT disease. Schematic 
representation of the sedlin gene (6 exons) and of the SEDT isolated mutations into the 
sedlin gene. Mutations are spread all over the sedl gene: there is no evident correlation 
between phenotype and genotype (adapted from Shaw et aI. , 2003). 
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Despite the ubiquitous expression of these two genes, the SEDT phenotypes 
are very specific. However, since SEDL and SEDLPI are under the control 
of different promoters, the lack of phenotypic effects in different tissues 
could be due to a function attributable to SEDLPI. 
SEDLPI was also isolated via a yeast two-hybrid analysis as a cDNA where 
the protein product was seen to interact with the c-myc promoter-binding 
protein 1 (MBP-I), and to relieve the activity of MBP-I as a transcriptional 
repressor (Ghosh et aI., 2001). This protein was thus defined as MIP-2A, 
standing for "MBP-I interacting protein-2A". MBP-l negatively regulates 
both human and mouse c-myc promoter activity and its ectopic expression 
induces cell death, reduction of c-myc expression and regression of tumour 
growth. 
MIP-2A was identified also as a transcriptional repressor of MBP-l that 
antagonized MBP-I-mediated cell death, suggesting a functional interaction 
between MIP-2A and MBP-I in cell growth regulation. 
This interaction of sedlin with the transcriptional repressor MBP-I is 
interesting in light of the finding suggesting that truncated sedlin 
accumulates in or around the nucleus (Gecz et aI., 2000). This could suggest 
that full-length sedlin may cycle in and out of the nucleus during its 
itinerary which would make interaction with nuclear proteins a likely 
possibility (Sacher, 2003). Thus, the interaction with MBP-I raises the 
intriguing possibility of a dual function for sedlin, both in membrane 
trafficking and in the regulation of gene expression. 
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Indeed, it has been reported that MIP-2A acts as a transcription factor by 
inhibiting the transactivation of the luteinizing hormone-p (LHb) promoter 
that is mediated by the SF-l nuclear receptor and by the pituitary homebox 
1 (Ptxl) protein (Ghosh et aI., 2003). In addition, sedlin mutations disrupt 
the interactions with Ptxl and SFl suggesting a potential cause of delayed 
puberty in boys with SEDT (Jeyabalan et aI., 2007). Thus, a role for 
sedlinIMIP-2A in the regulation of gene expression appears plausible. It 
would be of interest to determine whether sedlin interacts with chondrocyte-
specific factors involved in transcription. 
Another sedlin interactor has been identified by yeast two-hybrid screening. 
This screening reported an interaction between sedlin and a chloride 
intracellular channel proteins-l (CLIC1; Fan et ai., 2003). The CLICs have 
been reported to be present in membranes of the ER, mitochondria and 
nucleus. They are involved in the homeostasis of cell membrane potential, 
substance transfer, and maintenance of intracellular pH and cell volume. 
Considering their extensive homologies but distinct localizations, different 
CLICs may function similarly at distinct locations. 
CLICl is a transmembrane protein that is sufficient to form a functional ion 
channel as a tetrameric assembly of subunits. Fan and co-workers (2003) 
demonstrated that GFP-CLICI co-immunoprecipitated with FLAG-sedlin. 
Moreover, both proteins co-localized extensively in cytoplasmic vesicular/ 
reticular structures in COS-7 cells, suggesting their interaction at 
intracellular membranous organelles (Fan et al., 2003). According to this 
study, since both sedlin and CLIC are membrane-associated proteins, their 
interactions might be important either for functions of the TRAPP complex 
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or for the proper targeting and functions of the intracellular chloride 
channels. However, the implications of this interaction in the development 
in the SEDT remain to be established. 
Very recently, a new sedlin interactor was identified, SP A T A4, a 
spermatocyte-specific protein of unknown function (Duarte et aI., 2011). 
The implications of this novel interactor with sedlin functioning and the 
onset of the disease have still to be elucidated. 
From the few studies that have appeared to date, the specific role of sedlin is 
still unknown. The link to collagen transport has also been proposed as 
sedlin is part of the TRAPP complex that is involved in secretory 
trafficking. 
Indeed, Sedlin has 34% identity with the yeast TRAPP subunit Trs20. 
Moreover, the human Sedlin gene can complement the lethality caused by 
deletion of the Trs20 gene, illustrating conservation of function (Gecz et al., 
2003). Interestingly, although the different SEDL mutations display the 
same clinical phenotype, expression of three of the four missense mutations 
that are associated with the development of SEDT have shown that one of 
the mutations could not complement the yeast deletion, while the other two 
led to very subtle effects on yeast growth (Gecz et aI., 2003). 
The involvement of sedlin in membrane trafficking is also confirmed by the 
finding that its structure suggests a role in regulatory or adaptor functions 
via multiple protein-protein interactions (Jang et al., 2002). Indeed, despite 
having no sequence homology, the crystal structure of sedlin reveals a 
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similarity to the structures of the N-terminal regulatory domain of two 
SNAREs, Ykt6 and Sec22, suggesting a possible interaction between sedlin 
and SNAREs (Jang et aI., 2002; Figure 1.13). 
Recently, the relative position of sedlin inside the TRAPP I complex has 
been described: sedlin occupies a peripheral position in the complex and its 
yeast homologue Trs20 is not required for the GEF activity of the TRAPP 
complex (Kim et aI., 2006). However, despite these structural insights into 
the sedlin protein, its function remains completely unknown. In particular, 
the role of sedlin and how it operates in membrane trafficking, whether it 
has other functions, and how these result in the development of SEDT 
remain open questions. 
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Figure 1.13 Sed lin: gene expression and protein structure. (A) Pattern of mRNA 
expression from several tissues. Sedlin is ubiquitously expressed, as its pseudogene 
located on chromosome 19 (modified from Gecz et ai. , 2003). (8) Superimposition of the 
sedlin structure and Ykt6p-NT (140 residues). (C) Superimposition of the sed1in and 
mSec22b-NT (127 residues, modified from Jang et aI., 2002). 
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Chapter 2 
Materials and Methods 
2.1 Cell culture 
2.1.1 Materials 
Hepatocellular carcinoma (HepG2), NRK fibroblasts (NRK49F) and HeLa 
cells were bought from American tissue type collection (A TIC, number 
HB-8065, CRL-1570 and CCL-2, respectively). 
Human fibroblasts (HFs) were kindly provided by Dr. M. De Luca, Istituto 
Dennatologico dell' Immacolata, Rome, Italy. 
Rat chondrosarcoma chondrocytes (Rx chondrocytes) were provided by J. 
Kimura and B. Vertel. 
Primary fibrobalsts isolated from SEDT patient were provided by the 
Genetics Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni 
Rotondo, Foggia, Italy. 
Dulbecco's Modified Eagles Medium (DMEM), Minimum Essential 
Medium (MEM), RPMI-1640 Medium, Foetal Calf Serum (FCS) and Calf 
74 
Serum (CS), penicillin, streptomycin, trypsin-EDTA, non-essential amino 
acids (NEAA) and L-glutamine were from GIBCOTM (Invitrogen, USA). 
All these reagents were lOx stock solutions. All the plastic materials were 
from Corning (USA). Filters (0.45 and 0.2 Jlm) were from Amicon (USA). 
2.1.2 Propagation of cell lines 
2.1.2.1 Growth media 
Rx chondrocytes and HeLa cells were grown in DMEM supplemented with 
4.5 gil glucose, 2 mM L-glutamine, 1 U/ml penicillin and streptomycin, and 
10% FCS. HepG2 cells were grown using MEM supplemented with non-
essential amino acids (NEAA) and 4.5 gIl glucose, 2 mM glutamine, 1 Ulml 
penicillin and streptomycin, and 10 % FCS. HFs were grown in DMEM 
supplemented with 4.5 gil glucose, 2 mM L-glutamine, 1 U/ml penicillin 
and streptomycin, and 10% CS. Primary fibroblasts (control and SEDT 
isolated cell lines) were grown in RPMI-1640 supplemented with 4.5 gil 
glucose, 2 mM L-glutamine, 1 Ulml penicillin and streptomycin, and 10% 
FCS. 
2.1.2.2 Growth conditions 
All cell lines were grown in a controlled atmosphere in the presence of 5% 
CO2 at 37°C. Cells were grown in a flask to 80-90% confluence. The 
medium was removed and trypsin-EDTA solution (0.05% trypsin, 0.02% 
EDTA) was added for 3-5 min at 37°C. The medium was added back to 
block the protease action, cells were collected into a plastic tube and 
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centrifuged for 5 min at 2000 x g. The pellet was resuspended in fresh 
medium and placed in a new plastic flask. 
2.1.2.3 Establishment of primary fibroblast cultures from a SED! patient 
This procedure was carried out by Dr. Zelante (IRCCS Casa Sollievo della 
Sofferenza, San Giovanni Rotondo, Italy). 
Briefly, cutaneous specimens were placed in RPMI 1640 medium without 
serum immediately after biopsy removal, repeatedly washed with PBS and 
placed in a 30 mm Petri dish. The specimens were then fragmented in 1-2 
mm pieces and transferred to flasks containing D-MEM (Invitrogen) 
supplemented with 10% Foetal Bovine Serum (FBS, Invitrogen), 100 
units/ml penicillin and 1 00 ~g/ml streptomycin. Primary cultures were 
incubated at 37°C in 5% C02 humidified atmosphere, and 5 ml of complete 
medium were added 24 hours later. After one week primary cultures were 
washed with PBS to remove non-adherent fragments and fresh medium 
prewarmed at 37°C was added. These procedures were repeated every 3 
days until primary cultures reached local confluence. The mutational 
analysis of the sedlin gene was carried out as follows by Dr. Zelante. 
Coding exons 3-6 (including exonlintron boundaries) of the SEDL gene 
were amplified by PCR under standard conditions using the primers for 
genomic PCR amplification and sequencing described in Gedeon et al. 
(1999). PCR products were purified using an ExoSAP IT Kit (USB 
Corporation, GE Healthcare) and sequenced using a Big Dye Terminator 
ready reaction Kit (PE Applied Biosystems, CA, USA) according to the 
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manufacturer's specifications, on an ABI PRISM 3100 Genetic Analyzer 
(Applied Biosystems). 
2.2 Preparation of recombinant proteins and affinity-purified 
polyclonal antibodies 
The following procedures were carried out in collaboration with G. Di 
Tullio and M. Santoro (Consorzio Mario Negri Sud, Italy and TIGEM, 
Italy). 
2.2.1 Materials 
Restriction endonucleases were purchased from Amersham Phannacia Bio-
Tec (UK). The pEGFP-N, pEGFP-C vectors were purchased from Clontech 
(USA). 
Gluthathione, lysozyme, IPTG, sodium azide, Triton X-lOO, Freund's 
adjuvant, potassium acetate, RbCI, CaCh, MnCh were from Sigma 
Chemical Co. (MO, USA). The gluthathione sepharose resin and the 
pGEX-4T vectors were from Phannacia Bio-Tec, UK. Leupeptine, 
benzamidine, and PMSF (Protease Inhibitors Cocktail, PIC) were from 
Sigma Chemical Co. (MO, USA). 
The human Bet3 cDNA was purchased from the I.M.A.G.E Consortium 
(I.M.A.G.E clone 3051295). 
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pGEX-4T-Synbindin was kindly provided by Dr. Yu Yamaguchi (The 
Burnham Institute, La Jolla, California; Ethell et aI., 2000). 
GFP-Sedlin, with the GFP at the amino-terminus of the protein, was kindly 
provided by J.Gecz (Centre for Medical Genetics, Department of 
Cytogenetics and Molecular Genetics, Women's and Children's Hospital, 
Australia, (Gecz et aI., 2000). 
The DNA-oligonucleotides were purchased from SIGMA-Genosys Ltd. 
Tris (hydroxymethyl) aminomethane (TRIS), lysozyme, RbCI, MgCh, 
MnCh, 4-morpholinepropanesulfonic acid (MOPS), agarose, kanamycin, 
chloramphenicol and the SIGMA GenElute plasmid miniprep kit for mini-
scale plasmid DNA preparation were purchased from SIGMA (USA). The 
Qiagen plasmid kit for large-scale plasmid DNA preparation and the 
QIAEX® II kit were purchased from Qiagen (USA). BL21 DE3 E.coli 
bacteria were purchased from Novagen (Merck, Germany). XLI-blue E.coli 
bacteria were purchased from Stratagene (USA), T4 DNA ligase from 
Promega (USA), agar from GIBCOTM (Invitrogen, USA), ampicillin and 
kanamycin from Fluka (SIGMA, USA), glycerol from Merck (Germany), 
and isopropyl-p-D-thiogalactopyranoside (IPTG) from Calbiochem (Merck, 
Germany). Yeast extract and tryptone peptone were purchased from DIFCO 
(USA), DNase from Boeringher Mannheim (USA) and the Bio-Rad Protein 
Assay Kit from Bio-Rad (USA). 
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2.2.2 Sub-cloning 
The PstlIBamHI restriction sites were inserted in the Bet3 I.M.A.G.E clone 
by PCR reaction using the pnmers 
GCGCTGCAGATGTCGAGGCAGGCGAACCGT (Pstl forward primer) 
and GCGGGATCCTT ATTCCTCTCCAGCTGG (BamHI reverse primer). 
After its purification with the JET-QUICK® PCR Purification Spin Kit 
(GENOMED,USA) the product of PCR-reaction was ligated in frame with 
the pGEX vector, previously digested with the same restriction enzymes, by 
using the T4 DNA ligase (30 finol of the product of PCR-reaction were 
ligated with 10 finol of the purified PstIlBamHI pre-digested vector). 
The pGEX4T2-Sedlin was obtained by excision of Sedlin-insert from the 
pEGFP-CI-Sedlin vector digested with BglII and SalI restriction enzymes, 
and the insert was subsequently ligated in frame with the pGEX4T2 vector 
previously digested with the BamHI and Sail restriction enzymes. 
The products of ligation were used to transform competent bacteria. On the 
following day, some isolated bacterial colonies for each construct were 
picked up and used to inoculate 2 ml of LB-broth containing 50~g1ml of the 
appropriated antibiotic. The culture was incubated at 37°C overnight. Seven 
hundred and fifty ~l of sterile glycerol were added to 750 ~l of bacterial 
culture and stored at -80°C. Bacteria cultures were used to prepare cDNAs 
(section 2.7.1) and these were digested for 3 hat 37°C with the respective 
restriction enzymes in order to verify the presence of the inserts. Moreover, 
the obtained plasmids were sent to be sequenced by MWG Biotech (Italy). 
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The full-length Sec23 coding sequence was inserted into the BglIIlXhoI 
sites of the vector pEGFP-C2 (Clontech Laboratories). TRS31 was 
purchased from imaGenes GmbH ( IMAGE number 4869377). The CD8 
cDNA was kindly provided by Professor Stefano Bonatti. Rab 1 b-GFP was 
a kind gift of the Alvarez lab. 
2.2.3 Preparation of competent cells 
Competent bacterial cells were prepared with the help of G. di Tullio 
(Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy). 
A single colony of XL-I Blue E. coli bacteria was picked from aLB-agar 
plate (10 gil NaCl, 5 gil yeast extract, 10 gil tryptone peptone and 15 gil 
agar) and used to inoculate 10 ml of LB-broth (10 gil NaCI, 5 gil yeast 
extract and 10 gil tryptone peptone). Bacteria were grown overnight, then 
diluted in 190 ml of fresh LB broth and incubated at 37°C until the optical 
density (OD) reached 0.5 (at 1..=600 nm). Bacteria were harvested by 
centrifugation at 6,000 rpm in a JAIO rotor for 10 min at 4°C. The bacterial 
pellet was resuspended in 40 m1 of 30 mM potassium acetate, 100 mM 
RbC1, 10 mM CaCh, 50 mM MnCh, 15% (v/v) glycerol, pH 5.8, and left 
on ice for 2 h. After centrifugation and resuspension of the pellet in 4 ml of 
10 mM MOPS, 75 mM CaCh, 10 mM RbCI, 15% (v/v) glycerol, pH 7, 
cells were stored at -80°C in 400 JlI aliquots. 
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2.2.4 TransfOrmation of bacteria by heat shock 
The plasmid cDNA of interest (10 ng) was added to 200 III of competent 
bacteria previously thawed on ice. After gentle mixing, cells were left on 
ice for 30 min, heat shocked for 90 sec at 42°C and, after addition of 800 III 
LB broth, incubated with shaking at 37°C for 45 min. Bacteria were plated 
on LB-agar containing the appropriate selective antibiotic and incubated 
overnight at 37°C. The following day, an isolated bacterial colony was 
picked and used to inoculate 2 ml of LB-broth containing the appropriate 
antibiotic. The culture was incubated at 37°C overnight. For storage, 750 III 
of sterile glycerol were added to 750 III of bacterial culture and stored at -80 
°e. 
2.2.5 Expression and purification ofGST-(usion proteins 
A single colony of E. coli transformed with a pGEX vector containing the 
GST-fusion protein of interest was used to inoculate 100 ml of LB broth. 
The bacterial culture was grown to an OD6oo of 0.6. Expression was 
induced with 1 mM IPTG for 3 h at 37°C. Bacteria were harvested by 
centrifugation (6000 rpm, JAlO rotor, Beckman, eA, USA) for 10 min at 
4°C. The bacterial pellet was resuspended in 25 ml of 20 mM Tris-HCI pH 
8,0, 100 mM NaCl, 1 mM EDTA, 1 mg/ml lysozyme in the presence of a 
cocktail of protease inhibitors (leupeptin, benzamidine, and PMSF). 
TritonX-lOO was added to a final concentration of 1% and the suspension 
agitated continuously for 30 min, and then sonicated for 2 min on ice. The 
lysed bacteria were centrifuged for 20 min (1800 rpm, JA20) and the pellet 
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discarded. Meanwhile, 2.5 ml of a glutathione-Sepharose resin were diluted 
to 40 ml and centrifuged (2000 x g) for 5 min. The supernatant was 
discarded and the resin was resuspended in PBS. This procedure was 
repeated twice. The cleared bacterial lysate was then added to the 
glutathione-Sepharose resin, and incubated for 30 min at 4°C with 
occasional agitation. The beads were washed 3 times with 50 ml of PBS 
and packed onto a column. The resin was allowed to pack for 10 min, and 
the protein was eluted with 1 ml of elution buffer (100 mM Tris-HCI, 20 
mM gluthathione, 5 mM DTT). The eluate was collected and this operation 
was repeated an additional five times. The protein content of each of the six 
fractions collected was analysed by SDS-PAGE and fractions containing 
the higher protein concentration were pooled together and stored in 
aliquots. 
2.2.6 eDNA mutagenesis 
2.2.6.1 Materials 
The QuickChange® Site-Directed Mutagenesis Kit and Dpn I restriction 
enzyme were purchased from Stratagene (USA). 
2.2.6.2 Site-directed mutagenesis 
Mutagenesis was performed using pGEX-4Tl-Sedlin as a template in order 
to generate two sedlin mutants, H13A and de1387A. 
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The mutagenic oligonucleotides containing the desired mutation were 
designed following the instructions of the QuickChange® Site-Directed 
Mutagenesis Kit (Stratagene, USA) manual: 
SedlinH 13 A (+) 
5'-CTACTTTGT AA TTGTTGGCCACGCTGAT AA TCCAGTTTTTGAAA 
TGGAG-3' 
SedlinH13A (+) 
5'-CTCCATTTCAAAAACTGGA IT ATCAGCGTGGCCAACAA TTACA 
AAGTAG-3' 
Sedlin del387 (+) 
5'- CAAGTGCA TTTGACAGAAAGTTCAGTTTCTTGGGAAG -3' 
Sedlin del387 (-) 
5'- CTTCCCAAGAAACTGAACTTTCTGTCAAATGCACTTG -3' 
The polymerase chain reaction (PCR) was perfonned uing the following 
conditions: 
5 J..tl of lOX reaction buffer; 
5 III (5 ng) of DNA template; 
1.25 III (125 ng) of oligonucleotide primer forward; 
1.25 III (125 ng) of oligonucleotide primer reverse; 
1 III of dNTP (10mM) mix; 
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36.5 ~l of sterile double distilled water; 
1 ~l of Pfu Turbo DNA polymerase. 
The cycling parameters for the QuickChange Site-Directed Mutagenesis 
Method are: 95°C for 30 sec. (1 cycle); 95°C for 30 sec., 53°C for 1 min., 
68°C for 12 min (12 cycles); 72°C for 10 min (1 cycle). Amplification was 
checked by electrophoresis of 10 ~l of the PCR product on a 1% (w/v) 
agarose gel. One ~l of the Dpn I restriction enzyme (10 U/~l) was added 
directly to each amplification reaction and then the PCR product was 
incubated for I h at 37°C, in order to digest the parental non-mutated 
DNA. XL I-Blue supercompetent cells were transformed with 2 III of the 
Dpn I-treated DNA. On the following day, one colony was used to 
inoculate 2 ml of LB-broth containing the selective antibiotic and plasmid 
DNA was prepared. A DNA aliquot was precipitated as follows: to 20 ~l of 
DNA, 3 ~l of sodium acetate (3 M, pH 8), 66 III of ethanol and 14 ~l of 
sterile double distilled water were added. The sample was mixed and 
incubated for 10 min on ice and then centrifuged at maximum speed for 30 
min at 4°C. The supernatant was removed and the pellet air dried for 5-10 
min. and then sent for sequencing by MWG Biotech (Italy). 
2.2. 7 Procollagen type II cloning 
To generate fluorescently tagged procollagen type II, the cDNA sequence 
corresponding to amino acids 26-1487 of COL2Al was PCR-amplified 
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from the Image clone IRCFp5008C071 D (imaGenes GmbH) using the 
forward primer 5'-TTCAAGCTTGTCAGGATGTCCAGGAGGCTG-3' 
and reverse primer 5'-GAGGGATCCTTACAAGAAGCAGACCGGCC-3' 
and cloned HindIIIlBamHI into the pmCHERRY-C2 vector, a derivative of 
pEGFP-C2. This construct was digested Nhell Agel and a stuffer fragment 
corresponding to the procollagen signal peptide (amino acids 1-25) that 
included the Kozak: consensus sequence was ligated, upstream of the 
mCHERRY, by annealing the oligos 5'-
CTAGCACCATGGCAATTCGCCTCGGGGCTCCCCAGACGCTGGTG 
CTGCTGACGCTGCTCGTCGCCGCTGTCCTTCGGTGTCAGGGCA-3 ' 
and 5'-
CCGGTGCCCTGACACCGAAGGACAGCGGCGACGAGCAGCGTCA 
GCAGCACCAGCGTCTGGGGAGCCCCGAGGCGAATTGCCATGGTG 
-3' . 
2.2.8 Preparation of antibodies 
The preparation of the anti-Bet3, anti-Sedlin and anti-Synbindin antibodies 
has been performed by G. Di Tullio and M. Santoro (Consorzio Mario 
Negri Sud, Italy). Briefly, I mg of the specific antigen was resuspended in 2 
ml of PBS (1.5 mM KH2P04, 8 mM Na2HP04, 137 mM NaCI and 2.7 mM 
KCl, pH 7.4). Two ml of complete Freund's adjuvant were added and this 
mixture used to immunize New Zealand rabbits. The rabbits were boosted 
after 21 and 42 days with I mg of antigen containing the same volume of 
incomplete Freund's adjuvant. The rabbits were bled and the serum 
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prepared as described below. After collection, blood was allowed to clot at 
37°C for 60 min, then kept overnight at 4 °C in order to make the clot 
contract. The serum was removed from the clot and the insoluble material, 
by centrifugation at 10000 x g for 10 min at 4°C, and stored at -80°C in 
aliquots. Protein-A-sepharose beads (500 mg), suspended in 5 ml of 
distilled water, were packed into a column and washed with 100 ml of 
distilled water under constant flow. The packed beads were washed with 20 
ml of PBS and 2 ml of anti-TRAPP subunit (Bet3 or Sedlin or Synbindin) 
serum were loaded onto the column at 0.5 mllmin in a FPLC (Fast Protein 
Liquid Chromatography) system (Pharmacia Bio-Tec, UK). The beads were 
washed with 30 ml of PBS and the retained IgGs were detached using 15 ml 
of 100 mM glycine pH 2.5. Fractions of 1 ml were collected and their 
protein content quantitated by spectrometry (by the FPLC system). The six 
fractions containing the highest concentration of protein were pooled and 
the pH neutralised with 1 M Tris, pH 11. The protein concentration of the 
pooled fractions was determined using a commercially available protein 
assay kit (Biorad, UK) according to the manufacturer instructions. 
Typically this was 2.5 mg/ml. Different dilutions of the IgGs were tested 
both in Immuno-fluorescence (IF) and in Western blot (WB) and optimal 
working dilutions were reported in the Table 2.1. 
After the affinity-purification (see above) the anti-Bet3 antibody was 
dialysed against 70mM KCI, IOmM Na2HP04 pH7.2 for 4h using dialysis 
membranes with a molecular weight cut off of 6000/8000 Da (1 ml of 
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Antibody Company or Animal DllutionWB Dilution IF Catalog n° 
other source source 
Sigma Rabbit 1:10000 #A2066 
Oaichii chemical Mouse 1:200 #F-S6 
Hybridoma Bank Mouse 1:1000 1:200 
Hybridoma Bank Mouse 1:300 
Oako Rabbit 1:1000 #A 0001 
Oako Rabbit 1:1000 #A 0012 
G. Oi Tullio (CMNS) Mouse 1:800 
BO Mouse 1:5000 1:1000 #61082 
G. Oi Tullio (CMNS) Rabbit 1:10000 1:S00 
-
G. Oi Tullio (CMNS) Mouse l:S00 
glantln G. Oi Tullio (CMNS) Rabbit 1:1000 
G. Oi Tullio (CMNS) Rabbit 1:S00 
Serotech Sheep 1:7S0 
Serotech Sheep 1:lS00 #AHPSooG 
StressGen Mouse 1:200 #SPA-891 
Santa Cruz Rabbit 1:1000 #sc-311 
Santa Cruz Rabbit 1:1000 1:200 #sc-S99 
Upstate Rabbit 1:2000 1:200 #07-692 
ABR Rabbit 1:3000 #A3OD-S92A 
G. Oi Tullio (CMNS) Rabbit 1:2000 1:1000 
G. Oi Tullio (CMNS) Mouse 1:30 
Bethyl Rabbit 1:1000 #Al90-231A 
Mouse 1:2000 
G. Oi Tullio (CMNS) Rabbit 1:S000 1:200 
G. Oi Tullio (CMNS) Rabbit 1:5000 1:200 
G. Oi Tullio (CMNS) Rabbit 1:5000 1:200 
Heinemann lab Rabbit 1:1000 
Heinemann lab Rabbit 1:1000 
Vertellab Rabbit 1:1000 
Sigma Mouse 1:1000 #34660 
Rabbit 1:50 
Table 2.1. List of antibodies used in thi s study both for immunofluorescence (IF) and 
immunoblotting (W8). 
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antibody in 500 ml of buffer for two times). The antibody was then ready to 
be microinjected inside the cells. 
2.3 Cell transfection and RNA interference 
2.3.1 Materials 
TransIT-LTl transfection reagent was from Mirus (USA). OligoFectamine 
and LipoFectamine 2000 were from Invitrogen (USA), Dharmafect4 from 
Dharmacon (USA) and OptiMEM serum-free reduced culture medium was 
from OIBCO (UK). 
2.3.2 Preparation ofplasmid DNA and trans(ection of DNA 
2.3.2.1 Mini scale 
A single colony of XL-l Blue E. Coli bacteria, transformed with the 
plasmid of interest was used to inoculate 2 ml of LB-broth containing the 
selective antibiotic. After 15-20 h incubation with shaking at 37°C, 
bacteria were collected by centrifugation at 14,000 rpm in a Microfuge®18 
centrifuge [Beckman Coulter (USA)] for 1 min at RT and processed 
accordingly to the mini-plasmid preparation protocol of the "SIOMA-
plasmid-miniprep kit". The eDNA obtained was resuspended in 10 mM 
TRIS-HCI pH 8 and stored at 4 °C or, for long-term, at -20°C. 
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2.3.2.2 Large scale 
A single colony of XL-l Blue E. Coli bacteria, transformed with the 
plasmid of interest was used to inoculate 500 ml ofLB-broth containing the 
selective antibiotic. After 15-20 h incubation with shaking at 37°C, 
bacteria were collected by centrifugation at 6000 rpm in a JAlO rotor for 10 
min at 4 °C and processed according to the maxi-plasmid purification 
protocol of the "Qiagen-plasmid-kit". The cDNA obtained was resuspended 
in TE buffer (10 mM TRIS-HCI, 1 mM EDTA pH 7.5) to a final 
concentration of 1 mglml and stored at 4°C or, for long-term, at -20°C. 
2.3.3 TransIT-LT1-reagent-based cell trans(ection 
HeLa cells were seeded into 24-well plates at a concentration suitable to 
have 50%-70% confluence for transfection. The transfection mixture was 
prepared in a polypropylene tube: for each well, 0.3 III TransIT-LTI 
transfection reagent was diluted in 50 III OptiMEM culture medium. The 
mixture was shaken and incubated at RT for 5 min. Then 100 ng of total 
DNA was added to the transfection mixture, which was shaken and kept at 
RT for 15 min, to allow the DNA-TransIT-LTl complex to form. The cells 
were then incubated with the transfection mixture at 37°C in the presence 
of 5% CO2 for 16-20 h. 
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2.3.4 siRNA duplexes 
SiRNA oligonucleotides for sedlin, Bet3, RablA were purchased from 
Dharmacon (USA), while for Sec23 and RablB they were purchased from 
Sigma (USA). Non-targeting siRNA sequences were used as controls; the 
siRNAs sequences are listed in Table 2.2. 
2.3.5 siRNA-duplex transtection 
HeLa cells were transfected using OligoFectamine (Invitrogen, USA), Rx 
chondrocytes and NRK using LipoFectamine 2000 (Invitrogen, USA), and 
HepG2 cells using DharmaFect 4 (Dharmacon). The Cell Microporator 
System (CellBio) was used or electroporation of human fibroblasts 
according to the manufacturer's instructions (using the programme number 
5 of the Microporator System Software). 
HeLa cells were plated in 24-well plates to sub-confluent density on glass 
coverslips, in antibiotic-free medium. The day after, a transfection mixture 
was prepared: for each well, 50 pmol of specific siRNA duplexes were 
diluted in 40 III of OptiMEM culture medium in a polypropylene tube. In a 
separate polypropylene tube, for each well, I III of Oligofectamine Reagent 
was diluted in 7.5 III of the same medium. The mixtures were first shaken 
and incubated at RT for 7 min, then combined, shaken and kept at RT for 
20 min, to allow the siRNA-Oligofectamine complex to form. 
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name Sense sequence 3'-5' Species Purchased from 
Sedl n1 GGGCAUAUGAGGUUUAUUA UU human Dharmacon 
Sedl n2 GAGCUUCUACUUUGUAAUU UU human Dharmacon 
Sedl n3 ACAUGUGGCUAUCGAACAA UU human Dharmacon 
Sedl n4 CAUAAGACAAGAAGAUGGA UU human Dharmacon 
Sedl n5 GGGCAUAUGAGAUUUAUUA UU rat Sigma 
Sedl n6 AAGCUUCUACUUUGUAAUU UU rat Sigma 
Sedl n7 AUAUGUGGCUUUCUAACAA UU rat Sigma 
Sedl n8 UGUGAGGCAAGAAGAUGGA UU rat Sigma 
Sedl S1 UCCAUUUUAUGAACCCAAU UU human/rat Sigma 
Sedl S2 CAAUUCUCCUAUUCGAUCA UU human/rat Sigma 
Bet3 n1 GAUAACCACUCAUCCCUUA UU human Dharmacon 
Bet3 n2 GGGCAUCACUCCAAGCAUU UU human/rat Dharmacon 
Bet3 n3 GAAAGGAGACGGUGUGACA UU human Dharmacon 
Bet3 n4 GGAAACUGCGGAUGUCAUU UU human Dharmacon 
Rab1An1 CAGCAUGAAUCCCGAAUAU UU human/rat Dharmacon 
Rab1An2 GUAGAACAGUCUUUCAUGA UU human/rat Dharmacon 
Rab1An3 GGAAACCAGUGCUAAGAAU UU human Dharmacon 
Rab1An4 UGAGAAGUCCAAUGUUAAA UU human Dharmacon 
Rab1B CGUACACAGAGAGCUACAU UU human/rat Ambion 
Table 2.2. List of s iRNA sequences used in this study. 
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The cells were incubated with the transfection mixture at 37°C in the 
presence of 5% CO2 for 72 h. 
A similar protocol was adopted for Rx chondrocytes and NRK49F. SDS-
PAGE, Western blotting and densitometry analyses were carried out to 
evaluate the efficiency of siRNA treatment for each experiment. 
2.4 Immunofluorescence Confocal Microscopy 
2.4.1 lkfaterials 
Potassium acetate and magnesium acetate were from Merck (Germany). 
Paraformaldehyde was from Electron Microscopy Sciences (USA). Bovine 
serum albumin (BSA), saponin, NaCI were purchased from Carlo Erba 
(Italy). Alexa-Fluor-546, -568, -488 and -633 conjugated goat anti-mouse 
or anti-rabbit secondary antibodies were from Molecular Probes (USA). 
DAPI was from Molecular Probes (USA). Mowiol was from Calbiochem 
(USA). Primary antibodies used in this study and their origin are listed 
above,in Table 2.1. 
2.4.2 Solutions 
Phosphate buffered saline (PBS): 1.5 rnM KH2P04, 8 rnM Na2HP04, 2.7 
mM KCI, 137 mM NaCl, pH 7.4. 
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Paraformaldehyde: as 8% in H20, the paraformaldehyde was diluted in PBS 
(PH 7.4) to the appropriate concentration, and stored at 4 0c. 
Blocking solution: 0.05% saponin, 0.5% BSA, 50 mM NH4CI in PBS. 
Mowiol: 20 mg Mowiol were dissolved in 80 ml of PBS, stirred overnight 
and centrifuged for 30 min at 12000x g. 
2.4.3 Immunofluorescence procedures 
HeLa, HFs, NRK49F and Rx chondrocytes were grown to sub-confluent 
density on glass coverslips and treated as follows. They were fixed with 4% 
paraformaldehyde for 10 min at RT and washed twice in PBS. Blocking 
reagent was then added to the cells for 20 min, followed by a I-h incubation 
with the primary antibody in blocking reagent (see Table 2.1 for the 
dilutions used). When required, cells were permeabilised with 0.01 % 
Triton-X 100 in PBS. The cells were then extensively washed with PBS and 
incubated with secondary antibodies (1 :400) and with DAPI (where 
indicated, at a final dilution of 1: 1 000 from a 1 mglml stock) for 45 min, 
diluted in blocking solution. After immuno-staining, the cells were washed 
three times in PBS and once in sterile water, to remove salts. The coverslips 
were then mounted on glass microscope slides (Carlo Erba, Italy) using 
Mowiol. 
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2.4.4 Immunofluorescence analysis by laser scanning confocal microscopy 
IF samples were examined under a confocal laser microscope (Zeiss 
LSM51 0 META and LSM710 confocal microscope systems; Carl Zeiss, 
Gottingen, Germany) equipped with 63xl.4 NA oil objective. Optical 
confocal sections were taken at 1 Airy unit with a resolution of 1 024x 1024 
pixels or 2048x2048 pixels, and exported as TIFF files. Images were 
cropped with Adobe Photoshop and composed using Adobe Illustrator. 
2.4.5 Image processing and quantification of colo calis at ion on fixed cells 
For quantification experiments, 10-15 randomly chosen fields each 
containing 8-10 cells were scanned with the same microscope settings (i.e. 
laser power and detector amplification) below pixel-saturation. The mean 
intensity per cell was determined using the histogram function in the Zeiss 
LSM 510 Software (version 3.2), where all pixel values above the 
background level were quantified. All experiments were repeated at least 
three times. 
To quantify the level of co-localisation, confocal serial sections were 
acquired at the same magnification from 20 cells per experimental 
condition, exported in TIFF format, and processed. Briefly, an intensity 
threshold of 50 (in a range of 0-255) was applied. The percentage of co-
localisation represents the percentage of total pixels in the reference 
channel that were positive for the other channel. 
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2.4.6 Fluorescence Recovery After Photobleaching (FRAP) 
Human fibroblasts microinjected with the plasmid encoding GFP-Sec23 
were incubated at 37°C using a humidified temperature-controlled 
incubation chamber equipped on Zeiss LSM710 in carbonate-free culture 
medium. Cells were imaged using an LSM7l0 confocal microscope (Zeiss) 
fitted with a 488 and nm argon ion laser lines, using a 63x PlanApochromat 
NA 1.4 DIC oil immersion objective. FRAP experiments and time-lapse 
laser-scanning confocal microscopy were performed as described (Watson 
et aI., 2005). Briefly, a single ER exit sites was acquired 5 frames before 
bleaching (0.8 sec/frame). Bleaching was performed with 100% power of 
the 488 laser for 3 iterations. Recovery was monitored for 90 seconds after 
the bleaching event. At least 60 independent ERES were analysed for each 
condition in three different experiments. Data were exported using Zen 
software (Zeiss) and corrected for bleaching, by dividing the fluorescence 
intensity of the bleached area by that of an unbleached area. Bleaching was 
minimal during the time course of recovery, between 0-10% and where 
bleaching exceeded 10%, the recovery sequences were discarded. The half 
time for recovery, tll2, was calculated as previously described (Watson et 
al.,2005). 
2.4.7 Fluorescence loss in photo bleaching (FLIP) and Fluorescence 
recovery after photobleaching (FRAP) assays. 
Human fibroblasts (HF) plated on 35-mm glass bottom wells (Mattek, 
USA) were treated with siRNA against sedlin and Bet3, as described above. 
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After 96 hours, plasmids encoding GFP-Sec23 or GFP-Rabl (stock solution 
20 ng//-ll and 10 ng!/-ll, respectively) were micro-injected into the nuclei and 
analyzed 6 h after transfection. 
Fluorescence Loss In Photobleaching (FLIP) was perfonned (using Zeiss 
510 confocal microscope) by bleaching iteratively (100 times) the GFP-
associated fluorescence in the whole cell area except for the Golgi and 
monitoring the Golgi-associated fluorescence over time and the relative 
fluorescence intensity (% of pre-bleaching) was plotted. For the Golgi 
dissociation constant (Koff) and Golgi dissociation half time (tll2) 
calculations, FLIP curves were linearised according to the fonnula: 
F(t)=e-KolT*t 
where Koff represents the dissociation constant of the fluorescent protein 
from the Golgi membranes and t represents the time in sec. 
The tll2 value was obtained according to the fonnula: 
tl/2 =In(1I2)fKoff 
Fluorescence Recovery After Photobleaching (FRAP) was performed by 
bleaching the GFP-associated fluorescence in an area encompassmg a 
single ER exit site (5 bleaching iterations at the maximum laser 
fluorescence power) and then monitoring the fluorescence intensity 
recovery in the bleached area. Relative fluorescence intensity (% of pre-
bleaching) was plotted (the time required to bleach the samples is not 
96 
reported in the graphs). For the Golgi association constant (ICon) calculation, 
FRAP curves were linearised according to the fonnula: 
where ICon represents the association constant of the fluorescent protein to 
the Golgi and ICoff represents the dissociation constant of the fluorescent 
protein from the Golgi membranes and t represents the time in sec. 
2.5 Transport assays 
2.5.1 VSV-G transport assay 
For VSV-G assays, cells were infected with the VSVts045 variant for 1 hr a 
32°C in serum-free medium. After infection, the cells were washed several 
times and shifted for 3 hrs at 40°C in complete medium. Cycloheximide 
was added to a final concentration of 100 ).1g/ml and the cells were shifted 
to 32°C for the indicated times. To follow endogenous PC-I in fibroblasts 
and NRK cells or PC-II in Rx chondrocytes (both endogenous and 
expressed in primary fibroblasts), cells were incubated for 3 hrs at 40°C in 
DMEM supplemented with 1 % serum and 20mM HEPES pH 7.2, then 
shifted to 32°C in the presence of cycloheximide (100 ).1g/ml) and ascorbate 
(50 ).1g/ml). Then, the cells were fixed and processed as described above. 
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Quantitative evaluation of VSV -0 and PC (both I and II) transport was 
performed by analysing the immunofluorescence staining patterns of at 
least 200 cells in three separate experiments. 
2.5.2 CD8 transport assay 
For CD8 transport, a CD8 cDNA was injected into the cell nuclei, 
incubated 6 hrs at 37°C and then chased in the presence of cycloheximide 
(100 Ilg/ml) for the indicated times. Cells were fixed and processed for 
immunofluorescence. 
2.5.3 Albumin secretion assay 
2.5.3.1 Materials 
eSS]-Met-Cys Protein Labelling Mix was from Perkin Elmer (USA). 
Rabbit polyclonal anti-human-Albumin antibody was from 
DakoCytomation (Denmark). 
2.5.3.2 Procedure 
Human hepatoma Hep02 cells were plated in a 12-well culture tissue 
multi well plate to reach 80% confluence the day of the experiment. Cells 
were treated with non-targeting, sedlin and Bet3 siRNAs for 72 hours. The 
day of the experiment, cells were washed 3 times with 600 III PBS at 37°C, 
to remove any source of albumin from the serum. Then cells were 
incubated with 500 ilL of DMEM without methionine (Met) and cysteine 
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(Cys) for 30 min at 37°C. Subsequently, cells were pulse labelled with 500 
ilL DMEM e5S]-Met-Cys 1001lCi/ml for 5 min at 37°C. Cells were 
washed and chased in 500 ilL DMEM without FCS and for the indicated 
times. 
Medium was withdrawn and centrifuged (16,000 g for 5 min), the 
supernatant transferred to a new tube and immunoprecipitated overnight at 
4°C using the anti-albumin antibody. In the meanwhile, the cells were 
washed 3 times with ice cold PBS and lysed by adding 400 ilL of lysis 
buffer (70 mM TRIS-HCI pH 7.5; 150 mM NaCI; 0.05% SDS; 1 % TX-lOO; 
1 mM EDTA) on ice for 15 min. Lysates were collected, centrifuged 
(16,000 g for 5 min) and the supernatant was immunoprecipitated overnight 
at 4°C using the anti-albumin antibody. 
Antibody/antigen complexes were recovered by adding 20 JlL of Protein A-
Sepharose equilibrated in lysis buffer to each sample (45 min at 4°C). After 
extensive washing (at least 6 washes were performed), samples were 
processed for SDS-PAGE and Western blotting. Immunoprecipitated 
albumin was revealed by autoradiography and the percentage of albumin 
released into the medium after the indicated time points was calculated. 
2.5.4 a1 anti-trypsin glycosylation and secretion assays 
2.5.4.1 lkfaterials 
e5S]-Met-Cys Protein Labelling Mix was from Perkin Elmer (USA), 
Endoglycosidase-H was from New England Biolabs (USA). 
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Rabbit polyc1onal anti al anti-trypsin was from DakoCytomation 
(Denmark). 
2.5.4.2 Procedure 
HepG2 cells were siRNA treated in 12 well culture tissue multi well plates 
to reach 80% confluence the day of the experiment. Cells were pulsed and 
chased as described in the previous sections (albumin secretion, 2.5.3.2). 
After washing 3 times with PBS, the cells were lysed using 400 ~l (25 mM 
Tris-HCI pH 7.5; 150 mM NaCl; hnM EDTA; 1% TX-I00; protease 
inhibitors) 15 min on ice. Lysates were immunoprecipitated with 2.5 ~l of 
anti-a I-AT rabbit polyc1onal antibody per sample. 150 ~l of denaturing 
buffer (0.5% SDS; 1 % ~-Mercaptoethanol) was added to the samples that 
were then boiled for 10 min. Each sample was divided into two aliquots of 
75 ~l, and then 9 ~l of lOX glycosidase buffer (0.5 M Na-Acetate pH 5.5, 
50 mM CaCh) was added to each aliquot. 40U/sample of endoglycosidase-
H (Endo-H, Calbiochem) were added to one of the two samples. Samples 
were incubated 5 h at 37°C and then processed for SDS-PAGE and 
Western blotting. After autoradiography, the Endo-H resistant form was 
evaluated as a % of the total a I-AT (as a measure ofER to medial-Golgi 
transport). 
2.6 Metabolic labelling 
2.6.1 Materials 
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e5S]-Met-Cys Protein Labelling Mix was from Perkin Elmer (USA), BFA 
was from Sigma-Aldrich, Germany. 
2.6.2 Procedure 
Total secretion experiments were performed essentially as described 
previously (Saito et aI., 2009). Briefly, sedlin or Bet3 siRNA-treated or 
untreated Rx chondrocytes and HeLa cells were cultured in DMEM without 
L-methionine and L-cysteine for I h and then pulsed with 40 /lCi of 35S_ 
methionine and 35S-cysteine (Protein Labelling Mix, Perkin Elmer) for I h 
at 37°C. Cells were then washed and chased for 3 h in DMEM. Medium 
was collected and each sample was resolved by SDS-P AGE, followed by 
autoradiography. For BFA-treated cells, 10 J.lglml of BFA was added 10 
mins before the end of the pulse and left throughout the chase. Samples 
were resuspended in Sample Buffer and subjected to SDS-P AGE and 
followed by autoradiography and quantified using Instant-Imager (Perkin 
Elmer). 
2.7 Microinjection experiments 
Rx chondrocytes were plated on glass covers lips in complete culture 
medium the day before injection. Pre-immune IgG and anti-Bet3 antibody 
were injected (2 mg/ml) into cells using a 5246 transjector controlled by a 
5171 micromanipulator (Eppendorf, Germany). For the effects of the anti-
Bet3 antibody on PC and VSV -G transport, the antibody was injected into 
infected cells during the second hour of the 40°C block. 
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His-SarlH79G was injected at different dilution (2.5 mg/ml, 0.5 mg/ml and 
0.1 mg/ml) dissolved in 70 mM KCI, 10 mM NaH2P04, pH 7.2. Injections 
were performed into infected cells as described above. 
For the DNA microinjection, plasmids encoding the protein of interest 
(GFP-Sec23 and CD8) were diluted to a final concentration of 20 J..lg/ml 
with the same microinjection buffer. Briefly, cells were treated with sedlin 
and Bet3 specific siRNAs for 72 hours. After this procedure, the different 
plasmids were microinjected in the nuclei and left to express the protein at 
37°C for at least 3 hours. For PC-II mCherry expression in primary 
fibroblasts, microinjections were performed as described above (20ng/J..lI). 
After the injections, cells were incubated for 3 hrs at 37°C and then shifted 
to 40°C for an additional 3 hrs. Co-injection of PC-II mCherry plasmid with 
wild-type sedlin (lOOng/fll) was carried out under identical conditions. For 
rescue experiments, a plasmid encoding human sedlin was injected both in 
control and sedlin siRNA-treated Rx chondrocytes (IOOng/fll). Cells were 
incubated for 4 hrs before the experiments. For each microinjection 
experiment at least 150 cells were injected. 
2.8 SDS-PAGE 
2.8.1 Solutions 
Running buffer: 0,2 M glycine, 20 mM Trizma base. 4 mM SDS. pH 8.3; 
IX sample buffer: 0.125 M Trizma base. 4% (w/v) SDS. 20% (v/v) 
glycerol. 10% (v/v) ~-mercaptoethanol. pH 6.8. 
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2.8.2 Assembly ofpolyacrylamide gels 
Two 16 x 15 em glass plates were assembled to form a chamber using two 
1.5 mm plastic spacers lined on the lateral edges of the plates. This chamber 
was fixed using two clamps and mounted on a plastic base that sealed the 
bottom (Hoefer Scientific instruments, Germany). The polyacrylamide gel 
was then prepared using one solution of the desired polyacrylamide 
concentration (usually 13% to better separate the TRAPP subunits) or two 
solutions of 4 and 15% (v/v) polyacrylamide in a gradient maker device, to 
prepare a 4-15% (v/v) gradient gel. 
2.8.3 Samples preparation and run 
Samples were prepared by adding sample buffer and boiling for 5 min at 95 
°C before loading onto the gel. The end wells were loaded with 3 III of pre-
stained molecular weight standards (Sigma, USA). The chamber was then 
assembled into the electrophoresis apparatus (Hoefer Scientific Instruments, 
Germany) and electrophoresis was carried out under a constant current of 8 
rnA (for overnight runs) or 30-40 rnA (for 4 h runs). 
2.8.4 Western blotting 
2.8.4. J Solutions 
Transfer buffer: 0.2 M glycine, 20 mM Trizma base, pH 8.3; blocking 
buffer: 1% (w/v) BSA [or alternatively 5% (w/v) dry skim milk], 0.05% 
(v/v) Tween 20,150 mM NaCl, 50 mM TRIS-HCl pH 7.5. 
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ECL™ Western Blotting Detection Reagents was purchased from GE 
Healthcare (Sweden). 
2.8.4.2 Nitrocellulose blotting 
The polyacrylamide gel was soaked for 15 min in transfer buffer, placed on 
a sheet of 3 MM Whatman paper and covered by a nitrocellulose filter 
(Schleicher & Schuell, USA). The filter was covered by a second sheet of 3 
MM paper to form a "sandwich" that was subsequently assembled into the 
blotting apparatus (Hoefer Scientific Instruments, Germany). Protein 
transfer occurred at 400 rnA for 4-5 h. At the end of the run, the "sandwich" 
was disassembled and the nitrocellulose filter was soaked in 0.2% (w/v) red 
Ponceau in 5% (v/v) acetic acid for 5 min to visualise the protein bands and 
then rinsed with 5% (v/v) acetic acid to remove the excess of the unbound 
dye. 
2.8.4.3 Immunodetection of antigens 
Nitrocellulose filters were cut with a razor blade into strips. Strips 
containing the proteins of interest were incubated in blocking buffer for 30 
min at RT and then with fresh blocking buffer containing the primary 
antibody at its working concentration (see Table 2.1 for the antibody 
dilution used). 
After 2-3 h of incubation at RT, or overnight at 4 °C, the antibodies were 
removed and the strips washed with TTBS 3 times, 3min each wash. Strips 
were incubated for 1 h with the appropriate HRP-conjugated secondary 
antibody (diluted 1: 1 0,000 (goat anti-mouse) or 1 :20,000 (goat anti-rabbit) 
for ECL development) and washed 2 times, 3min each wash, with TTBS 
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and 2 times, 3min each wash, with TBS. After washing, strips were 
incubated with the developing solution: 
ECL TM from GE Healthcare (UK). 
Strips were incubated with the ECL developing solution for I min at RT 
and visualised by chemoluminescence. 
2.9 Pull-down assays 
Increasing concentrations (0.1, 0.3 and I IlM) of His-SarI were incubated 
with GST-fusion proteins or GST alone (0.5 IlM) as previously described 
(Cai et aI., 2007). After overnight incubation at 4°C in 300 III binding 
buffer (50 mM TRIS pH 7,4, 100 mM NaCI, Img/ml BSA, 0.1% Triton X-
100, 0.1 % NP-40, 0.1 mM GTP or GDP), glutathione-beads were added, 
incubated for 2 hrs at 4°C, washed extensively at least 5 times (50 mM 
TRIS pH 7.4, 100 mM NaCI), eluted and analysed by SDS-PAGE. 
2.10 SarI GTPase activating assay 
These experiments are carried out in collaboration with Giuseppe Di Tullio 
and Michele Santoro (CMNS, Santa Maria Imbaro , Chieti, Italy and 
TIGEM, Naples, Italy respectively). 
2.10.1 Sar 1 Protein purification 
Overnight cultures of Escherichia coli BL21(DE3) carrying pet28a-Sarl 
WT or pet28a-SarlH79G were diluted into Lwia Broth. The cells were 
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grown at 37°C to an A600 of 0.3, transferred to 25°C, and further grown 
to an OD6oo of 0.5. Expression of hamster Sarla was induced with 0.1 mM 
isopropyl I-thio-~-d-galactopyranoside for 3 h. The induced cells were 
harvested by centrifugation at 4,500 rpm for 10 min in a JAlO (Beckman) 
rotor at 4°C. The pellet was resuspended according to manufacturer's 
instructions (Qiagen, NiNTA agarose beads). Proteins were quantified by 
the Bradford assay using bovine serum albumin as a standard. 
2.10.2 Preparation of Rat Liver Cytosol 
Rat liver cytosol was prepared as described previously (Nohturfft et aI., 
2000). Briefly, male Sprague-Dawley rats were anesthetized by halothane 
inhalation and livers were excised and disrupted in 2 mLlg ice-cold buffer E 
(50 mM HEPES- KOH pH 7.2, 250 mM sorbitol, 70 mM KOAc, 5 mM 
potassium-EGTA, 2.5 mM Mg(OAch) supplemented with protease 
inhibitor cocktail (Roche). Livers were each cut in 20 smaller pieces and 
homogenized using a T18 UltraTurrax dispenser (IKA). All subsequent 
steps were carried out at 4°C. Homogenates were centrifuged at 960 x g for 
10 min. Supernatants were sequentially centrifuged 186,000 x g for 1 hour. 
This resulting supernatant (the rat liver cytosol, 15-22 mg protein/mI), was 
divided into mUltiple aliquots, snap-frozen in liquid nitrogen, and stored at 
-80°C. To prepare TRAPP-depleted rat liver cytosol, equal amount of 
pre immune IgG and Bet3 specific antibody (250 J,lg) were cross-linked to 
Protein A Sepharose beads (Sigma) and packed into a 0.3 cm diameter 
column. 3 mg of rat liver cytosol were loaded onto the column on an FPLC 
system (AKT Amicro™, GE Healthcare Lifesciences) at a flow rate of 0.5 
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mllcm. Fractions were collected and blotting analyses were performed to 
assess the efficiency of TRAPP depletion. 
2.10.3 Sar 1 GAP assay 
The protocol used in this study was adapted from Jacques et al. (2001). 0,5 
J.lM recombinant SarI-His was incubated in buffer C (25mM HEPES-KOH 
pH 7.2, ImM DTT, 0.25 mM BSA, 0.25 mM Mg(OAch, 1 mM ATP and 
50nM a-32P-GTP) at 32°C alone or in presence of 60 Ilg of wild type or 
TRAPP-depleted rat liver cytosol. At variuos times (15, 30, 60, and 120 
minutes) 2.5 J.lI of the samples were removed and diluted in 50 ilL of 2M 
formic acid. 2.5 J.lI of these mixtures were spotted onto a TLC plate (PEl 
Cellulose F, Merck), rapidly air dried and subjected to a separation run. 
Radiolabeled GTP and GDP were separated by placing the bottom of the 
TLC plate in a shallow reservoir containing TRIS-HCI 1.2 M, pH 7.4. The 
buffer was allowed to migrate up the TLC plate until it reached 2-3 cm 
from the top. Radiolabeled nuc1eotides were measured using Istant-Imager 
(Perkin-Elmer), and expressed as a percentage of the sum of the two 
detected species. 
2.11 Assay in permeablilised cells 
2.11.1 Materials 
Streptolysine 0 (Sclavo, Italy). 
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2.11.2 Procedure 
HeLa cells were treated with specific siRNAs for 72 hours, then treated as 
previously reported (De Matteis et aI., 1993) with some modifications. 
Mock, sedlin-KD and Bet3-KD Cells were incubated with streptolysine-O 
(Sclavo, Italy, 1 UIImL) for 10 minutes on ice, in a buffer containing 20 
mM HEPES-KOH pH 7.2, 110 mM KOAc, 2 mM Mg(OAc)2, 1 mM DTT. 
Cells were washed twice with the same buffer, then they were shifted to 
37°C for 20 minutes, to allow membrane pore formation. Reactions 
contained 1 mM ATP, and/or 0.1 mM GTPyS, an ATP regeneration system 
(5mM creatine phosphate and 20 UIImL creatine phosphate kinase) and 
transport buffer (25 mM HEPES KOH, 2.5 mM Mg(OAch, 120 mM 
KOAc, 5 mM EGT A and 1.8 mM CaCh). The media was collected as the 
cytosolic fraction while the cells were considered as the membrane-bound 
part. The media was precipitated with TCA while cells were lysed at 4°C 
using a Lysis buffer (25mM TRIS pH 7.4, 150 mM NaCI, 1 mM EDTA, I 
% Triton X-100 and a protease inhibitors cocktail). 
Both media and cellular fractions were analysed by Western blot. As 
negative and positive controls, antibodies against GM130 (a bona fide 
membrane marker) and GAPDH (a cytosolic marker) were used, 
respectively. In parallel, the same experiment was performed for 
immunofluorescence analyses. GM130 antibody was added during the 37°C 
incubation, as a read-out of the extent of the permeabilisation step. After 
this incubation, cells were fixed in 4% paraformaldehyde and processed for 
indirect immunofluorescence. Sec31 antibody was used to visualise ERES, 
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while for GM 130 only the Alexa-conjugated secondary antibody was used. 
F or fluorescence analyses, only cells positive for double-staining were 
considered. 
2.12 Electron microscopy techniques 
The following experiments were perfonned in collaboration with A. A. 
Mironov, G. Beznoussenko and D. Di Giandomenico (Consorzio Mario 
Negri Sud, Italy) and Elena Polishchuck (lBP, Naples, Italy). 
2.12.1 Post-embedding techniques 
The name of these techniques derives from the fact that the labelling is 
perfonned after the sample embedding. The cryosectioning technique is the 
most important technique for post-embedding sub-cellular 
immunocytochemistry . 
2.12.2 Materials 
MultiwellTM (6 well) tissue culture plates were purchased from Becton 
Dickinson (France). Acetylated bovine serum albumin (BSA-cTM) was 
purchased from Aurion (Wageningen, The Netherlands). Protein A 
conjugated with 5, 10 and 15 gold particles were provided by J. Slot 
(Utrecht University, Utrecht, The Netherlands). Grids, paraformaldehyde 
and glutaraldehyde were purchased from Electron Microscopy Sciences 
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(USA). Uranyl acetate and glycine were purchased from Fluka (CH). Cold 
fish skin gelatin, gelatin, BSA and methyl cellulose were purchased from 
Sigma (USA). Sucrose was purchased from Carlo Erba (Italy). Whatman 50 
filter papers were purchased from Whatman (UK). 
2.12.3 Ultrathin cryosectioning 
The cells were fixed by adding to the culture medium the same volume of a 
mixture of PHEM (l0 mM EGTA, 2 mM MgCI2, 60 mM PIPES, 25 mM 
HEPES, pH 6.9) buffer, 4% paraformaldehyde, 2% glutaraldehyde for 2 h, 
and finally stored in storage solution (PHEM buffer, 0.5 % 
paraformaldehyde) overnight. After washing with 0.15 M glycine buffer in 
PBS, the cells were scraped and pelleted by centrifugation, embedded in 
10% gelatin, cooled on ice, and cut into 0.5-mm blocks in the cold room. 
The blocks were infused with 2.3 M sucrose, which acts as a cryo-
protectant, and then placed onto small specimen pins. The pins were frozen 
by immersion in liquid nitrogen, quickly transferred to a pre-cooled (--60 
°C) cryo-chamber fitted onto an ultramicrotome (Leica Ultracut R) and 
trimmed to a suitable shape. The sections were cut at -120 °C using a dry 
diamond knife and collected on the knife surface. Sections were retrieved 
from the knife by picking them up on a small drop of a 1: 1 mixture of 2.3 M 
sucrose and 2% methyl cellulose and transferred onto forrnvar- and carbon-
coated specimen grids. Samples were processed for immuno-Iabelling as 
described in the following section. 
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2.12.4 Labelling of cryosections. 
During immuno-Iabelling, the grids were kept floating on drops of buffered 
saline solution, with the section side in the liquid. The back of the grid was 
kept dry and the section side was kept hydrated at all times. The grids were 
washed in 500 ~l droplets of PBS for 3 x 10 min and then additionally 
washed 3x 3 min with 0.02 M glycine in PBS, pH 7.4. For double immuno-
labelling, the grids were incubating with anti-SarI and anti-Sec31 antibodies 
diluted 1 :20, then with goat anti-mouse or rabbit immunoglobulin antibodies 
(bridge antibody). Finally, sections were incubated with Protein A-gold of 
different sizes (10 nm and 15 nm). Then, the grids were washed 5x 1 min in 
distilled water and stained for 5 min in 1.8% methyl cellulose plus 0.4% 
uranyl acetate, on ice. The grids were retrieved with a stainless steel loop, 
onto a piece of Whatman 50 filter paper at an angle of 45°. After air-drying, 
the grids were examined under a Philips Tecnai-12 electron microscope 
(Philips, Einhoven, The Netherlands) using an ULTRA VIEW CCD digital 
camera. 
2.13 Sedlin expression in Medaka 
Total RNA, total lysates and sections derived from Orytias Latipes 
(Medaka) were kindly provided by Dr. Ivan Conte. 
RT-PCR to detect sedlin transcript was performed using the following 
pnmers: 
Sedlin-Medaka-fw 5'- GGAAGCAAA TTTCAACAAAGG -3' 
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Sedlin-Medaka-rev 5'- GTGTGATTGGTAGACTACAC -3' 
Western blotting analyses and immunofluorescence studies were carried out 
as described in the previous sections. 
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AIM 
The main aim of my Ph.D. project was to investigate the role of sedlin, a 
component of the TRAPP complex and the product of the gene (SEDL) 
mutated in Spondylo-epiphyseal dysplasia tarda (SEDT). To date, the 
TRAPP complex has been implicated in the homotypic fusion of COPII 
carriers (Yu et al., 2006; Cai et aI., 2007) and as a guanine exchange factor 
(GEF) for Rabl in mammals (Yamasaki et aI., 2009 and see Introduction 
section). However, the specific role of sedlin has not been determined so 
far. Defining the role of sedlin will not only shed light on the role of the 
mammalian TRAPP complex but will be also extremely important for 
understanding the molecular mechanisms underlying the onset of SEDT. 
It has been proposed that mutations in the SEDL gene cause defects in 
collagen homeostasis/transport (Tiller et al., 2001; Sacher, 2003). However, 
there is little direct evidence at present to substantiate this hypothesis, which 
is based mainly on the histology of a single SEDT patient whose 
chondrocytes showed a dilated rough ER and some short or frayed collagen 
fibrils (Tiller et aI., 2001). Whether these characteristics are truly 
representative of the SEDT disorder is uncertain, due to the lack of more 
extensive histopathological analyses (Tiller et al., 2001). How sedlin might 
regulate this homeostasis/transport remains elusive and there are no data 
available about the role of sedlin in membrane trafficking. 
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As mentioned above, the link to collagen homeostasis and transport has 
been also proposed as sedlin is a component of the TRAPP complex that is 
involved in early steps of the secretory pathway (Sacher et aI., 2001; Yu et 
aI., 2006; Cai et aI., 2007; Barrowman et aI., 2010). Many hypotheses about 
the role of sedlin in cartilage development or in membrane trafficking have 
been generated, but so far no evidence about its functions has been 
provided. 
The main goals of my Ph.D. project were thus to: 
1. investigate the role of sedlin in membrane trafficking; 
2. define molecular mechanisms in which sedlin is involved (through 
the identification of novel interactors); 
3. study the impact of the sedlin KD/mutations reported in SEDT 
patients on membrane trafficking in SEDT -related cell lines (i.e. 
chondrocytes ); 
4. set up the basis for the development of an animal model of SEDT. 
In Chapter 3, I will focus on the results related to tasks 1 and 2, while the 
task described in point 3 will be discussed in Chapter 4, and finally task 4 
will be discussed in Chapter 5, the last of the Results section. 
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Chapter 3 
Results 
The role of sedlin in membrane trafficking 
Previous studies performed in Dr. De Matteis' laboratory in mammalian 
systems regarding the most evolutionarily conserved TRAPP subunit, Bet3, 
led to the finding that this TRAPP subunit is specifically required for ER 
exit of large secretory cargoes (i.e. procollagen I, PCI). Injection of a 
blocking anti-Bet3 antibody caused a block in PCI transport at the level of 
the ER, while different cargoes, such as the reporter protein vesicular 
stomatitis virus glycoprotein (VSV-G), reached the GC (Scanu T., PhD 
Thesis, 2008 unpublished data). This suggested that TRAPP is selectively 
required for procollagen incorporation into transport carriers leaving the ER. 
Based on these results, and on the consideration that SEDT had been 
hypothesized to result from defective secretion of ECM components, I 
focused my studies on the role of sedlin in membrane transport. 
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3.1 Sedlin depletion in different cell lines 
At the beginning of this study nothing was known about the effects of 
silencing sedlin in human cells, so I developed a cell model system in which 
to study the impact of sedlin knock-down (KD) using siRNA inhibition. 
Sedlin KD was compared not only to control conditions (using non-
targeting siRNAs), but also with the KD of another component of the 
TRAPP complex, namely Bet3, which is a key component of the TRAPP 
complex (Sacher et aI., 2001). Moreover, from the comparative analyses of 
the two conditions, I sought to discriminate whether the consequences of 
sedlin KD could be ascribed to the impainnent of the function of the 
TRAPP complex or to sedlin-specific dysfunction, unrelated to the TRAPP 
complex. 
Conditions for the transient silencing of sedlin in different cell lines (He La, 
human fibroblasts and HepG2) were established using siRNAs against 
sedlin (Figure 3.1). These siRNAs target both sedlin and the "transcribed" 
sedlin pseudogene SEDLPl (see Introduction). The efficiency of the siRNA 
silencing was measured by Western blot analysis with sedlin-specific 
antibodies that were developed in the lab (see Materials and Methods). 
Sedlin levels were significantly reduced (to 10-15% of the level in untreated 
cells or in cells treated with non-targeting siRNAs) after 72 hrs of treatment 
(96 hrs for HF, Figure 3.1). Sedlin KD did not affect the levels of other 
TRAPP subunits (Figure 3.1 and Scrivens et al., 2009), in contrast to Bet3 
116 
A 
B 
CH X ~G CTGGGAGCTTCTACTTTGTAATTGTTGGCCACCATGATAATCCAGTTTTTGAAATG 60 
CH19 TG CTGGAAGCTTCTACTTTGTAATTGTTGGTCACCATGATAATCCAGTTTTTGAAATG 
*.* •••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CH X GAGTTTTTGCCAGCTGGGAAGGCAGAATCCAAAGACGACCATCGTCATCTGAACCAGTTC 
CH19 GAGTTTTTGCCAGCTGGGAAGGCAGAATCCAAAGACGACCATCGTCATCTGAACCAGTTC 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CH X ATAGCTCATGCTGCTCTCGACCTCGTAGATGAGAACATGTGGCTATCGAACAACATGTAC 180 
CH19 ATAGCTCATGCTGCTCTCGACCTCGTAGATGAGAACATGTGGCTGTCGAACAACATGTAC 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CH X TTGAAAACTGTGGACAAGTTCAACGAGTGGTTTGTGTCGGCATTTGTCACTGCGGGGCAT 
CH19 TTGAAAACTGTGGACAAGTTCAACGAGTGGTTTGTGTCAGCATTTGTCACCGCGGGGCAT 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CH X ATGAGGTTTATTATGCTTCATGACATAAGACAAGAAGATGGAATAAAGAACTTCTTTACT 300 
CH19 ATGAGGTTTATTATGCTTCATGACATAAGACAAGAAGATGGAATAAAGAACTTCTTTACT 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CH X GATGTTTATGATTTATATATAAAGTTTTCAATGAATCCATTTTATGAACCCAATTCTCCT 
CH19 GATGTTTATGATTTATATATAAAATTTTCAATGAATCCATTTTATGAACCCAATTCTCCT 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CH X ATTCGATCAAGTGCATTTGACAGAAAAGTTCAGTTTCTTGGGAAGAAACACCTTTTAAGC 420 
CH19 ATTCGATCAAGTGCATTTGACAGAAAAGTTCAGTTTCTTGGGAAGAAACACCTTTTAAGC 
ffi
···················································· ..... CH X GA 423 
CH19 GA 
•• 
~-actin 
synbindin 
Bet3 
sedlin 
Name Sequence 3'-5' 
SedlN1 GGGCAUAUGAGGUUUAUUA UU 
SedlN2 GAGCUUCUACUUUGUAAUU UU 
SedlN3 ACAUGUGGCUAUCGAACAA UU 
SedlN4 CAUAAGACAAGAAGAUGGA UU 
SedlS1 UCCAUUUUAUGAACCCAAU UU 
SedlS2 CAAUUCUCCUAUUCGAUCA UU 
-RQ .f>Q 
;V ~~ ~~ «-'v ~~ ~l 6~ ~ ft- C ,,~ <¢'" kDa 
" ~ kDa 
~" 1 __ _ 1-45 31 1---r31 -
1- - ~21 I~- 1-21 
1- b4 ~ ~14 
HeLa HF 
-RQ ,,~ ~~ ~l 
c.; ,,~ <¢'" kDa 
1 __ _ 1-45 
1-- 1-
31 
1-- 1-21 
1- 1- 14 
HepG2 
Figure 3.1 Sedlin depletion in different cell lines. (A) Sequence alignment between the 
SEDL ORF on chromosome X and the EDLP I ORF on chromosome 19, generated u ing 
ClustalW oftware. The two sequences differ from each other only by six nucleotides. 
Asterisks mark nucleotide identity. The start (ATG) and stop (TGA) codons are boxed. 
siRNAs used in this Thesis are highlighted with two different colours: green refers to the 
Dharmacon pools used in this study (n 1-n4), pink to the published sequences (S I and S2, 
Scrivens et aI., 2009). The sequences are listed in the bottom part of the panel. (B) Western 
blot analyses of He La, HF and HepG2 cell s after treatment with control, sedlin and Bet3 
siRNAs. 60 ~g of total lysate from each sample were separated by SDS-PAGE ( 13% gel). In 
sedlin-KD cell s only the edlin protein is reduced, while in Bet3-KD cells the three analysed 
TRAPP subunits ( edlin, Bet3 and synbindin) were strongly reduced compared to control cells. 
p-actin was used as a loading control. 
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KD where the levels of the other TRAPP subunits are decreased (Figure 
3.1), as also reported by Yu et aI., 2006. 
Since Bet3 KD caused the depletion of the entire TRAPP complex, such 
cells will hereafter be referred to as TRAPP-depleted cells. The mechanism 
by which Bet3 controls the levels of the other TRAPP components is 
unclear, be it through the regulation of gene expression or protein stability. 
The latter possibility appears more likely considering the central position 
that Bet3 occupies in the TRAPP complex. Sedlin, instead, occupies a 
peripheral position in the complex (Kim et aI., 2006), which may explain 
the lack of consequences of sedlin KD on the stability of the other TRAPP 
complex subunits. 
After setting up efficient conditions for transient knock-down of sedlin by 
siRNAs, I studied the effect of its absence on general cell morphology and 
on the organization of the secretory apparatus. 
3.2 Effects of sedlin depletion on cell morphology and the actin 
cytoskeleton 
HeLa cells lacking sedlin appear flatter and larger than control cells. To test 
whether this reorganisation depends on alterations of actin cytoskeleton, I 
performed fluorescence-based analyses of sedlin-KD and mock-treated 
HeLa cells. Sedlin depletion affects dramatically not only the organization 
but also the dynamics of the actin cytoskeleton and focal adhesions in HeLa 
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cells, resulting in increased fonnation of stress fibres, decreased sensitivity 
to actin depolymerizing drugs (i.e. latrunculin B, LA-B) and an increase in 
number of focal adhesions (Figure 3.2). Immunofluorescence studies 
revealed that actin tips of the newly-fonned stress fibres colocalised with 
markers of focal adhesions such as vinculin and phospho-tyrosine (Figure 
3.2). Furthennore, compared to control cells, the actin stress fibres observed 
in sedlin-KD cells were refractory to treatment with the actin-
depolymerising agent LA-B, but were totally disassembled in the presence 
of the selective non-muscle myosin II inhibitor, blebbistatin (Figure 3.2). 
After LA-B wash-out, the refonnation of these stress fibers in sedlin-KD 
cells was faster than in control cells where it was possible to detect only 
subcortical fibres. These findings indicate that sedlin regulates actin 
dynamics. As a role for actin in membrane trafficking is emerging from the 
literature, this stabilisation of the actin cytoskeleton observed upon sedlin 
impainnent deserves further and more detailed analyses to assess whether it 
is connected with the secretory phenotype we have identified in sedlin-
depleted cells, which is described below. 
3.3. Effects of sedlin depletion on the structure of the Golgi complex 
The effect of sedlin depletion on the structural organization of the Golgi 
complex was examined by immunofluorescence analysis, using different 
Golgi markers (GM130 and TGN46), and by EM analysis (in collaboration 
with Sasha Mironov). 
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Figure 3.2 edlin depletion affects actin organi ation. (A) iRN -treated IleLa cell 
were ftxed, penneabilised and incubated with a primary antibody again t vinculin (focal 
adhesion marker) and with phalloidin (to vi ualise actin). edlin KD cau e re rganization 
of the actin cytoskeleton (which i not found in control cell) with the appearance o[ tre 
fibres and focal adhesions locali ed at the tip of the e tructures. cale bar 20f,lM. (B) 
Sedlin KD cau e the [onnation of tres fibres re istant to latrunculin-B treatment. 
siRNA-treated HeLa cells were fixed and pro e d with phalloidin or treated for 30 
minute at 370 with I f,lM latrunculjn-B. In control cells th actin redi tribute 
completely into round phalloidin-positi e aggregate , while in ilenced cell the tre 
fibres are still pre ent. cale bar 20 ~un . 
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In contrast to Bet3 KD, which has been shown to induce Golgi 
fragmentation (Yu et aI, 2006, Figure 3.3), the Golgi complex in sedlin-KD 
cells appears well developed and organized, both at the 
immunofluorescence and ultrastructural levels (Figure 3.3). Indeed, the 
ultrastructural analysis showed a well-preserved ribbon and the average 
lengths of the Golgi cisternae were twice that of control cells (Figure 3.3). 
These findings, i.e. that sedlin depletion does not induce fragmentation of 
the Golgi complex, are in apparent contrast with data from Scrivens et ai. 
who reported a compromised GC morphology upon sedlin KD (Scrivens et 
aI., 2009). I explored the reasons underlying this apparent discrepancy. 
Scrivens et al. used siRNA sequences (Table 2.2 and Figure 3.1, see 
Methods) that were different from the ones used for most of my experiments 
(NI-N4 from Dhannacon, see Materials and Methods). I performed 
experiments to compare the effects of the different sets of sedlin siRNAs 
and verified that the siRNAs used by Scrivens et al. do indeed induce 
extensive GC fragmentation (Figure 3.4). Then I analysed the differences in 
the sequences of the siRNA used (Figure 3.1). The siRNA sequences S 1, 
S2 (used by Scrivens et aI.) target transcripts from the sedlin gene on 
chromosome X and SEDLPI on chromosome 19. but also one from another 
pseudogene located on chromosome 8 (Gecz et aI.. 2000). This gene, called 
SEDLP2. is not translated, but it could be transcribed and thus it might play 
a role in the stability of sedlin mRNA, as recently reported for other 
products of processed pseudogenes (Berger et aI., 2011). This difference 
may underlie the higher efficiency of depletion achieved with the siRNA 
sequences SI. S2 (to 5% residual sedlin) compared to the sequences I used 
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Figure 3.3 edlin depletion does not affect the tructure of the Golgi comple . (A) I leLa 
cells were mock ( TRL), sedlin- or BeG-siRN treated for three day . ells were then fixed 
and stained u ing two different Golgi markers: TG 46 (green) and GM 130 (red). In control 
cells, the G appear as a continuou structure concentrated in the perinuclear region. A 
similar G morphology is evident also in edlin-KD HeLa cell, while upon BeG depletion, 
the GC hows a fragmented staining pattern, in accordance with previ u report (Yu et aI. , 
2006). cale bars, I 0 ~m. (B) Ultra tructural analy i of edlin-KD HeLa cell how an inta t 
GC morphology. (Left) HeLa cells were treated as de cribed in (A) and then proce ed for M 
( ee Materials and Methods) . Notably, in edlin-KD cell the GC appeared unaltered compared 
to control conditions. cale bars, 200 nm. (Right) Morphometric analy es show that the 
average length of the Golgi cisternae i doubled in edlin KD cells compared to control cell 
(n=50). 
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throughout this work, NI-N4 (to 10-15% of control value). A possibility 
that remains to be explored for the SI, S2 siRNAs (and that we have 
excluded for the NI-N4 siRNAs with rescue experiments, see below) is that 
of off-targeting effects. 
The sedlin depletion achieved with the NI-N4 siRNAs more closely mimic 
those of cells from SEDT patients, where the structure of the Golgi complex 
is preserved (see section Figure 4.14 below and Tiller et at., 2001) and 
where residual levels of wild type sedlin may persist as a product of the 
transcribed retropseudogene on chromosome 19 (Tiller et al., 200 I, Scrivens 
et aI., 2009). 
3.4 Sedlin in membrane transport: analyses of different classes of cargo 
upon sedlin depletion 
The trafficking of different classes of cargo molecules was analysed to 
study the impact of sedlin KD on ER-to-Golgi transport. I chose several 
model proteins as representative of distinct classes: VSV -0 and CDS as 
membrane cargoes, albumin and aI-antitrypsin as small soluble cargoes, 
procollagen I (PCI) as a large soluble cargo. 
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3.4.1 Transmembrane cargoes 
Secretory transport has been typically studied using ts045-G, a temperature 
sensitive transmembrane glycoprotein derived from the vesicular stomatitis 
virus, VSV-G (Balch and Keller, 1986; Kreis, 1986; Presley et ai., 1997; 
Scales et ai., 1997; Stephens et ai., 2000), which enables one to follow a 
synchronized wave of transport along the secretory pathway. The transport 
of VSV -G along the secretory pathway can be synchronized by incubating 
cells at 40°C, which results in reversible misfolding and retention in the ER, 
and then shifting the cells to 32°C to release the ER block. Adopting this 
synchronisation protocol I followed the intracellular transport of VSV -G in 
sedlin-KD and Bet3-KD cells by immunofluorescence. BeLa cells were 
treated with non-targeting (control), sedlin and Bet3 siRNAs for three days. 
The cells were then VSV -infected at 32°C for 45 minutes and incubated for 
3 hrs at 40°C, to allow VSV -G accumulation inside the ER. They were then 
shifted to the pennissive temperature (32°C) in the presence of 
cycloheximide (CHX, 50 J.lglml, to inhibit further protein synthesis) and 
fixed at different times (0, 15, 30, 60, 90 and 120 minutes) for 
immunofluorescence analyses. 
In control cells, VSV -G reached both the GC and the PM after 60 minutes at 
the permissive temperature. At 90 minutes, VSV -G was no longer visible at 
the GC, but only at the PM. 
Sedlin-KD cells did not show any significant delay in the transport ofVSV-
G compared to control cells (there was a delay of about 10% between 
control and treated cells after 60 minutes at 32°C), while Bet3-KD showed a 
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marked delay in VSV -G arrival to the PM, in agreement with previous 
reports (Loh et aI., 2005; Yu et aI., 2006 and Figure 3.5). 
Moreover, in Bet3-KD cells VSV -G reached the fragmented GC but failed 
to leave the GC, revealing a defect in intra-Golgi or in Golgi-to-PM 
transport. The arrival to the GC was also deduced by the results of 
experiments in which the glycosylation state of VSV -G was assessed by 
pulse-labelling, immunoprecipitation and treatment with endo-H 
glycosidase. Here it was shown that VSV -G acquires endo-H resistance 
(Scanu T., PhD Thesis, 2008), which is a hallmark of arrival at the medial 
Golgi (see Methods). 
To study the transport of the transmembrane cargo CD8, which is not 
synchronizable, a CD8 cDNA was micro-injected into the nuclei of control, 
sedlin-KD and Bet3-KD cells. Three hours post-injection the cells were 
treated with CHX (to inhibit further protein synthesis) and the transport of 
CD8 through the secretory pathway was followed by IF. CD8 was detected 
at the GC and at the PM 30 minutes after CHX addition and at the PM after 
60 minutes in both control and sedlin-KD cells. In contrast CDS was 
retained in the GC and failed to reach the PM in Bet3-KD cells (Figure 
3.6). These fmdings clearly demonstrate that these transmembrane cargoes 
exit the ER both in sedlin and in TRAPP-depleted cells, but that TRAPP-
depleted cells suffer a Golgi secretory defect compared to sedlin-depleted 
cells. 
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Figure 3.6 edlin-KD does not affect CD8 arrival to the pIa rna membrane. (Upper panel) 
HeLa cells were mock (CTRL), sedlin- or Bet3- iR A treated for three days . ell were then 
micro-injected with a pia mid encoding a D8 cD A. Five hours post-injection, CHX was 
added for 30 minute and then the cell were fixed and proces ed for immunofluore cence 
analy e . A monoclonal antibody recogni ing D8 wa used. D8 reache the PM in control 
and sedlin-KD cell , while its delivery to the PM i trongly inhibited in Bet3-KD cell . cale 
bars, 20 ~m . Image were taken u ing the ame la er parameter. (Bottom panel) 
Quantification of D8 transport in control, edlin- and Bet3-KD HeLa cell . HeLa cells were 
treated a described above. After injection the cells were incubated at 37° for the indicated 
time points. Mean value (± D) from 5 independent experiments (n= 100). The data are 
expre ed a % cells with CD8 at the PM . 
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3.4.2 Small soluble cargoes 
To analyse small soluble molecules, the trafficking of the endogenous 
cargoes albumin and aI-antitrypsin was measured in HepG2 cells by pulse-
chase experiments. Non-targeting (control), sedlin and Bet3 siRNA-treated 
cells were pulsed for 10 minutes with eSS]-methionine and eSS]-cysteine, 
washed extensively, and then chased for the indicated times. The 
supernatant was collected and the cells were lysed at each time point and the 
amount of labelled proteins analyzed by immunoprecipitation and 
autoradiography. Sedlin-KD cells did not show any significant difference in 
the amount of secreted albumin or aI-antitrypsin compared to control cells 
(Figure 3.7). By contrast, TRAPP depletion significantly inhibited the 
release of the two soluble cargoes (Figure 3.7). 
I then defmed the trafficking step where the transport of the different 
cargoes was impaired as a consequence of TRAPP depletion by evaluating 
the glycosylation state of the neosynthesized a I-antitrypsin as an index of 
its progression along the secretory pathway. 
As shown in Figure 3.7, TRAPP depletion only marginally inhibited the 
ER-to-Golgi transport of aI-antitrypsin (as judged by the acquisition of the 
endo-H resistance after 20 minutes). These data suggested the existence of a 
intra- or post-Goigi transport block that would explain the marked inhibition 
of aI-antitrypsin release in TRAPP-depleted cells. Similarly to VSV-G, the 
rate of arrival of the protein to the Goigi complex was almost 
indistinguishable from that measured in control cells, while its progression 
to the PM was markedly inhibited. 
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Figure 3.7 Sedlin depletion does not inhibit smaU soluble cargo secretion in RepG2 cells. (A) 
HepG2 cells were mock (CTRL), sedlin- or Bet3-siRNA treated for three days. Cells were then 
pulse/chased as described in Materials and Methods. Media and cell lysates were 
immunoprecipitated with anti-albumin (left) or anti-al-anti-trypsin (aI-AT, right) antibodies, 
separated by SDS-PAGE and quantified using InstantImager. Mean values (±SD) from three 
independent experiments perfonned in duplicate. Control and sedlin-KD cells secrete both 
albumin and aI-AT at a similar rate, while Bet3-KD cells show a significant delay in the 
secretion of both cargoes. (B) Endoglycosidase H resistance analysis of a I-A T in control and 
Bet3-KD HepG2 cells. Control and Bet3-KD HepG2 cells were pulse/chased as described in (A). 
After immunoprecipitation of cell Iysates the samples were treated (+) or not (-) with 
endoglycosidase H and then analysed by SDS-PAGE and autoradiography (top panel). aI-AT 
shows three discrete bands (mature, P I and P2). PI is the a I-A T band sensitive to the EndoH. 
(Panel labels in top). The graph shows quantification of the PI band, mean data (±SO) from 3 
independent experiments run in duplicate. No differences are detected between mock and TRAPP 
depleted cells, meaning that the a I-AT arrival to the GC is not impaired. 
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Moreover, similar results from the CD8 analysis (whose arrival to the PM 
but not to the GC was severely impaired in TRAPP depleted cells) 
reinforced this hypothesis. 
Together with the above results on the Golgi complex disorganization 
induced by TRAPP depletion, these results on the trafficking of 
neosynthesized proteins show that the TRAPP complex is required for the 
structure and the function of the Golgi complex. 
By contrast, sedlin depletion alone does not affect neither the structure of 
the Golgi complex nor the trafficking of analysed cargoes. 
3.4.3 Large soluble cargoes 
To evaluate the impact of sedlin and TRAPP depletion on the trafficking of 
large soluble cargo, I chose to analyse procollagen type I (PCI). PCI has 
been extensively studied because of its unique features and "special" 
requirements in terms of synthesis, folding, transport and secretion. 
PCI is a thermo-sensitive synchronizable cargo as it is partially unfolded 
and blocked in the ER at 40°C: in order to leave the ER it needs the 
permissive temperature of 32°C and ascorbic acid (ascorbate), a cofactor for 
prolyl 4-hydroxylase which regulates synthesis and folding of collagens to 
generate a trimeric collagen in the ER (Pinnel et aI., 1987). Following exit 
from the ER, PCI is transported to the Golgi complex and then to the PM 
where it is secreted into the extracellular medium (Mironov et aI., 2001). 
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First, I set up a protocol to obtain very efficient reduction of sedlin and Bet3 
protein levels in human fibroblasts (professional PCI secretory cells) by 
electroporation of the siRNAs and by prolonging the treatment to 96 hours. 
The synchronizable PCI transport assay was then applied to these cells. 
The exit of PCI from the ER was strongly inhibited both in sedlin-KD and 
Bet3-KD fibroblasts (Figure 3.8), in contrast to the other cargo molecules 
described above. The small fraction of PCI that reached the OC in these 
fibroblasts remained blocked in this compartment. 
I measured also the ability of control, sedlin and Bet3 siRNA-treated HFs to 
secrete PCI into the extracellular medium. Both sedlin-KD and Bet3-KD 
cells showed a decreased amount of secreted PCI compared to control cells 
(Figure 3.8). 
To test whether the impaired exit of PCI from the ER upon sedliniTRAPP 
depletion was induced or exacerbated by cargo overload in the ER during 
the 40°C block, sedlin-KD and Bet3-KD fibroblasts were treated with 
ascorbate for 24 hours at 37°C, to facilitate PCI intracellular trafficking. The 
cells were then fixed and PCI distribution analysed by immunofluorescence. 
PCI was found at the OC in control cells but was localised in the ER and in 
the OC in both sedlin-KD and Bet3-KD cells (Figure 3.8). Thus, the defect 
in PCI exit from the ER in sedlin and TRAPP depleted cells is not due to 
protein overload or temperature stress, but instead is a very specific effect of 
sedliniTRAPP impainnent. 
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Figure 3.8 Sedlin and TRAPP complex a re electively required for ER exit of p rocolJagen 
type I in human fibroblasts. (A) HF cells were mock ( TRL), sedlin- or Bet3-siRNA treated for 
96 hours. Cells were infected with VSV -ts045 for I hour at 32°C and then shifted to 40°C for 3 
hours, to accumulate both PCI (red) and V V-G (green) into the ER. Fibroblasts were either fixed 
or incubated for 30 minutes at 32°C in the pre ence of ascorbate and HX and fixed. (Upper 
panels) During the temperature block, mock, sedlin-KD and Bet3-KD cells accumulate PCI and 
VSV-G inside the ER. (Bottom panels) After the addition ofCHX and ascorbate, cells were shifted 
to 32°C for 30 minute, fixed and stained. In control cells both V V-G and P I localise in the 
perinuclear area. PCI fails to exit the ER in sedlin-KD and Bet3-KD cells while VSV- reache the 
GC similarly to control cells. Scale bars, 10 11m. (B) Quantitative analysis of the ER exit of PCI 
(top) and of pcr secretion (bottom) in human fibroblasts. ER exit is expressed as % of cells with 
PCI in the ER while PCI secretion is expressed as % of total PCI (pCI in the mediumIP T in the 
medjum+PCI in the cell). The data refer to 5 independent experiments run in duplicate. The graphs 
report mean values (±SD) (n =200). (C) PCI transport in HFs without the synchronisation protocol. 
Mock, sedlin-KD and Bet3-KD cells were incubated at 37°C for 24 hours in the presence of 
ascorbate. Cells were then flXed and stained for P I (red). In control cells, PCI is mainly localised 
in the perinuclear area, while in sedlin-KD and Bet3-KD ceIls it is still present into the ER. cale 
bars, 10 11m. 
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Identical results were obtained analysing ER-to-Golgi transport of 
endogenous PCI in rat fibroblasts (NRK) after sedlin and Bet3 depletion 
(Figure 3.9). 
To directly compare the differential effect of sedlin and TRAPP depletion 
on ER exit of different cargoes, I then studied the trafficking of VSV -G and 
PC-I within the same cells. As above, while VSV -G reached the GC, PCI 
was retained into the ER in sedlin-KD and Bet3-KD cells (Figure 3.9). 
3.4.4 Total protein secretion 
Finally, in order to assess in an "unbiased" way (i.e. not looking at specific 
cargoes) the role of sedlin in the secretory pathway, I studied its role in total 
protein secretion. To this end, HeLa cells were transfected with control or 
sedlin siRNAs and the cells were then pulsed with eSS]-methionine and 
eSS]-cystheine for 1 hour followed by a chase for 3 hours. As a positive 
control for conditions that block total protein secretion, HeLa cells were 
treated with brefeldin A (BFA), an inhibitor of protein export, and subjected 
to the same pulse-chase experiment. Media from the three conditions were 
collected at 0, 1,2, and 3 hours of the chase and analyzed by SDS-PAGE on 
4%-15% gradient gels (to separate the high- and low-molecular weight 
polypeptides on the same gel) followed by autoradiography. 
BFA treatment, as expected, efficiently inhibited total protein secretion 
from HeLa cells, since no bands were visible even after 3 hours (Figure 
3.10). 
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Figure 3.9 Sedlin and TRAPP complex are selectively required for ER exit of procollagen 
type I in NRK49F fibroblasts. (A) Mock (CTRL), sedlin-KD, and Bet3-KD NRK49F were 
analyzed for PCI and V V-G trafficking as described in Figure 3.8 (A). cale bars, IO!IDl. (B) 
Quantitative analysis of the ER exit of per in NRK fibrobla t . ER exit is expressed a % cells 
with PCI in the ER. The data (means ± D) refer to 3 independent experiments run in 
duplicates (n=100). (C) NRK fibroblasts (NRK49F) were treated with the indicated siRNA. 
Cell Iysates (60 ~g/sample) were analyzed by SDS-PAGE and immunoblotting with the 
indicated antibodies. p-actin was used as a loading control. Asterisk indicate non- pecific 
band. Note that sedlin KD does not the affect protein levels of other TRAPP ubunits, BeG or 
synbindin. 
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Figure 3.10 Sedlin-KD does not affect total secretion in BeLa cells. HeLa mock treated 
(CTRL) or edlin siRNA (sedlin-KD) treated cells were pulsed with -e5S]-cy theine and 
methionine for 60 minutes, then wa hed and cultur d in tandard medium with unlabelled 
methionine. After 0.5, 1, 2 and 3 hours the medium was analyzed by D -PAGE fo llowed 
by autoradiography. As a negative control, mock cells were treated with 101lg/ml BFA (a 
blocker of protein secretion) for the last ten minute of the pulse and during the chase. 0 
significant difference is detectable between edlin-KD and control cell , while BFA-
treated cells fail to secrete any protein. 
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Importantly, sedlin knockdown did not affect the overall amount of protein 
secreted by HeLa cells (Figure 3.10). These findings indicate that sedlin 
does not have a role in global protein secretion but in contrast exerts a 
specific role in PCI secretion. 
Sedlin is selectively required for PCI to exit the ER, but it is dispensable for 
ER exit of all the other analysed cargoes (transmembrane and small soluble 
ones). Also the TRAPP complex is selectively needed for ER export of PCI 
but not of other cargoes, even though the absence of a functional TRAPP 
has an inhibitory effect on intra-Golgi and Golgi-to-PM trafficking steps. 
3.5 Rabl is not involved in the selective inhibition of the ER exit of PCI 
Next, I dissected the molecular mechanism underlying the requirement for 
sedliniTRAPP in PCI export by analyzing the involvement of a known 
TRAPP effector, the small GTPase Rabl. 
Rab 1 has been implicated in the tethering and fusion reactions occurring 
during ER-to-Golgi trafficking. COPII vesicles, which develop from 
specialized exit sites on the endoplasmic reticulum (ER exit sites: ERES), 
are tethered together by the action of Rab 1 together with its effector p 115 to 
give rise to vesicular-tubular clusters (VTCs) adjacent to the Golgi (Allan et 
aI., 2000; Alvarez et aI., 1999; Bannykh et aI., 1996; Cao et aI., 1998). As 
mentioned above, recent findings show that TRAPP binds COPII vesicles 
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by direct interaction with the coat, thus providing a mechanism to ensure 
that all vesicles can recruit active Rabl (Cai et aI., 2007). Indeed, the 
TRAPP complex acts as a GEF for Rabl. In addition to its role in COPII 
vesicle tethering, Rab 1 may also have a function in regulating the exit of 
secretory cargo from the ER. This idea derives from the observation that 
Yptl and Usol, the yeast homologues ofRabl and plIS, respectively, were 
found to play a role in coupling the sorting of secretory cargo to vesicle 
formation (Morsomrne and Riezman, 2002). 
Thus, I assessed whether the defect in PCI transport out of the ER observed 
in TRAPP depleted cells could be ascribed to Rabl. To this end I used two 
approaches: I assessed the effect of sedliniTRAPP depletion on the Rab 1 
cycle in living cells and examined whether or not the depletion of Rab 1 
(both Rab 1 a and Rab 1 b) reproduced the secretory phenotype of 
sedliniTRAPP depletion. Rab GTPases switch between a GTP-bound state 
in which they are membrane-associated and a GDP-bound state in which 
they become cytosolic upon membrane extraction by the Rab GDI (Seabra 
and Wasmeier, 2004). Thus, the membrane-cytosol cycle of Rab GTPases 
reflects their GTP/GDP bound state and the rate of membrane release of 
Rab GDP (as assessed by FLIP) gives an indication of the 
RabGDPlRabGTP ratio (McCray et aI., 2010). 
The rate of release of Rab 1 from membranes, as measured by FLIP (see 
Materials and Methods) was unaffected in sedlin-KD cells (Figure 3.11), 
thus indicating that sedlin depletion does not affect the Rab 1 cycle. This 
observation is consistent with the report that sedlin is not required for the 
Rab 1 GEF activity of TRAPP in vitro (Kim et aI., 2006). 
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Figure 3.11 Bet3-KD, but not sedlin-KD, affects the Rabl cycle. Human fibroblasts 
were treated with non-targeting (CTRL), sedlin, or Bet3 siRNAs and then transfected with 
aRab I-GFP construct by micro-injection . The control and silenced cells were analyzed in 
Fluorescence Loss In Photobleaching (FLIP) experiments to assess the cycle of Rab I at 
the Golgi complex (see Materials and Methods). While GFP-Rabl has comparable 
dynamics in control and sedlin-KD cells, it dissociates faster from membranes in Bet3-KD 
cells. The values are the mean (±SD) from 4 independent experiments, n= 15. The FLIP 
half-life (tid is indicated. 
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By contrast, depletion of the entire TRAPP complex by Bet3 KD severely 
altered the cycle of Rab 1, which was more readily released from the Golgi 
membranes (Figure 3.11). Since Bet3 KD causes Golgi fragmentation, I 
considered the possibility that the faster dissociation of Rab 1 from Golgi 
membranes might be a non-specific consequence of this fragmentation. To 
this end, the GFP-Rabl cycle was measured using an alternative approach 
that leads to GC fragmentation. Cells were treated with GM130 siRNAs 
(Marra et aI., 2007) to induce Golgi vesiculation. Upon GMl30 depletion 
GFP-Rabl showed the same rate of association and dissociation to and from 
membranes as control and sedlin-KD cells (not shown). This finding rules 
out the hypothesis that the Rabl cycle depends on the integrity of the GC. 
Importantly, the depletion of Rabl by the combined KD of Rabla and 
Rab 1 b mimicked the effects of TRAPP depletion on the Goigi complex, 
which was extensively vesiculated (Figure 3.12), but did not reproduce the 
selective inhibition of PCI exit from the ER observed upon sedlin (and 
TRAPP) depletion in HFs (Figure 3.13). 
The above data solicited a search for molecular mechanisms underlying the 
requirement for sedlin in the ER export of PCs. Our first consideration was 
the possibility that sedlin affects the machinery responsible for cargo export 
from the ER, which is driven by the small GTPase SarI. 
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Figure 3.12 Rabl depletion affects Golgi comple morpbology. (A) HFs were mock 
(CTRL) treated or treated with specific siRNA directed against the A and/or B isoforrns of 
Rabl. 96 hours after electroporation (see Materials and Methods) cells were lysed and 30 
I-lg of total Iysates were eparated by SDS-PAGE and processed for imrnunoblot analysis. 
Notably, RablA-KD does not cause any alteration in Rab lB levels and vice versa. [3-actin 
was used as a loading control. (B) HFs were treated with siRNAs as described in (A), then 
fixed and stained to evaluate the GC structure by indirect immunofluore cence. While in 
control cells giantin (green) highlights a continuous Golgi structure, under Rab I depletion 
giantin marks a very fragmented Gc. Scale bars, 10 !lID. 
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Figure 3.13 Rabl depletion induce ve iculation of the Golgi complex but doe not 
induce the selective inhibition of PCI exit from the ER. (A) Human fibroblasts were 
treated with non-targeting iRNA (CTRL) or iRNAs again t both RablA and RablB 
isoforms (Rab I KD) for 96 hrs, incubated at 400 to synchronize cargo tran port, shjfted 
to 320 for 30 minute and then stained for P I (red) and giantin (a Golgi marker). P I 
reaches the giantin po itive compartment under both control and Rabl-KD conditions. 
cale bars: 20 /ilTl. (B) V Vt 045-infected human fibroblasts were treated as in (A) and 
stained for P I and V V-G. Both analy ed cargoe leave the ER similarly in control and 
Rabl -KD cell . cale bar : 20 /ilTl. (C) Quantitative analysis of the transport ofP lout of 
the ER. The data, expressed as % of cells with P I in the ER, are mean value (± D) of 
four independent experiment in duplicate (n=200). 
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3.6 Sed lin effectors: sedlin binds SarI 
To characterize the role of the sedlin protein, I first assessed its subcellular 
localisation using a specific anti-sedlin antibody. Western analysis of total 
cell lystaes from HeLa cells identified a band of 14 kDa, corresponding to 
the molecular weight of sedlin. Moreover, this band is sensitive to sedlin 
siRNA treatment, implying that this antibody can specifically recognize 
sedlin (Figure 3.14). Immunofluorescence experiments on He La cells with 
the anti-sedlin antibody showed a spotty perinuclear staining pattern 
together with a very bright nuclear staining (Figure 3.14). The presence of 
sedlin in the nucleus has been reported previously where it may regulate 
transcription by interacting with PAM14, MBP-l, SF-l and PTX-l (Liu et 
aI., 2010; Jeyalaban et aI., 2010). The identity of the spotty perinuclear 
stuctures was analysed using different compartment-specific markers. 
Sedlin shows a very clear colocalisation pattern with the ER exit site 
(ERES) marker Sec31 (Figure 3.14). On the other hand, sedlin was not 
found on the Goigi complex as shown by colocalisation analyses using 
different Golgi markers, either under control conditions or after nocodazole 
treatment (Figure 3.15). Nocodazole, a microtubule-depolymerising drug, is 
widely used to precisely define the localisation of a protein on the GC. The 
formation of so-called "mini-stacks" allows the clear determination of the 
protein at the GC and its cis- or trans-side localisation. After nocodazole 
treatment, sedlin does not localise at the GC, but remains in the proximity of 
the mini stacks. Similar behaviour was also observed for COPII components 
(Figure 3.16). 
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Figure 3.14 edlin localises at the ER exit sites in BeLa cell . (A) HeLa cell were 
treated with non-targeting siRNA (CTRL) or sedlin siRNAs for 72 hrs, then cells were 
lysed and 60 Ilg of total protein were subjected to 0 -PAGE analysis. Immtmoblot 
using a pAb against sed lin recognises a protein of 14 kDa (corresponding to sedlin) 
sensitive to the siRNA treatment. ~-actin wa used as a loading control. (B) Control HeLa 
cells were fixed and stained with the same anti-sedlin Ab used in (A) (green) and with an 
anti-Sec31 Ab (red). DAPI stain cell nuclei . White arrows indicate edlin- ec31 po itive 
ERE . Scale bar : 10 1lIn. 
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Figure 3.15 edlin doe not localise at the Golgi complex. HeLa cell were eeded on 
glass coverslips. The next day, cell were fixed imm diately or tr ated for 3 h ur with 
nocodazole at 37°C and fixed. (A) Immunofluorescence analyse of control cell how 
that edlin (green) appear locali ed in potty structures (corre ponding to ER , ee 
Figure 3. 12) in proximity to the G , tained using giantin (red) and TG 46 (blue). (B) 
After nocodazole treatment, sedlin locali es close to but does not co-localise with the 
Golgi mini- tacks. White boxes delimitate higher magnifications, hown in the lower 
panels of (A) and (B). cale bar : 10 11m. 
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Figure 3.16 edlin colocali e with ec31 upon nocodazole treatment. Control 
HeLa cells were treated a de cribed in Figure 3.15. Immunofluore cence analy e 
show that sedJin (green) i still clo e to the Golgi mini- tack after nocodazole 
treatment, but does not co-localise with TGN46. In tead, sedlin co-Iocali e perfectly 
with ec31 (red). White boxes delimitate higher magnification , shown on the right 
ide. White arrows indicate the TGN46 mini-stacks. cale bar: I 0 ~m. 
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The COPII-sedlin localisation was performed under the same conditions and 
sedlin still colocalised with Sec31, indeed to an even greater extent (Figure 
3.16). 
I also followed the distribution of sedlin in (HeLa) cells treated cells with 
Befreldin A (BFA). BFA is a fungal toxin that provokes the redistribution of 
the GC into the ER, by inactivating Arfl, a GTPase that governs the 
structure and function of the GC. Upon BFA treatment the GC disassembles 
and Golgi enzymes are redistributed into the ER while Golgi matrix proteins 
of the cis-compartments relocalize in small punctate structures representing 
Golgi remnants. The ERES components are instead unchanged upon BFA 
treatment. Confirming its association with ERES, sedlin did not undergo 
redistribution upon BFA treatment, but still colocalized with Sec31-positive 
structures (Figure 3.17). 
To further test the association of sedlin to ERES, I treated HeLa cells with 
CI-976, a compound that inhibits lysophospholipid acyl-transferase activity 
thus preventing COPII budding events (Brown et aI., 2008) and leading to 
accumulation of COPII at the ERES. Under these conditions, I observed that 
sedlin was even more associated to Sec31, demonstrating that its binding to 
COPII components is dynamically dependent on their cycling (Figure 
3.18). 
The localisation of sedlin at ERES is not completely unexpected, 
considering the fact that Bet3, the protein mainly responsible for sedlin 
presence into the TRAPP complex, binds directly to another COPII protein 
Sec23 (Cai et aI., 2007). 
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Figure 3.17 edlin still colocaH es with ec31 upon BFA treatment. Control HeLa cells 
were fixed or treated for 30 minute with BFA (2.5 Ilg/ml) and then fixed and proces ed 
for immunofluorescence analysis. edlin (green) ti ll co localises with ec31-po itive 
structures (green) after BFA treatment. DAPI was used as a nuclei marker. cale bar: 10 
11m. 
148 
Q) 
...... 
ro 
'tn 
>-
"'0 
ro 
Q) 
...... 
V'I 
\D 
t--. 
0\ 
I 
U 
c 
E 
o 
\D 
t--. 
0\ 
I 
U 
c 
Figure 3.18 Sedlin is recruited to the ERES in the presence of the 1-976 fi sion 
inhibitor. Control HeLa cells were fixed or treated with CI-976 for the indicated time (10 
/-lM) and then fixed and processed for immunofluorescence analysis. Since 1-976 is an 
inhibitor of COPII fission, ec31 (green) is progressively recruited to the central ERE 
after the addition of the inhibitor. Under the same conditions, sedlin (red) i recruited to 
Sec31-positive structures (green). DAPI was used as a nuclear marker. cale bar: 10 /-lm. 
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In this scenario, one possibility is that the whole TRAPP complex localises 
at ERES via Bet3-Sec23 interaction and that sed lin localisation is driven by 
Bet3-binding to COPII. The second possibility is that sedlin can localise to 
the ERES independently of Bet3. 
I explored this possibility, also in the light of peculiar structural features of 
sedlin that, as described in the Introduction), is essentially composed of a 
longin domain. Longin domains have been proposed to exert a large variety 
of membrane trafficking processes (Rossi et aI., 2004). Members of this 
family act as regulatory modules in different classes of proteins, mainly 
SNAREs, such as Ykt6, Sec22b, Vamp7 and others (Schenkler et aI., 2006). 
Recently, longin domains have been also shown to be involved in the 
regulation of small GTPases belonging to ArfiSar family (Schenkler et al., 
2006). This is the case of signal recognition particle (SRP) and its receptor 
(SR). 
SRP and its receptor (SR) are involved in targeting of nascent secretory and 
membrane proteins to ER membranes (Keenan et aI., 2001; Luirink and 
Sinning, 2004). SRP recognizes N-terminal hydrophobic signal sequences 
as they emerge from the ribosomal polypeptide exit tunnel. The complex is 
targeted to the SR at the membrane, and the ribosome-nascent chain 
complex is transferred to the translocon. Thus, SRP and SR are the 
"initiation factors" of protein translocation mediating both targeting and the 
formation of the ribosome/translocon junction. Upon GTP hydrolysis in 
SRP and SR the complex dissociates (Doudna et aI., 2004; Wild et al., 
2004). Both SR and SRP are complex structures: SRP is a ribonucleoprotein 
consisting of six distinct protein subunits and one RNA subunit (Walter and 
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Blobel, 1980; Walter and Blobel, 1982). The SR complex consists of a 
heterodimeric membrane protein of two GTPases, SRa and SR~, of 69 kDa 
and 30 kDa, respectively (Tajima et aI., 1986). SRa mediates the binding to 
SR~ anchored to the ER membranes through its N-terminal domain, called 
SRX. SRX is a globular domain of 130 amino acids belonging to the 
SNARE-like superfamily, known as longin domains (Schwartz et aI., 2003; 
Filippini et aI., 2001). The interaction of SRX (the longin domain) and SR~ 
is very similar to other GTPase-effector complexes, strongly suggesting a 
co-GAP function (Schenkler et aI., 2006). Sequence homology within the 
members of the longin domain family is very low, but the structural 
homology is remarkably high. The structural homology between sedlin and 
SRX had been noted by Schenkler et aI. (2006) who reported a very nice fit 
of sedlin with SRX (Figure . .in Schlenker et aI.). As noted above, SRX binds 
SR~, which belongs to the Arf-Sar family and SarI is the aTPase 
responsible for the assembly, formation and regulation of COPII carriers. 
Thus, I tested whether sedlin and SarI might interact similarly to SRXI SR~. 
In collaboration with Dr. Alex Spaar, based on this structural similarity 
existing between the two proteins, we superimposed SarlA-GTP and sedlin 
onto the SR~:SRX complex and generated a model of a putative complex 
between SarI and sedlin (Figure 3.19). 
Prompted by this homology modelling I investigated whether sedlin can 
directly interact with Sar 1. I assessed sedlin-Sar 1 binding (both the A and B 
isofonns) in pull-down assays and found that aST-sedlin, but not aST 
alone, was able to bind both SarlA and SarIB (Figure 3.20). 
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Figure 3.19 Modelling of the sedlin-Sarl interaction. Superimposition modelling shows 
that the sedlin structure overlaps with that of the longin domain of SRX. Sar l is the GTPase 
most similar to SR (SRB), as reported by Schenkler et aI. , in 2006. The modelling wa 
created in collaboration with Dr. Alex Spaar. 
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Figure 3.20 Sed lin binds directly to SarI in vitro. Pull-down assays were performed on 
glutathione-Sepharose beads using increasing concentrations of His- arl (both A and B 
isoforms, 0.1, 0.3, I j.iM) with GST-sedlin or GST alone (each 0.5 ~). Input, 200ng Sari 
(equivalent to 2.5% of the amount used in the I ~ incubation). Sedlin binds similarly to 
both Sari isofroms. The graphs report the results of the quantitative analysis of edlin-
Sari binding. Values are expressed as % of the sedlin-Sarl binding relative to I ~M His-
Sari (Maximum), and are the means (± SD) of three experiments performed in duplicate. 
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Among the TRAPP subunits tested, only SarI bound specifically to sedlin, 
as neither Bet3 nor Trs31 could pull down Sar I in the same assay (Figure 
3.21). 
I next checked the dependence of this interaction on the nucleotide bound 
state of SarI and found that sedlin preferentially interacts with Sarl-GTP 
(Figure 3.22). Taking advantage of the structural homology existing 
between sedlin and SRX (Schlenker et aI., 2006) and between SarI and SR~ 
we modelled the sedlin-Sarl complex on the SRX- SR~ complex and 
identified a putative interaction surface between sedlin and SarI (Figure 
3.23). To define the site of interaction between sedlin and SarI, we used the 
docking programs PatchDock (Schneidman-Duhovny et aI., 2005) together 
with FireDock (Mashiach et aI., 2008), and identified the energetically more 
favorable configurations of the sedlin-Sar I complex. Several of the lowest 
energy docking models basically showed the same binding interface as the 
structure obtained by superimposing sedlin-Sarl with SRX-SR~ (shown in 
Figure 3.19), but with a rotation of around 180°. From this docking analysis 
and from the collaboration with Dr. Spaar, I was able to predict that the 
His13 residue of sedlin should participate in the sedlin-Sarl interaction 
(Figure 3.24). Indeed, we found that the single point mutant H13A sedlin 
has a greatly impaired ability to interact with SarI (Figure 3.24). This 
finding was very important as it adds a new level of interaction between the 
COPII-TRAPP machineries. 
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Figure 3.21 Sedlin, but not other TRAPP subunits, specifically interacts with SarI. 
Pull-down assays were performed on glutathione-Sepharose beads using 1 ).1M of Ris-Sarl 
with GST-sedlin, GST-BetJ, GST-Trs31 or GST alone (each 0.5 ).IM). Input, 200ng SarI 
(equivalent to 2.5% of the amount used in the 1~ incubation). Sedlin is the only TRAPP 
subunit to bind SarI. The graph reports the results of the quantitative analysis of SarI 
binding. Values are expressed as % of the sedlin-Sarl binding relative to 1 ).1M His-SarI 
(Maximum), and are the means (± SD) of three experiments performed in duplicate. 
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Figure 3.22 Sedlin interacts with SarI in a GTP-dependent manner. Pull-down assays 
were perfonned using increasing concentrations (0.1, 0.3 and 1 IJM) of His-Sar I T39N (the 
GDP-restricted mutant) or His-SarlH79G (the GTP-restricted mutant) with GST-sedlin, or 
GST alone (each 0.5 IJM). Input, 200ng SarI (equivalent to 2.5% of the amount used in 
the IIJM incubation). Sedlin binds efficiently to the H79G mutant of Sar I, but has a lower 
affmity for the GDP-bound mutant. Thus, the nucleotide association state of SarI affects 
sedlin binding. The graph reports the results of the quantitative analysis of SarI binding. 
Values are expressed as % of the sedlin-Sarl binding relative to 1 IJM His-Sari 
(Maximum), and are the means (± SD) of three experiments perfonned in duplicate. 
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Figure 3.23 Homology modelling of sedlin-Sarl interaction based on SRX-SRB 
interaction. (A) Homology modelling of the sedlin-Sar l complex on the SRX-SRP 
complex (see Schlenker et aI. , 2006). Sedlin has structural homology with SRX (Figure 9 
in Schlenker et aI., 2006, not shown here); Sari was modelled on SRJ3 as also described in 
Figure 3. 17. (B) Close up of the interaction surface between sedl in (cyan) and arl 
(orange) showing the involvement of the H 13 residue, predicted to be critical for the 
interaction between the two proteins. 
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Figure 3.24 Sedlin R13 residue is critical for the interaction with SarI. Pull-down 
assay were perfonned using increasing concentration (0. 1, 0.3 and I 11M) of His- arl 
with G T-sedlin wild type, G T-sedlin H 13A or GST alone (each 0.5 !J.M). Input, 200ng 
Sari (equivalent to 2.5% of the amount used in the I f.!M incubation). The H 13A mutant 
has low affinity for Sari. The graph reports the results of the quantitative analysi of arl 
binding. Values are expressed as % of the edlin-Sari binding relative to I 11M His- arl 
(Maximum), and are the means (± D) of three experiment performed in duplicate. 
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Recent evidence has shown that, at least in yeast, Bet3 interacts with Sec23 
only when Sec23 is not engaged in an interaction with SarI (Lord et aI., 
2011), in a fashion that guarantees the sequential and the proper direction to 
anterograde transport. SarI is associated with eOPII carriers during the very 
early stages of eOPII carrier formation but it is released faster than the 
other eOPII components (Le. Sec23/24 and Sec13/3I). This is consistent 
with the observation that eOPII vesicles have sub stoichiometric amount of 
SarI compared to Sec23/24 and Sec31113 (Barrowman et aI., 2000). The 
interaction I report here between sedlin and Sar 1 would occur at an earlier 
step, i.e. during vesicle budding, suggesting a possible involvement of 
sedlin in a very initial stage of eOPII assembly. 
To ascertain whether sedlin binds Sar 1 also in the presence of Sec23, I 
designed a GST-pull down assay to explore this possibility. SarI was loaded 
with GTPyS overnight at 4°e. The next day it was incubated with Sec23 and 
with GST -sedlin or GST alone. GST alone, as expected, failed to bind any 
protein, while GST -sedlin was able to bind SarI together with Sec23 
(Figure 3.25). This experiment demonstrated clearly that the sedlin-Sarl 
interaction is compatible with Sarl-Sec23 binding. 
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Figure 3.25 Sed lin binds Sari complexed with Sec23. (A) Pull-down assays were 
perfonned using 1 IJM of His-Sec23 with GST-sedlin, GST-Bet3 or GST alone (each 0.5 
IJM). Input, Sec23 equivalent to 10% of the amount used in the IIJM incubation. GST 
sedHn fails to pull down Sec23, while GST-Bet3 interacts with Sec23, as expected and as 
reported by Cai et al. (2007). (B) Pull-down assays were perfonned using I IJM of His-
Sec23, IIJM of His-Sari with GST-sedlin or GST alone (each 0.5 IlM). His-SarI was pre-
loaded overnight with GTPyS. Input, Sec23 equivalent to 2.5% of the amount used in the 
IIJM incubation. GST-sedlin on its own fails to pull down Sec23, but in presence of SarI 
it can bind to the complex. This finding shows that sedlin can contact SarI when it is 
active and bound to Sec23 . 
160 
3.7 Sedlin associates to the ERES in a SarI-dependent fashion 
To corroborate the in vitro assays described above, I explored the functional 
correlates for the sedlin-Sarl interaction in vivo by co-localization studies 
and by an assessment of reciprocal effects on their membrane-cytosol cycle. 
Hela cells were transfected with the GFP-Sarl wild type protein and the 
GFP-SarlH79G mutant (see Introduction) and assayed for effects on the 
localisation of sedlin. No perturbation of the sedlin distribution was 
observed in cells over-expressing GFP-Sarl (Figure 3.26). In cells 
expressing GFP-SarlH79G, however, sedlin underwent a dramatic 
reorganisation and was recruited to Sar 1 H79G positive structures (Figure 
3.26). To test whether sedlin recruitment to GFP-SarlH79G structures was a 
primary effect mediated by sedlin-Sarl interaction, I micro-injected the His-
SarlH79G protein into cells to observe the acute recruitment of sedlin to the 
ERES (Figure 3.26). As shown in Figure 3.26, sedlin was rapidly recruited 
to ERES (stained with Sec31 protein), soon after the injection and increased 
during the time course of the experiment (1, 1.5 and 3 hrs post injection). 
Together these data support the hypothesis that sedlin and Sar 1 can interact 
in vivo. Despite the fact that SarI locked in its active state recruits sedlin in 
vivo, this alone does not provide an answer about the role of Bet3 at this 
stage. To address this point, I analysed the role of Sec23 in the binding 
between sedlin and SarI. He La cells were treated with specific siRNAs 
directed against Sec23 (A and B isofonns), which reduced the Sec23 protein 
in the cell (Figure 3.27). 
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Figure 3.26 SarlH79G recruits sedlin in vivo. (A) HeLa cells were tran fecled with a 
plasmid encoding a GFP- arl H79G protein. After 16 hours of expres ion, cell were fixed 
and proces ed for immunofluore cence analysis. ote that the GTP-restricted mutant of 
Sari (green) accumulates at the perinuclear region, as well as Sec31 (blue). Under these 
conditions, sedlin (red) i almo t completely recruited to the positive SarI-structures. 
White arrowhead highlight the recruitment to arl-positive structures. cale bar, 10 11m. 
(B) HFs were micro-injected with 2.5 mglml of the His- arlH79G protein and left for I 
hour at 37°C. Cells were then fixed and tained for ec31 (green) and sedlin (red). After 
injection, both sedlin and ec31 change their usual locali ation and appear to be 
concentrated at a perinuclear area. The white arrow-head indicates the injected cell. Bar, 
10 JlfD. 
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Figure 3.27 ec23 depletion doe not impair edlin- arl interaction in HeLa cell . 
HeLa cells were mock or ec23 iRNA treated as de cribed in Material and Method. 
ec23 depletion doe not cause destabili ation of the other OPII ubunits analy ed 
( ec3l or ar I). Control and ec23-KD cell were fi ed and tained with a marker of the 
ERE (ec3l, green) and with scdlin (red). In ec23-KD cells, ec31 appear to be 
redi tributed compared to control cells, while edlin accumulate in structures mainly 
locali ed in the perinuclear region. In parallel, control and ec23-KD cells were fixed and 
stained for the presence of arl (green, bottom panel ). In cells with reduced ec23, edlin 
colocalises with arl. (Right) HeLa cells were treated as de cribed above. ell Iysates (60 
Ilglsample) were analyzed by SD -PAGE and immunoblot analy i with the indicated 
antibodies. p-a tin wa used a a loading control. 
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After 72 hrs, control and siRNA treated cells were fixed and processed for 
indirect immunofluorescence experiments. After Sec23 siRNA treatment, 
Sec3I did not form the spotty structures with a perinuclear concentration 
typical of control cells but appeared to be dispersed throughout the cytosol. 
Moreover, Sec3I was present in few round structures distributed throughout 
the cell (Figure 3.27). By contrast, sedlin was distributed in very large and 
bright roundish structures located all around the nucleus, very different from 
the Sec3I-positive structures (Figure 3.27). 
The colocalisation of sedlin and Sec31 was no longer detectable under 
Sec23-KD conditions. The sedlin positive structures, however, showed 
positive staining for the presence of SarI (Figure 3.27). This finding shows 
clearly that sedlin binds SarI even in absence of functional Sec23, and by 
extension that Bet3 is dispensable for the interaction of the two proteins. 
Moreover, these data enforce the hypothesis that sedlin can interact with the 
COPII machinery before the Bet3-Sec23 interaction, which, according to 
the current literature, should occur after COPII formation and budding (Yu 
et aI., 2006, Cai et al., 2007; Lord et aI., 2011). These data shed a 
completely new light on the interactions between TRAPP-COPII, revealing 
a new and, until now, hidden player, sedlin. 
3.8 Sedlin controls the membrane-cytosol cycle of SarI and COPII 
I next investigated the role of sedlin in the SarllCOPII cycle by following 
the dynamics of the membrane-cytosol cycle of a COPII component (OFP-
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Sec23) in control and sedlin-KD cells using FRAP analysis. This method 
allows the precise calculation of the half-life of COPII subunits at the level 
of a single ERES (Watson et aI., 2005; Forster et aI., 2006). 
It is essential to use low-level expression of fluorescently tagged proteins to 
ensure faithful replication of the behaviour of the endogenous protein. 
Moreover, to limit in time the expression of the fluorescent protein I also 
microinjected the GFP-Sec23 eDNA into the nuclei of cells. The GFP-
Sec23 localised properly at ERES as shown by co-localisation with Sec31 
(Figure 3.28). 
Analyses of sedlin-KD and Bet3-KD HFs showed a partial redistribution of 
Sec31 structures from the perinuclear area to the cytoplasm, which still co-
localised with the GFP-Sec23 protein (Figure 3.28). 
Using FRAP analysis (see Materials and Methods), a consistently longer 
time of recovery of the GFP-Sec23 fluorescence was observed after 
photobleaching in sedlin KD cells compared to control cells (FRAP half-
time of 9.2 sec and 4.9 sec, respectively, Figure 3.29), indicating that the 
membrane-cytosol cycle of the COPII coat is slowed down in the absence of 
sedlin. In order to understand whether the slower cycle of GFP-Sec23 was 
due to a delayed association to or delayed dissociation from membranes, I 
performed FLIP measurements (see Materials and Methods), to calculate the 
Koff of GFP-Sec23. Sedlin KD slowed down the dissociation of GFP-Sec23 
from ERES membranes as the Koff was 0.032 sec'! in control, 0.022 sec'! in 
sedlin KD and 0.015 sec'! in TRAPP-depleted cells. 
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Figure 3.28 GFP- ec23 properly localise at ERE in buman fibroblast. HFs were 
treated with non-targeting (CTRL), sedlin or BetJ siRNA for 96 hour. Then, a eDNA 
encoding a GFP-tagged ec23 protein (green) wa micro-injected into the nu lei. Five 
hour post-injection, cell were fixed and processed [or immunofluore cence analy i . 
GFP-Sec23 perfectly colocali e with ec 31 (red), a marker of ERE . cale bar : 10 !1m. 
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Figure 3.29 Sedljn depletion lows down the cycle of COPJl. Human fibroblasts were 
treated wi th non-targeting (CTRL), sedlin or BeG specific siRNA fo r 96 hours. ells were 
then micro-injected with GFP- ec23 construct, and single ER ex it site dynamics were 
analysed. An example of Fluorescence Recovery After Photobleaching (FRAP) of a single 
COPlI ( ec23-GFP)-labelled ERES in non-targeting ( TRL), sedlin and Bet3 iRNA-
treated human fi brobla t is shown. The fo ur image show different time points (in 
seconds) of a time-lapse sequence. The white square indicates the bleached RE . The 
bleaching area encompa sing a single ER exit site was maintained constant during a ll 
mea urements. "0" is the firs t image acquired after the bleaching. Sca le bars, 2 )llll. The 
graph shows the tl l2 for the FRAP of the indicated number of E RE in human fi brobla t 
under the three condition: non-targeting (CTRL), edlin and Bet3 siRNA. TRL, n=24; 
sedlin-KD, n=38; Bet3-KD, n=24, where n indicates the number of analyzed pot. 
P<O.OOO I. The experiment wa run three independent time in duolicates with similar 
results. An average of 65 spots (corresponding to the single ERE ) were analy ed for each 
experiments. 
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I reached similar conclusions using an alternative and independent approach 
in which I evaluated the fraction of COPII components remaining associated 
with membranes in permeabilized cells. To this end, I took advantage of a 
temperature-sensitive bacterial toxin, streptolysine 0 (SLO), which can bind 
to cholesterol on the plasma membrane and produce holes in the membrane. 
With this procedure, it is possible to measure the release of cytosolic 
materials without permeabilising any other intracellular organelles (i.e. ER, 
GC or nuclear membranes). Using this procedure, I measured the amount of 
SarI and COPII components associated with membranes (visualised by 
immunofluorescence and quantified by Western blot analysis). I found that 
the levels of the COPII components were significantly and consistently 
higher in sedlin and Bet3 depleted cells compared to control cells (Figure 
3.30). Western blot analyses revealed that Sec3I, Sec23 and Sar I are 
retained more in sedlin-KD cells compared to control conditions. GM130 
and GAPDH, a membrane and a cytosolic marker, were monitored as 
negative and positive controls, respectively (Figure 3.30). The addition of 
GTPyS to the reaction leads to a disappearance of this difference, indicating 
that interfering with SarI cycle impaired the release of the COPII 
components from membranes (Figure 3.30). 
Therefore, not only COPII coat components but also SarI are more stably 
associated with membranes in sedlin depleted and Bet3 depleted cells than 
in control cells (Figure 3.30). This increased association of SarI with the 
ERES in TRAPP-depleted cells was confirmed by IEM and morphometric 
analyses, which show a three fold increase in the labelling density of Sari 
on ERES membranes as compared to mock cells (Figure 4.12). 
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Figure 3.30 copn subunits are more associated to membranes in sedlin and TRAPP 
depleted HeLa cells. (A) He La cells were mock, sedlin or Bet3 siRNA treated for 3 days. Cells 
were then incubated with streptolysine-O in order to remove the cytosolic pool of proteins. ( ee 
Materials and Methods) Images are single optical sections of paraformaldehyde fixed cells 
showing ec31 localization. Oiantin was used as a permeabili ation control. Scale bar, 10 lim .. 
(B) Western blot analyses shows that Sec23 and arl are retajned more both in sedlin-KD and in 
Bet3-KD cells compared to mock cells. OM 130 and GAPDA were monitored as negative and 
positive controls, respectively. Note that the addition of GTPy to the reaction lead to a 
di appearance of thi s difference. The graph reports mean values (± SO) from at least 4 
independent experiments performed in duplicate. 
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Taken together, the above results strongly support the hypothesis that 
sedliniTRAPP controls the membrane-cytosol cycle of SarI, possibly acting 
as a co-GAP. 
3.9 TRAPP acts as a co-GAP for SarI 
As SarI associates with membranes in its GTP-bound state, its prolonged 
association with membranes in TRAPP-depleted cells suggested that 
TRAPP might control the rate of GTP hydrolysis by SarI. GTP hydrolysis 
on SarI requires Sec23/24, which acts as a GAP (GTPase-activating 
protein) (Yoshihisa et aI., 1993), and is accelerated by Sec 13/31 (Antonny et 
aI., 2001). I thus assessed the SarI GAP activity of control cytosol or of 
cytosol immunodepleted for TRAPP (using an anti-Bet3 Ab, see Materials 
and Methods) but containing normal levels of Sec23 and Sec31 (Figure 
3.31). 
His-SarI was incubated alone or in presence of untreated RLC, mock-
treated RLC or TRAPP-depleted RLC, in a buffer containing [32p] a-GTP 
(Jacques et aI., 2001) and the amount of GDP produced was measured by 
separating the two species ([32p]_GDP versus e2p]-GTP) by thin layer 
chromatography after 15, 30, 60, 90 and 120 minutes. SarI alone did not 
show any hydrolytic activity, as expected. Control RLC and mock-treated 
RLC induced a very high and similar activation of the GTPase activity of 
SarI. 
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Figure 3.31 TRAPP depletion significantly reduces Sarl GTPase activity in vitro. 
(A) Rat liver cytosol (RLC, prepared as described in Materials and Methods) wa 
incubated with pre-immune JgG (I) or with Bet3-Ab to deplete TRAPP (2). 60 )lg of 
each RLC were subjected to SDS-PAGE and immunoblot analysis. TRAPP-depleted 
RLC has reduced levels of all the analysed TRAPP subunits (sed lin, Bet3, Trs33A, 
Trs33B and synbindin), while copn components are similar to the mock-depleted 
RLC. (B) A representative TLC is shown of the GAP assay described in (C). (C) 
Recombinant His-Sari was incubated with a_32p GTP alone or with 60 ~lg of mock-
depleted RLC or TRAPP-depleted RLC for the indicated times. TLCs were analysed 
to quantify different a_J2p nucleotide specie. As reported in the graph, TRAPP-
depleted cytosol has a greatly impaired ability to promote Sari GTPa e activity 
compared to mock-depleted cytosol. The GAP activity is expressed as % of a_32p 
GOP over a_32p GDP + a_32p GTP. The graph shows mean values (± SO) from 7 
different experiments performed in duplicate . 
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On the other hand, TRAPP depleted RLC showed strongly reduced Sar 1 
GTPase activity (the percentage of e2p]-GDP produced in control samples 
after 60 minutes is 58.2% ± 1.68, while in TRAPP depleted cytosol the 
percentage is 26.6 ± 5.6%, Figure 3.31). Thus the absence of TRAPP 
severely impairs the cytosolic SarI-GAP activity, prolonging its GTP-bound 
state and thus disclosing a possible mechanism underlying the increase in 
residence time and local concentrations of Sar 1 on ERES membranes of 
TRAPP depleted cells. This confirms the hypothesis that it can function as a 
co-GAP for Sar 1 and identifies a novel function for the TRAPP complex. 
I performed GAP assays using Sar 1, Sec23 and sedlin (Figure 3.32) or 
GST -Bet3 (Figure 3.33) without the addition of RLC but no increase of the 
SarI GTPase activity was observed. These data can be explained by the fact 
that not all of the COPII components or all of the TRAPP components were 
present that could favour the action of sedlin as a co-GAP. It cannot be 
excluded that the presence of the outer layer of the COPII machinery 
(Sec 13/31) might be required to trigger the co-GAP activity of sed lin on 
SarI or that, in measuring the overall production of e2p]-GDP, small 
changes were not considered statistically significant. I also prepared the 
cytosol from HeLa and HepG2 cells but they failed to stimulate SarI 
GTPase activity (not shown). 
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Figure 3.32 Recombinant sed lin does not stimulate the GTPase activity of Sari in 
vitro. (A) Recombinant His-Sari ( I ~) was incubated with a_32p GTP alone or with His-
Sec23 (0,5 pM) or GST-sedlin (0,5 ~) and GST-Bet3 (0,5 ~). TLCs were analysed to 
quantify different a _32p nucleotide species. As reported in the graph, the presence of edlin 
without Sec23 does not trigger the conversion of GTP in GDP. Similarly, the addition of 
Bet3 does not act on Sar I activi ty. The GAP activity is expressed as % of a_32p GDP over 
a_32p GOP + a_32p GTP. The graph shows mean values (± SO) from 3 di ffe rent 
experiments performed in duplicate. (B) Recombinant His-SarI (1 pM) was incubated 
with a_32p GTP alone or with His-Sec23 (0,5 ~) and GST-sedlin (0,5 pM). TLCs were 
analysed to quanti fy different a_32p GTP species. As reported in the graph, the presence of 
sedlin together with Sec23 does not cause any change in the GTPa e activity of Sar I. The 
GAP activity is expressed as % of a }2p GDP over a_32p GOP + a _32 p GTP. The graph 
shows mean values (± SO) from 3 di fferent experiments performed in duplicate. 
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Discussion 
Here I have reported that the transport particle complex TRAPP controls the 
formation of COPII-dependent transport carriers at the ERES where it is 
selectively required for the ER export of large soluble cargo, such as PCI. 
TRAPP is required to keep the cycle of SarI and COPII efficient and fast. In 
the absence of the TRAPP complex (achieved by silencing its key 
component Bet3) the cycle of SarI and COPII is slowed down: the GFP-
Sec23 halftime of FRAP in living cells is considerably higher, the fraction 
of endogenous SarI and COPII associated with the membranes in 
permeabilised cells is strongly increased, while the SarI GAP activity of 
TRAPP-depleted cytosol is lower than what is observed using a control 
cytosol. 
In this scenario sedlin plays a key role in regulating this mechanism. Its 
depletion reproduces perfectly all the phenotypes induced by the whole 
TRAPP depletion: the slow down of SarI and COPII cycle and the 
inhibition of PCI export. 
Interestingly, sedlin regulates proper COPII dynamics by binding directly 
and exclusively to Sarlp. Sedlin possesses a longin domain, a domain found 
in different classes of proteins including non-syntaxin SNAREs, adaptors, 
and a subunit of the signal recognition particle receptor SR (Schlenker et ai., 
2006). Based on the observation that the longin domain of SRX interacts 
with and acts as a co-GAP for the GTPase SR~, a model has been proposed 
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according to which the longin domain is a general GTPase-interacting 
protein module. The observation that sedlin binds SarI and regulates its 
cycle supports this model. 
Thus two subunits of the TRAPP complex, sedlin and Bet3, interact with 
SarI and Sec23, respectively, two components of the machinery controlling 
the packaging of nesosynthesized cargo into transport carriers at the ERES. 
Intriguingly, the binding between sedlin and SarI can occur simultaneously 
with the SarI engagement with Sec23. As reported recently, the Bet3-Sec23 
interaction, on the other hand, takes place only in the absence of Sar 1, when 
COPII coated carriers are already formed (Lord et al., 2011). 
Sedlin contacts SarI in its GTP-bound state thereby favouring the Sarl-
GAP activity of Sec23 and accelerating the release of SarI from the 
membranes. Under these circumstances, it appears clear that sedlin binds to 
SarI during the first step of COP II formation. 
SarI possesses a lower association/dissociation rate compared to the other 
members of the coat (i.e. Sec23 and Secl3, Watson et aI., 2005; Forster et 
aI., 2006), implying that it dissociates faster from the COPII-coated carrier. 
Bet3-Sec23 interaction occurs to guarantee the proper directionality of the 
formed carrier (homotypic fusion or heterotypic fusion, Cai et aI., 2007; 
Lord et aI., 2011). 
This particular role of sedlin at the ERES appears dispensable for the ER 
exit of small cargo but is required for the ER exit of large cargo, such as 
PCI. 
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The efficient coupling between Sec23/24 and Sec 13/31 is required for the 
ER exit of PCI but not for VSV -G (Townley et al., 2008), demonstrating 
that COPII dynamics are fundamental for the exit of special cargoes. 
As mentioned above (see Introduction), protein sorting into different 
transport carriers occurs during their exit from the ER, as suggested by the 
different molecular requirements of different cargoes for their entry into the 
secretory pathway. This is the case for procollagen I as compared to VSV-
G, which have common and also different molecular requirements during 
pre- and post-Golgi trafficking events (Starkuviene and Pepperkok, 2007), 
and for the angiotensin II type lA receptor and the beta-2 adrenergic 
receptor (AR) compared to the alpha-2B AR (Wu et aI., 2003). 
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Chapter 4 
Results 
The role of sedlin in membrane trafficking: insights into the 
pathophysiology of Spondylo-epiphyseal dysplasia tarda. 
A defect in sedlin leads to SEDT, a condition characterized by a failure in 
the secretion and assembly of the ECM in chondrocytes (Tiller et al., 2001). 
In further consideration of the clinical overlap that results from some 
mutations of pcn (Bleasel et al., 1995; Zankl et aI., 2004) and sedlin (Tiller 
et al., 2001), which both cause spondyloepiphyseal dysplasia, I initially 
examined the impact of sedlin depletion on the trafficking of PCII. PCII is 
the most abundant collagen in articular cartilage and it is found 
predominantly, but not exclusively, in hyaline cartilage where it accounts 
for 90% of the total collagen. Together with other tissue-specific collagens 
and proteoglycans, pcn provides the cartilage tissue with its shock-
absorbing properties and its resilience to stress. Similarly to PCI, PCII 
forms homotrimeric helices and fibrils. 
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In this Chapter, I report the results obtained in assessing the impact of 
inhibiting sedlin on the transport of pcn in chondrocytes. As a control, I 
followed in parallel the effect of sedlin KD on the trafficking of a "generic" 
reporter cargo VSV-G. Lastly, I verified the relevance of the phenotypes 
observed in cultured cell lines by studying SEDT patient-derived 
fibroblasts. 
4.1 Sed lin depletion in rat chondrosarcoma (Rx) chondrocytes 
Firstly, I set up conditions to efficiently deplete sedlin and also Bet3 using 
rat chondrosarcoma (Rx) cells as a model (King and Kimura, 2003). 
siRNAs directed against sedlin efficiently reduced the levels of the protein 
by 75 to 90% while siRNA directed against Bet3 drastically reduced its 
levels as well (Figure 4.1). 
I further analysed the impact of sedlin and Bet3 siRNAs on the GC in 
chondrocytes. I observed that, in line with the data obtained in the other 
previously analysed cell lines, the GC was well organized and properly 
polarized (cis-trans polarization, as verified by the cis and trans Golgi 
marker GM130 and TGN38) in mock-treated, sedlin-KD and Bet3-KD cells 
(Figure 4.1). The organization of the GC appeared severely compromised 
exclusively in Bet3-KD cells (Figure 4.1). 
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Figure 4.1 edlin KD in Rx chondrocyte does not affect TRAPP stability and Goigi 
structure. (A) Rx chondrocyte were treated with the indicated iRNA as described in Materials 
and Methods. Cell lysate (60 /lglsample) were anaJyzed by 0 -PAGE and immunoblot 
analysis with the indicated antibodies. [3-actin wa used a a loading control. edlin does not 
cause de tabilisation of the other analy ed TRAPP ubunits (i.e. Bet3 or synbindin) in contrast to 
Bet3 depletion. The graph shows the amount of the sedlin protein in Rx chondrocytes after 
siRNA treatment a determined by Western blot analy is of cell Iysates u ing an anti- edlin 
antibody. Mean values are reported (± D) from 7 independent experiments. (8 ) Control, edlin 
and Bet3 depleted chondrocytes were fixed and tain d with several marker of the G (TGN38, 
red ; GRA P55, green and GM 130, blue) to evaluate structure and proper polarity of the 
organelle. Sedlin-KD doe not affect GC structure or the cis-trans distribution (note the merge 
panels), while Bet3-KD perturb profoundly GC architecture, but without strongly affecti ng cis-
trans polarity. 
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4.2 Effect of sedlin and TRAPP depletion on pell trafficking in 
chondrocytes 
Control (mock) and sedlin-KD chondrocytes were analyzed for the 
trafficking of PCII using synchronization protocols. Similarly to PCI, the 
formation of PCII triple helices is temperature sensitive, and PCII stays 
trapped into the ER when cells are incubated at the non-permissive 
temperature (40°C block). The transport of both cargoes along the secretory 
pathway was synchronized by imposing this temperature block, resulting in 
reversible misfolding and retention in the ER, and then shifting the cells to 
32°C to release the ER block. Neosynthesized PCII localised almost 
completely with the Golgi marker GRASP55 30 min after release of the 
trafficking block in mock-treated cells while the transport of PCII was 
severely impaired by sedlin depletion, with a marked inhibition of exit from 
the ER (Figure 4.2). PCII in sedlin-KD cells perfectly co-localized with the 
ER marker GRP78 (BiP, Figure 4.2). 
Next, in order to determine whether the effects of sedlin depletion operated 
within the context of the TRAPP complex, I reduced the levels of the entire 
complex by depleting of the expression of the TRAPP subunit Bet3 in Rx 
chondrocytes, which induced destabilization and possibly degradation of the 
entire complex, as expected (Figure 4.1) and as reported above in other cell 
lines. (Figures 3.1 and 3.9) 
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Figure 4.2 edlin is requi red for the elective e it of P n in Rx chond rocytes. (A) 
pcn trafficking in chondro arcoma cell (Rx chondrocytes). Mock-treated Rx 
chondrocyte or Rx chondrocytes treated with edlin or Bet3 iRN s were in ubated for 
3 hours at 40°C, shifted to 32°C for 30 min and then fixed and double tained with mAb 
against pcn (red) and an antibody against GRP78 (a marker for the ER compartment) or 
GRA P55 (a marker of the Golgi complex). Top panel show the P n taining after the 
40°C temperature block, a classical ER taining. After 30 minute at the penni sive 
temperature, pcn is concentrated in the perinuclear area in control cell and colocali e 
with GRA P55 but not with GRP78. pcn exhibits a clear ER pattern, as demon trated by 
the almost complete co-localisation with GRP7 , in sedlin-KD and Bet3-KD cell cale 
bars 10 11M. (B) Quantification of the ER exit of P II in sedlin, Bet3 iRNA-treated or 
mock-treated Rx chondrocytes. ell were treated a de cribed in (A) and fixed at the 
time point shown. The data are ex pres ed a % of cell with P Il in the ER. Ea h 
experiment was repeated at least 4 times in duplicate (n =200 cells each) and the data are 
represented as mean values (± D). 
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Here too, the ER exit of pcn was strongly inhibited by TRAPP depletion 
(Figure 4.2). The depletion of TRAPP severely affected the structure of the 
Golgi complex, which appeared extensively vesiculated (Figure 4.1). 
Then, I analysed the transport of VSV -G using the same synchronization 
protocols. By contrast, the transport of VSV -G to the GC (Figure 4.3) was 
indistinguishable in sedlin-depleted compared to control cells. In Bet3-KD 
cells, VSV -G reached the vesiculated structures of the GC (Figure 4.3). I 
measured also the VSV -G arrival to the PM, and found that after sedlin KD 
it was not altered compared to the control, while it was strongly inhibited in 
Bet3-KD cells (Figure 4.3). By analysing PCII and VSV -G in the same 
cells, I could observe that PCII was retained in the ER after sedlin and Bet3 
depletion, while VSV -G appeared to reach the GC similarly to control 
conditions (Figure 4.4). Finally, I analyzed total protein secretion in pulse-
chase experiments in chondrocytes (as also reported for HeLa cells, see 
Figure 3 .• 0). Secretion was not significantly affected by sedlin KD, 
similarly to what I reported previously for HeLa cells (Figure 4.5). 
To assess whether the selective impairment ofER exit ofPCn in sedlin- and 
Bet3-KD cells was a specific and direct consequence of the depletion 
achieved during the three days of siRNA treatment, I adopted two 
alternative approaches. First, I verified the specificity of the transport delay 
by expressing siRNA-resistant forms of sedlin. A cDNA encoding the 
human sedlin (which encodes an identical protein but with a different 
mRNA, resistant to rat siRNA) was microinjected into the nuclei of control 
and sedlin-KD Rx chondrocytes. Four hours post-injection, the cells were 
subjected to the 40°C block and release protocol. 
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Figure 4.3 edlin is d ispensible for tbe ER exit of V V-G in Rx cbond rocytes. (A) 
Mock-treated Rx chondrocytes or Rx chondrocyte treated with sedlin or Bet3 s iRNAs were 
infected for I hour at 32°C with VSVts045 and then incubated at 40° for 3 hour . ells 
were shifted to the pennissive temperature for 30 minute . Here, V V-G wa localized 
using the P5D4V V-g mAb (red). Top panel repre ent the starting point at 40° , where 
VSV-G i in the ER under all conditions. After 30 minutue at 32° , V V- rea he the 
GC in control , sedlin- and Bet3-KD cell (as demon trated by the co-Iocali ation with th 
Golgi marker GRASP55 , green). cale bar I 0 ~. (B) Quantification of the ER exit of 
VSV-G in edlin, Bet3 siRNA-treated or mock-treated Rx chondrocyte. ell were treated 
as de cribed in (A) and fi ed at the time point shown. The data are expres ed a % cell 
with V V-G in the ER. Each experiment wa repeated at lea t 4 times in duplicate and th 
data are repre ented as mean alues (± D). (C) V V-G arri al to the PM . ell were 
treated as described in (A) and then fixed but without detergent permeabilization. ontrol , 
sedlin- and BeG-depleted cells were incubated with an antibody that recognize the V V-G 
luminal domain (LD). While in control and edlin-KD cells V V-G is clearly on the PM, in 
Bet3-KD cells it arrival is strongly impaired. Scale bars, 10 11M. 
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Figure 4.4 edlin and the TRAPP complex are required for the elective ER e it of P II , 
but a re d i pen ible for V V-G in Rx chondrocyte. Mock-treated Rx chondrocytes orRx 
chondrocytes treated with sedlin or BeG iRNAs were infected for I hour at 32° with 
V Vts045 and then incubated at 40°C for 3 hour . ell were hilled t the penni sive 
temperature for 30 minutes . VSV-G was localized u ing the P5D4V V-g pAb (green). Top 
panels represent the taTting point at 40° ,where V V-G and PCIl (red) are in the R under 
all three condition . fter 30 minutues at 32° , V V-G reaches the in control, edlin- and 
Bet3-KD cells. In control cell, P II exit the ER and concentrate in the perinuclear region. 
By contrast, P II remain into the Rafter sedl in and BeG depletion. Bar 10 11M. 
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Figure 4.5 Sed lin KD does not affect total secretion in chondrocytes. Rx chondrocytes 
mock-treated (CTRL) or sed lin siRNA-treated (sedlin-KD) were pulsed with e sS]-
cystheine and methionine for 60 minutes, then washed and cultured in standard medium 
with unlabelled methionine. After I , 2 and 3 hours the medium was analyzed by SDS-
PAGE followed by autoradiography. As a negative control, mock cell s were treated with 
10/lglml BFA (a blocker of protein secretion) for the la t ten minutes of the pulse and 
during the chase. No significant difference is detectable between sedlin-KD and control 
cells, while BFA-treated cells fail to secrete any protein. 
185 
I observed that expression of human sedlin could rescue the secretory 
inhibition (Figure 4.6). Intriguingly, the co-expression of one of the disease 
related sedlin mutants (sedlinR90X) failed to rescue the PCll phenotype 
(Figure 4.6). This is a very important result, because it unequivocally 
correlates a sedlin mutation with the PCll phenotype. 
Second, I devised an experimental protocol in which the acute block of 
TRAPP was achieved by microinjecting a blocking anti-Bet3 antibody. In 
De Matteis' laboratory, previous studies led to the finding that injection of 
the Bet3-Ab caused extensive fragmentation of the GC and impaired the ER 
exit of PCI in fibroblasts, while injection of pre-immune IgG did not (Scanu 
Ph.D. thesis, 2008 and see also Yu et aI., 2006). 
Neosynthesized pcn reached the Golgi complex 30 mm after the 
temperature shift from 40°C to 32°C in pre-immune Ig-G-injected cells, but 
were retained in the ER of chondrocytes that had been injected with the 
anti-Bet3 antibody (Figure 4.7). Compared to the TRAPP depletion 
achieved through siRNAs, the acute block of TRAPP induced a pronounced 
and persistent inhibition of the ER exit pcn (Figure 4.7 compared to 
Figure 4.2). The Golgi complex, however, was markedly fragmented in the 
Bet3-Ab injected cells, even more extensively then that induced by siRNA 
treatment (Figure 4.7). Consistent with the data reported above for the 
TRAPP depletion by Bet3 KD, VSV -G transport out of the ER was not 
impaired in the cells injected with the anti-Bet3 antibody (Figure 4.7). 
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Figure 4.6 Re-expression of wild-type sedlin in sedljn-KD chondrocytes rescues the P 11 exit 
from the ER while a disease-causing mutant does not. (A) Rx chondrocytes mock-treated 
(CTRL) or sedlin siRNA-treated chondrocytes (sedlin-KD) were microinjected with a pia mid 
encoding human wild-type sedlin, which i not ensitive to the R Ai treatment (two upper rows) or 
with a plasmid encoding a SEDT-causing mutation, R90X (bottom row) . 4 hour po t-injection, 
cells were incubated for 3 hours at 40°C and then shifted to the permissive temperature of32° for 
30 minutes. Cells were then fixed and analysed by immunofluorescence. In control cells, the 
expre sion of WT- edlin does not perturb pcn arrival to the Golgi, as ob erved in non-injected 
cell s. Ln sedlin-KD chondrocytes, the expre sion of the sedlin protein restores the P n exit from 
the ER. By contrast, the R90X-sedlin mutant fails to re tore the ER exit of P II. cale bar , 10 f.-Im . 
(B) Quantification of the ER exit ofPCn in sedlill siRNA-treated or mock-treated Rx chondrocyte 
(CTRL) after the injection of edlin RNA-resistant can truct. Cells were treated a de cribed in (A) 
and fixed at the time point shown. The data are expres ed as % cells with P II in the ER. ach 
experiment was repeated at least 3 time and the data are represented as mean values (± D), 
n= IOO. 
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Figure 4.7 An acute block of TRAPP prevents pen exit from the ER in Rx chondrocytes. 
(A) Rx chondrocytes were microinjected with pre-immune Ig or an anti-Bet3 antibody (Bet3 
Ab) during the second hour of the 40°C block. lmmunofluore cence analy i wa perfonned 
30 min after shifting to the pennissive temperature (32°C) using anti-P II (red) and anti-
TG 38 (green, a Golgi marker) antibodies. While in IgG-injected cells, pcn reache the G , 
in Bet3 Ab-injected cells, PCII exhibits an ER pattern. Asteri ks indicate microinjected cells. 
Scale bars, 10 J.U11. (B) Quantitative analysis of pcn transport in IgO- and Bet3 Ab-injected Rx 
chondrocytes. Cell were treated as described in (A) and analyzed at the indicated time points. 
Mean values (± D) from 4 independent experiments, n=100. (C) The acute block of TRAPP 
does not inhibit V V-G exit from the ER in Rx chondrocytes. V V-infected cell were 
microinjected with pre-immun IgG or an anti-Bet3 antibody (Bet3 Ab) during the 40° block, 
similarly to the protocol used in (A). Immunotluore cence analysis was perfonned 30 min after 
shifting to the penni sive temperature (32° ) u ing anti-VSV-G (red) and anti-TG 38 (green, 
a Golgi marker) antibodies. Asterisks indicate microinjected cells. In et shows the 
colocalization of V VS-G with the Golgi marker TO 38. cale bars, 10 J.U11 . (D) Quantitative 
analyses of VSV-G tran port in VSV-infected Rx chondrocytes in IgG- and Bet3 Ab-injected 
cells. Cells were treated as described in and analyzed at the indicated time points. 
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4.3 Sed lin role in aggrecan trafficking 
Since I evaluated pcn trafficking in sedlin-KD chondrocytes, I wanted to 
extend the analysis to another major constituent of ECM secreted by 
chondrocytes, the aggrecan. Aggrecan is required to concentrate negative 
charges . in the ECM, thereby providing the high degree of hydration 
necessary to maintain an expanded cartilage ECM volume. 
This function reflects the covalent addition of several hundred chondroitin 
sulfate and keratan sulfate glycosaminoglycan chains to the aggrecan core 
protein. The 340 kDa core protein represents only 10% of the 
biosynthetically complete monomer and is further modified (N- and 0-
linked oligosaccharides). Aggrecan, link protein (a separate gene product) 
and hyaluronic acid are assembled in the extracellular space into large 
aggregates, which are further associated with the type n collagen-containing 
fibres. Biochemically, chondrocytes in culture synthesize the aggrecan core 
protein in the ER, process it to its mature form in the Goigi and secrete 
aggrecan into the medium. 
Aggrecan is not a synchronysable cargo, so I set up a protocol to measure 
the ER "clearance" under sedlin depletion in chondrocytes. After siRNA 
treatment, chondrocytes (both mock and sedlin siRNA-treated) were 
incubated with hyaluronidase for 60 min to remove the ECM present on 
chondrocyte membranes, allowing the detection of the intracellular 
aggrecan. Then, cells were incubated with cycloheximide for an additional 
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30 minutes. In control cells, soon after hyaluronidase treatment, aggrecan 
localized at the ER and at the GC. By contrast, in sedlin-KD chondrocytes, 
aggrecan was mainly in the ER, with little or no evident Goigi localisation 
(Figure 4.8). 
Moreover, after 30 minutes of CHX treatment in control cells, aggrecan was 
no longer localised at the GC but appeared at the PM. Conversely, in sedlin 
depleted chondrocytes aggrecan failed to reach the PM (Figure 4.8). Further 
and more detailed studies (such as pulse-chase and secretion experiments) 
will be required to dissect aggrecan intracellular transport in chondrocytes, 
but I can conclude that sedlin depletion perturbs aggrecan trafficking 
(Figure 4.8). 
4.4 The inhibition of the ER exit of pen by sedlin depletion does not 
involve Rabl 
As Rab 1 was found not to be involved in the TRAPP-mediated block of PCI 
in the ER (Chapter 3), I also controlled its possible involvement in the 
secretory phenotypes induced by sedlin and TRAPP depletion (inhibition of 
the ER exit of PCIl) in chondrocytes. 
RablA and B protein levels were depleted by using specific siRNAs in Rx 
chondrocytes. After three days of Rabl siRNA treatment, Rabl A and B 
were strongly reduced (up to 90%, Figure 4.9). 
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Figure 4.8 Aggrecan trafficking is affected in sedlin-KD chondrocyte. R:x 
chondrocytes were mock or edlin siRNA treated for three days and then incubated for I 
hour at 37°C with hyaluronidase. After this treatment, control and KD cell were fixed (A) 
or incubated for an additional 30 minutes in presence of CHX (B) and then fixed and 
processed for immunofluorescence experiments. (A) After hyaluronidase treatmcnt, 
aggrecan (green) shows an ER and Golgi pattern in control cells (as highlighted by the co-
localisation with the Golgi marker GMI30 in red). In edlin-KD chondrocyt s, aggre an 
exhibits ER staining but not the Golgi staining. (B) 30 minutes after hyaluronidase 
removal , aggrecan is no longer present at the GC in control cells. By contra t, in sedlin-
KD cells aggrecan begin to appear not only in the ER (a depicted at the teady state) but 
also in the GC. Scale bars, I 0 ~m. 
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Figure 4.9 Rabl KD doe not affect the ER exit of pelT in Rx chondrocytes. R.x 
chondrocytes were mock-treated (CTRL) or treated with siRNAs again t both Rab I A and 
RablB (RablAB) (A) Western blot analysis of iRNA treated cell: cell Iystaes (60 
)lgllane) were probed with an anti -Rab antibody. 80th RablA and 8 are reduced. ~-actin 
was used as a loading control. (D) After 72 hours of siRNA treatment, the cells were 
incubated for 3 hours at 40°C and then shifted to the pennissive temperature (32°C) for 30 
min. Cells were fixed and tained for pcn (red) and the Golgi marker GRA P55 (green). 
ote the exten ive vesiculation of the Goigi complex after Rab I KD, clearly visible by 
GRASP55 staining. cale bars 10 )lffi. (c) Quantification of the ER locali ation of P n 
over time in mock-treated (CTRL) and Rab I AB silenced cell . P II e it out the R is 
similar between control and Rabl-KD cells. The value are the mean (± D) from 3 
indeoendent exoeriments. n=200. 
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I performed a synchronisation protocol on control and RabI-KD cells to 
evaluate PCII trafficking in these cells and found that PCII was not retained 
into the ER (Figure 4.9). In addition, the GC morphology appeared heavily 
compromised, as shown by the vesiculated GRASP55 staining (Figure 4.9). 
Therefore, Rab I depletion obtained by the combined KD of Rab I a and 
Rab I b mimicked the effects of TRAPP depletion on the Golgi complex, 
which was extensively vesiculated but did not reproduce the selective 
inhibition of PCI and PCII ER exit observed upon sedlin (and TRAPP) 
depletion. 
Having excluded a role for the GTPase Rab I as part of the function exerted 
by sedlin in PCII trafficking, I considered the possibility that sed lin could 
act also on the COPII machinery. On the one hand I analyzed the 
localization of sedlin (paragraph 4.5) and, on the other, having found that 
sedlin can control the SarI cycle (Chapter 3) I compared the requirement for 
SarI cycle for the exit of PCII and that of the reporter protein VSV-G 
(paragraph 4.6) 
4.5 Rx chondrocytes: sedlin localisation 
I analysed sedlin distribution in wild type Rx chondrocytes to validate the 
localisation found in other cell lines. Also here sedlin localised at the ERES 
where it co-stained with the COPII component Sec3I (Figure 4.10). 
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Figure 4.10 Sedlin is actively recruited to ERES during a traffic pUl e in Rx chondrocyte. 
(A) Rx chondrocytes at teady tate or during a 40°-32° ynchroni ation protocol were 
paraformaldehyade-fixed, penneabilised with 0.1 % Triton X-IOO and proce ed for 
immunofluore cence analyse at the indicated times. Sedlin (green) co-I cali e with e 31 (red) in 
all the analysed time points, with a clear increa e at 5 minutes after the hi ft to the permi ive 
temperature. White boxes indicate regions magnified in the lower panels. Arrow mark edlin and 
ec3l positive ERE . Scale bar , 10 /lm . (B) olocaJi ation analy e of sedlin and ec I were 
carried out under steady state conditions and during a trafficking wave (3 hour at 40° and then 5, 
15 and 45 minutes at 32°C). Three different single optica l slice wer taken for each cell (n=20), 
and the mean va lues (± SD) are shown. 
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Next, I studied the behaviour of sedlin in Rx chondrocytes during a 
synchronised wave of PCll transport induced by imposing the temperature 
block/release protocol. At 40°C, no significant changes in sedlin 
distribution was detected compared to steady state conditions (Figure 4.10). 
After 5 minutes at 32°C, sedlin appeared to be heavily recruited on 
roundish Sec3I-positive structures. At later time-points (15 and 45 
minutes), sedlin appeared less associated to Sec3I compared to 5 minutes, 
gradually restoring the steady state conditions (Figure 4.10). These data 
suggested that sedlin is involved in some early events of PCII carrier 
formation, because the increased co-localisation at ERES was a very 
transient event, likely coinciding with peak PCll-carrier formation at ERES. 
These data indicate the sedlin is actively recruited at the ERES, supporting 
the role of sedlin in COPII function consistent with its capability to bind and 
regulate the SarI cycle (Figure 4.10). 
4.6 The ER exit of pen requires a higher rate of Sari cycling than the 
exit of VSV-G 
Altogether the previous findings both in chondrocytic and non-chondrocitic 
cell lines indicated that sedlin (and the TRAPP complex) are selectively 
required for the exit of PC (PCll and PCl) and can control the SarI cycle via 
the direct interaction of sedlin with Sar 1. 
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I now wanted to assess whether the two activities are related, and thus 
whether the ER exit of PC have "special" requirement in term of SarI cycle 
compared to the exit of other cargoes (i.e. VSV -G). 
As the slower SarllCOPII cycle induced by sedlinITRAPP depletion was 
still permissive for the export of many cargoes (including VSV -G) from the 
ER, but not for that of PCs, I tested the hypothesis that different cargoes 
require a different rate of SarI cycling to exit the ER. I evaluated the impact 
of progressively blocking the SarI GTP/GDP cycle on the ER exit of PCII 
and VSV -G by microinjecting increasing amounts of the GTP-Iocked 
mutant of SarI (SarlH79G). At a low level of SarlH79G (0.1 mg/ml) the 
exit of PCII and VSV -G from the ER was not affected, while at an 
intermediate level (0.5 mg/ml) the ER exit of PC I and PCII, but not ofVSV-
G, was selectively impaired (Figure 4.11). Higher levels of SarlH78G (2.5 
mg/ml) blocked the exit of all cargo, in agreement with previous reports 
(Pepperkok et aI., 1998). I can conclude that ER exit of the large cargo 
molecules (such as PCII) requires a faster SarI cycle than that of VSV-G 
(Figure 4.11). 
A possible explanation for the requirement of a higher rate of SarI cycling 
for the export of PCI (compared to the exit of VSV-G) might be found in 
the ability of Sarl-GTP to induce membrane bending/constriction (Long et 
al., 2010). A prolonged GTP-bound state of SarI at the ERES would induce 
local membrane narrowing that would remain permissive for the entry of 
small but not large cargoes into the nascent carriers. 
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Figure 4.11 Efficient arl cycling is required for the exit of pcn but not V V-G from 
the ER (A) Rx chondrocyte were V Vt 045-infected for I hour at 32° and th n 
incubated at 40°C for three hours. During the la t hour, cells were microinjccted with Hi -
arl H79G (a teri ks) at the indicated dilution (0.1, 0.5 and 2.5 mglml) and then hitted to 
the penni sive temperature. 30 minute after the hitt to 32° , the cells were fixed and 
proces ed for indirect immunofluore cence to analyse intracellular trafficking of V V-
(green) and P II (red) . cale bars, 10/lfll. A low concentration of ar I H79G d e not afTect 
the ER exit of the two eargo molecule , while a high concentration completely block the 
ER exit of V V-G and P II. By contra t, at an intermediate con entration (0.5 mglml) 
SarlH79G inhibit only perl but not V V-G e it from the ER. eale bar , 10 ~m (B) 
Quantification of the ER exit of V V-G and P n with increasing concentration of Hi -
arl H79G at the indicated time points. Data are reported a mean value (± D) from three 
independent experiments. 
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A prolonged membrane association of Sarl-GTP leads to local increases in 
Sarl-GTP concentration which, by inducing closely-spaced membrane 
constrictions, might prevent the formation of carriers large enough to 
accommodate PC prefibrils. In order to test this hypothesis we performed 
IEM and tomographic analyses of ERES in TRAPP depleted cells. Indeed, 
the IBM analysis showed that, compared to control cells, TRAPP depleted 
cells had a twofold increase in SarI labeling density on the round and 
tubular profiles of the ERES (Figure 4.12). 
Finally the tomographic analysis showed that the ERES in TRAPP-depleted 
cells, compared to those in mock treated cells (Scanu, Ph.D. Thesis, 2008), 
were characterized by a higher number of tubules with very narrow 
constrictions which appeared as round profiles connected with each other as 
"beads on a string" (Scanu, Ph.D. Thesis, 2008). 
198 
A CTRL 
• 
• 
• 
•• 
.. 
Bet3 KD 
r-------------------------~~ 
• • 
B 
>-.~ 1.8 
c 
<lJ 
-0 1.4 
0) 
.~ 1.0 
<lJ 
..0 
ro 0.6 
.-
~ 0.2 
VI 
~ .-
: . 
• 
Sar1 10 nm. Sec31 15 nm 
. 
• 
·0 . 
o 
• CTRL 
o Bet3-KD 
Figure 4.12 SarI is more associated to ERES membranes in TRAPP-depleted cells. 
(A) Immunoelectron microscopic analyses of HeLa cell treated with non-targeting 
(CTRL) and BeG siRNAs (Bet3-KD) show that the KD of Bet3 cau es an accumulation of 
SarI and Sec31 near the Golgi stack remnants. cale bars, 200nm. (B) Quantitative 
analysis of Sari labelling (expressed as labelling density). 
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4.7 Analyses of disease-associated mutants of sedlin 
At this stage of my studies it became crucial to assess the relevance of all 
these findings for the pathogenesis of SEDT. To this end, I first tested two 
disease-associated sedlin mutants (de1387a and R90X) in the SarI-binding 
assay. I produced OST-sedlin fusion proteins bearing the two mutations 
identified in SEDT patients. Next, I performed the GST pull down assay 
under the same conditions used to perform the other binding assays and I 
found that they exhibited a significantly lower affinity for SarI compared to 
wild-type (WT) sedlin (Figure 4.13). I tested also another mutation, D47Y, 
one of the four missense mutations identified in SEDT patients. Sedlin 
D47Y was still able to bind Sar I, but its affinity appeared higher compared 
to wild type sedlin (Figure 4.13). 
Among the identified disease-causing mutations of sedlin, the majority 
result in early termination during translation, leading to degradation of 
partially translated peptides. Recent biochemical studies showed that three 
of the four missense mutations, S73L, F83S and V130D, caused misfolding 
of the mutant protein, activating protein degradation pathways when mutant 
sedlin proteins were over-expressed as OFP-tagged proteins in cells (Choi et 
aI., 2009). These missense mutants also failed to bind known interacting 
proteins of sedlin, including MBPl, pituitary homeobox 1 (PITXI) and 
steroidogenic factor 1 (SFl; Jeyabalan et al., 2010). 
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Figure 4.13 SEDT mutation re ult in an altered affini ty for art. (A) G T, G T- edlin (WT) 
and the di ease-associated sedlin mutants G T-sedlin del387a (upp r panel) G T-sedlin D47Y and 
sedlin R90X (lower panel) were incubated with increasing concentration of His- arl, as indicated . 
After overnight incubation, G H-agaro e bead were added to each ample, to perfonn the G T-
pull down. Except for the D47Y mutant that exhibits lightly increased affinity for arl (note th 
O. I )lM point), all the mutants show a reduced affinity for arl. (B) Graph report mean value 
(±SD) of three experiments performed in duplicate. Values are expre sed a a percentage of the 
sedlin- arl binding relative to 1)lM arl (% of Maximum). ( ) G P sedlin D47Y perturb the 
ERES distribution. HeLa cella were transfected for 16 hour with a pIa mid encoding a FP -
tagged edlinD47Y protein. ells \i ere fixed and stained with a ec3 I b. In edlin D47Y 
expressing cells, ec31 i strongly recruited to the perinuclear area as compared to non-tran fected 
cells. cale bar, 10 11m. 
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Since proteins encoded by sedlin mutants are more prone to degradation, 
one possibility is that the loss of interaction between sedlin mutants and its 
interactors in the cell might be due to the instability of proteins caused by 
protein degradation. 
The D47Y mutant was of particular interest since the mutation per se does 
not perturb the stability of the protein. Moreover, the amino acid 
substitution does not cause a dramatic change in the protein properties. 
Recent studies revealed that sedlin-D47Y has an increased affinity for Bet3 
and remains associated to Bet3 for a longer time compared to WT sedlin 
(Choi et aI., 2009). Furthermore, this mutant has been found not to bind to 
two TRAPP subunits, TRAPPC8 and TRAPPC9, revealing the importance 
of sedlin as an adaptor protein for the assembly of TRAPP complexes (Zong 
et aI., 2011). 
On the basis of the finding that sedlin-D47Y has an altered affinity for SarI, 
I decided to express a GFP-tagged version of this mutant in HeLa cells and I 
checked its impact on the COPII machinery by immunofluorescence. I 
found that the expression of GFP-sedlin-D47Y caused a recruitment of the 
COPII marker Sec3I to larger structures, similar to what was observed upon 
SarIH79G over-expression. By contrast, GFP-sedlin at low levels of 
expression did not cause any significant changes in Sec31 distribution 
compared to control cells (Figure 4.13). 
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All the three tested sed lin mutants showed an altered affinity for Sar 1 
compared to WT sedlin. These findings suggest that this interaction is 
relevant for SEOT pathogenesis. This correlation was reinforced by the 
observation that while the WT sedlin was able to rescue the ER exit of PCII 
in sedlin-depleted chondrocytes, the disease-associated sedlin mutant (the 
R90X), unable to bind Sar 1 in vitro, was not. 
4.8 COPll dynamics and pcn trafficking in SEDT and control primary 
fibroblasts 
As a final and most relevant test of our model, i.e. that sedlin is required for 
PCII exit and for a fast Sar 1 cycle, I used fibroblasts isolated from a SEOT 
patient bearing one of the studied mutations: sedlin de1387a. This mutation 
leads to a frameshift at the C-tenninal that causes the loss of the last 6 
amino acids (Figure 4.14). 
I analysed the morphology of these primary fibroblasts first by 
immunofluorescence and secondly by ultrastructural analyses. I analysed 
the Golgi structure and the COPII Sec31 in SEOT fibroblasts and in primary 
fibroblasts isolated from a healthy subject. The GC of SEOT fibroblasts 
appeared indistinguishable from the GC of the control fibroblasts (Figure 
4.14). A slight difference was evident regarding COPII staining: in SEOT 
fibroblasts Sec31 appeared more associated to membranes compared to 
control fibroblasts (Figure 4.14). 
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Figure 4.14 SEDT fibroblasts show a normal Golgi morphology but a lightly a ltered ER 
exit site d istribu tion. (A) equence alignment between wild-type sedlin and a mulant sedlin 
i olated from a EDT patient. Deletion of a ingle nucleotide at po ition 3 7 cau es a 
frame hift resulting in a truncation of the la t C-terminal 9 amino acid. The alignment wa 
generated using ClustalW. (8 ) Control (CTRL) and S · DT fibroblasts were seeded onto 
coverslips the day before the experiment. ells were PF A fixed and pro essed for indirect 
immunofluorescence experiments. GM 130 (green) was used to analyse the GC morphology, 
while Sec31 (red) to evaluate the ERES organisation. In both CTRL and EDT fibroblast the 
GC appears nonl1al and is not vesiculated. On the other hand, ERE distribution appears 
slightly different between control and SEDT fibroblasts . While a large number of peripheral 
Sec31-positive spots are evident in control cell, ec31 is more concentrated at the ERE in 
EDT flbroblasts, with a slight reduction in the number of ec31-po itive spots. ( ) S EDT 
fibrobla ts exhibit dilated ER and a regular Golgi complex. Wild type ( TRL from a healthy 
subject) and SEDT fibroblasts were fixed and proce sed for electron microscopy analy is. G , 
Golgi complex; ER, endopla mic reticulum. ote that the C in EDT fibroblast appear 
similar to CTRL fibroblasts. Arrowheads indicate dilated ER. cale bars: 200 nm . 
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Notably, these SEOT fibroblasts exhibited a dilated ER at the EM level, a 
finding in accordance with what was observed in a SEOT bioptic sample 
reported previously (Tiller et al., 2001). 
I then compared COPll dynamics in control and SEOT fibroblasts. The 
fibroblasts were injected with the Sec23-GFP plasmid and the FRAP half-
life of single ERES was measured. Sec23-GFP exhibited remarkably slower 
dynamics in SEOT fibroblasts than in WT fibroblasts (Figure 4.15). 
Importantly, the expression of WT sedlin in the SEOT fibroblasts partially 
corrected the COPll cycle defect (Figure 4.15). 
Finally, I assessed the trafficking of PC in control and SEDT fibroblasts. 
First, I analysed the ER-to-Golgi transport of endogenous PCl. I found that 
PCI exit from the ER was slower in SEnT fibroblasts compared to control 
fibroblasts (Figure 4.16). To follow the ER export of PCll, control and 
SEOT fibroblasts were transfected with a plasmid encoding a fluorescently-
tagged PCll and subjected to a synchronized trafficking protocol. 
During the 400 block, pcn was retained in the ER in both WT and SEOT 
cells. 
After 30 minutes at the permissive temperature and in the presence of 
ascorbate and CHX, pcn was almost completely concentrated in the 
perinuclear region (positive for the Golgi marker TGN46) in WT fibroblasts 
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Figure 4.15 The COPIJ cycle is slower in EDT fibroblasts. FRAP analysis of ' RE 
(labelled with GFP-Sec23 and perfonned a described in hapter 3) is hown in 
fibroblasts from a healthy ubject (CTRL), in fibrobla ts from a EDT patient ( DT) or 
in fibrobla t from a EDT patient transfected with WT edlin ( DT+WT- edlin). The 
four images show different time point of a time-lap e sequence. The white quare 
indicate the bleached ERE . '0" is the fir t image acquired after the bleaching. cale bar, 
2 ).llTI. The graph reports the t l/2 for the FRAP of single ERE in fibrobla t from a healthy 
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expressed WT sedlin (GFP- ec23 + WT edlin). GFP- ec23 CTRL n=20, EDT n=27 ; 
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Figure 4.16 PCI exit from the ER is impaired in EDT-i olated primary fibroblasts 
(A) Primary fibroblasts isolated from a healthy ubject ( TRL) or from a EDT patient 
(SEDT) were incubated for 3 hours at 40°C. After the temperature block, cells were 
hifted to 32°C for 30 minutes in the pres nce of ascorbate and CHX. ells were then 
fixed and processed for immunofluorescence. In control fibrobla t , pcr (red) reaches the 
GC (green), and it is not retained into the ER (PDI, blue). By contrast, PCI exit from the 
ER is lower in EDT fibroblasts, as shown by the co-localisation between PCI and PDI. 
Scale bars, 10 J.lm. (B) The graph reports mean value (±SD) of three experiment 
performed in duplicate (n= lOO). Values are expressed as a percentage of cells with PCI 
into the ER. 
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but remained distributed in the ER throughout the cytoplasm in SEDT 
fibroblasts (Figure 4.17). Importantly, the expression of a full-length WT 
sed lin protein in SEDT fibroblasts could rescue the pcn export from the ER 
(Figure 4.17). 
Collectively, the above results provide a molecular basis for the defective 
chondrogenesis resulting from sedlin mutations in SEDT patients. 
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Figure 4.17 T he exit of pcn from the E R is impaired in EDT fibroblasts a nd 
cor rected by WT edlin. (A) A plasmid en oding (luorescently-tagged P II (m herry, 
red, top two rows) or the arne con truct together with a plasmid encoding full-length WT 
sedlin (bottom row) were microinjected into the nuclei of human fibrobla ts i olated from 
from a healthy ( TRL) or a SEDT subject and incubated at 37° for 3 hours. The ells 
were then incubated at 40°C for 3 hours, and ub equently hitted to the permi ive 
temperature for 30 minutes. ell were fix d and pro e ed for indire t 
immunofluorescence using anti-TGN46 (a Golgi marker) or anti-PDI (and ER marker). In 
control fibrobla t , P ]] reaches the after 30 minute while in EDT fibrobla t it 
fails to leave the ER, as demon trated by the co-localisation with PDI. The overe pre s ion 
of a WT edlin re tore pcn transport. cale bar , I 0 ~lm . (8 ) Quantitative analy e of the 
transport of pcn out of the ER asses ed a described in (A). Mean value (± D) fr m 3 
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Discussion 
The TRAPP complex is involved in several and important membrane 
trafficking steps along the secretory pathway. 
Here, for the very first time, I provide different lines of evidence that 
correlates the function of the TRAPP complex and of its subunit sedlin in 
membrane trafficking and the onset of Spondyloepyphiseal dysplasia tarda 
(SEDT). 
I analyzed the role of TRAPP in rat (Rx) chondrocytes, a cell line relevant 
for SEDT, where the main affected tissue is the cartilage (Tiller et aI., 
2001). As discussed in Chapter 3, sedlinlTRAPP are involved in controlling 
the ER exit of procollagen type I in fibroblasts by regulating Sar 1. In this 
scenario, I wanted to verify whether also the trafficking of pcn, the major 
cargo in chondrocytes, was dependent on TRAPP (and sedlin). 
pcn shares some similarities with PCI in terms of shape and size (a triple 
helix of 300 nm). Interestingly, mutations occurring in pcn are responsible 
for the onset of a similar pathology, Spondyloepyphiseal dysplasia 
congenita, highlighting the importance of pcn in endochondral bone 
formation processes. 
I found that sedlin is selectively required for the ER exit of pcn but it is 
dispensable for VSV -G in chondrocytes. Similarly to sedlin, TRAPP 
depletion does not affect VSV -G trafficking out of the ER in chondrocytes, 
but strongly inhibits its arrival to the PM. Furthermore, as observed in HeLa 
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cells, total protein secretion is not compromised by sedlin depletion in Rx 
chondrocytes. On the other hand, the loss/impairment of the entire TRAPP 
complex affects the trafficking of all the analyzed cargoes at the level of the 
Golgi complex that appears fragmented under these conditions. 
The molecular mechanism underlying the specific requirement for sedlin in 
ER-exit of pcn does not involve Rabl. As observed also for PCI, selective 
impairment of Rab I does not affect the ER exit of pcn in Rx chondrocytes. 
Thus, sedlin and TRAPP exert their function on ER exit of selected cargoes 
independently of the TRAPP exchange factor activity on Rab 1. 
I found instead that the role of the TRAPP complex in controlling the ER 
exit of pcn involves the copn machinery. Bet3 is known to bind Sec23, 
and I have shown here that sedlin contacts the SarI OTPase, controlling its 
cycle. 
Furthermore, sedlin is actively recruited to the ERES during a pcn 
trafficking wave, pointing out a very early step of transport in which sedlin 
is involved. 
, " 
SarI dictates the timing of copn carrier formation, and its cycling is ! 
fundamental for the proper exit of large molecules such as pcn. To 
determine whether prolonging the active (GTP-bound) state of SarI 
, , 
differentially affects the ER exit of pcn or VSV -0 in chondrocytes, the 
SarIH790 mutant was expressed in cells during a synchronised wave of 
transport. I found that pcn is more sensitive to Sar I H79G mutant than 
VSV -0. In the light of this evidence, I can conclude that a highly efficient 
copn cycle is necessary for the ER exit of pcn. 
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Thus, these results lead to the conclusion that sedlin regulates PCII exit 
from the ER by regulating SarI GDP-GTP cycle. But what is the relevance 
of these findings for SEDT pathogenesis? To address this important issue I 
studied a cell line derived from one SEDT patient where I could confirm the 
importance of sedlin in the control of Sar I cycle. Indeed, studies aimed at 
evaluating COPII dynamics reveal that Sec23 was more persistently 
associated with ER membranes in SEDT fibroblasts compared to fibroblasts 
isolated from a control healthy subject. This important finding definitively 
correlates the alteration of the COPII and SarI cycle to the disease. 
Furthermore, the co-expression of a WT sedlin in the SEDT fibroblasts 
almost completely rescued the phenotype, revealing the importance of 
sedlin for COPII cycling. 
Finally, the alteration of the COPII cycle in SEnT fibroblasts causes a delay 
in ER exiting of PCI and PCII (fluorescently tagged version), again almost 
completely rescued by the re-introduction of a functional sedlin molecule. 
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Chapter 5 
Results 
Establishing a SEDT animal model 
Having an animal model to test the results from in vitro and cellular model 
systems represents an important step towards the development of 
therapeutic strategies but presently no animal model of SEDT is available. 
Establishing this animal model is the natural evolution of my studies on 
sedlin and as a model vertebrate organism we have selected medaka fish 
(Oryzias [atipes). This medaka sedlin-KD model will be developed in 
collaboration with Sandro Banti and Ivan Conte who have established the 
medaka system at TIGEM. The medaka-based approach offers the 
indisputable advantage, compared to other animal models, of obtaining a 
KD animal in an extremely efficient and "fast" way with the use of anti-
sense morpholino oligonucleotides. Importantly, medaka is a well-
established model system to study chondrogenesis. 
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Medaka, Oryzias latipes (order Beloniformes), is a small egg-laying 
freshwater teleost fish that is primarily indigenous to Japan, Korea, Taiwan, 
and China. The adult is approximately 2-4 cm long, and the female lays 
every day a cluster of eggs (10-30 eggs). The embryos develop externally, 
and both the embryo and chorion are transparent. The embryos hatch seven 
days after fertilization at 28°C and grow to sexual maturity within 2 to 2.5 
months. These biological features are mostly shared by zebrafish (Danio 
rerio). 
During the last two decades, zebrafish research has been increased 
enormously, while medaka has more recently generated much interest. 
There are, however, several advantages of using medaka over the more 
commonly used zebrafish. First of all, the medaka genome is smaller (800 
Mb). It corresponds in size to one-third of the human genome and less than 
half that of the zebrafish. 
Second, there are highly polymorphic inbred medaka strains available, 
which can be used for mutagenesis screening and genetic mapping. 
Finally, unlike zebrafish, which are tropical, embryos of the temperate 
medaka can develop at a wider range of temperatures, 6°C to 40°C, which 
facilitates the isolation of temperature-sensitive mutants and the staging of 
developing embryos by temperature. Moreover, medaka is more resistant 
than zebrafish and less susceptible to disease. In contrast with zebrafish, 
medaka has clearly defined sex chromosomes, and sex determination is 
intensively studied. 
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F or decades, medaka was regarded as an important test system for 
ecotoxicology and carcinogenesis studies. Notably, medaka has many 
attributes that make it a perfect model laboratory organism, among them the 
clarity of its eggs, hardiness, and lack of aggression. 
Furthennore, a fish model has been recently adopted to study bone and 
cartilage development and defects. In particular, fish animal models were 
used for studying defects occurring in members of early secretory pathway 
machinery such as COPII (Sarmah et al., 2010; Ohisa et aI., 2010; Schwarz 
et aI., 2009; Townley et al., 2008; Boyadjiev et aI., 2006; Lang et aI., 2006). 
Since the medaka model is available at TIGEM, and since a SEDT animal 
model has not been created yet, I decided to start generating a medaka 
animal model for the SEDT disease. 
First of all, I perfonned in silico analyses to search for a sedlin gene in the 
medaka genome. This analysis showed that there is a gene closely related to 
the human sedlin (Figure 5.1) 
Sedlin is highly conserved in the medaka genome and importantly it is 
present as a single gene (Figure 5.1). This is very noteworthy infonnation, 
since sedlin possesses a very complex genomic organisation in mammals, 
with the presence of several additional pseudogenes. The nucleotide 
sequence of medaka sedlin (ENSORL T0000022285.1) was obtained from 
the medaka genome sequence database at NCBI. 
Next, I decided to verify whether the medaka sedlin gene is also transcribed. 
The sequence obtained from NCBI was used to design specific primers to 
detect sedlin mRNA. 
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Figure 5.1 Sedlin is highly conserved in Orytias latipes genome (medaka). Sequence alignment of 
sedlin proteins from different species shows that the protein is evolutionarily highly conserved. Thi s 
alignment was generated using ClustalW program. 
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U sing these probes I verified that the sedlin gene is expressed and is present 
as a single variant corresponding to the entire spliced coding sequence 
(Figure 5.2). Sedlin mRNA is also translated in medaka, as detected by 
Western Blot using an antibody raised against the human sedlin (Figure 
5.3). 
Then, to monitor sedlin localisation in medaka, embryos were 
morphologically staged according to Iwamatsu (Iwamatsu et aI., 2004, stage 
32) and fixed in 4% paraformaldehyde overnight. Sections were stained by 
indirect immunofluorescence using several antibodies. 
As observed in mammals, sedlin is ubiquitously expressed in medaka 
(Figure 5.4). I also stained the sections with an anti-type PCII antibody and 
I observed staining of the extracellular space in different tissues, including 
the spine (Figure 5.4). These are very positive premises for the 
development of the sedlin KD medaka model and for the analysis of a 
possible phenotype on pcn trafficking. I have already designed specific 
anti-sedlin morpholinos from GeneTools. Further studies will be necessary 
also to verify whether medaka can recapitulate the symptoms of the SEDT 
disease, but undoubtedly these are very encouraging preliminary data that 
allow to work with medaka to generate a SEDT animal model. 
Moreover, in De Matteis' laboratory we will also consider the possibility, if 
necessary, of generating a transgenic fish by injection of circular plasmids 
into medaka with mutant forms of sedlin described in patients, as mCherry 
or GFP fusion proteins to follow their fate during fish development. 
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1 Kb-
0,5 Kb-
Figure 5.2 Sedlin gene is transcribed in Orytias latipes (medaka). Total mRNA from medaka 
was isolated, rever e-transcribed and amplified by RT-PCR using primers specific for the sedlin 
transcript. A single product was detected , supporting the hypothesis that sed lin i expressed as a 
single not-processed mRNA. 
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-30 KDa 
-21 KDa 
-14 KDa 
-6KDa 
Figure 5.3 Sedlin gene is translated in Orytias latipes (medaka). Western analysis of a medaka 
protein extract (a ll developmental stages) with an anti-sedl in antibody. A sing le band 
correspond ing of 14 kDa was detected. 
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Figure 5.4 edlin locaH ation in embryon c section of Orytia latipe (medaka). 
Immunofluore cence of frozen medaka embryos. edlin i ubiquitou Iy expressed. t thi 
developmental stage ( tage 32), pcn is easily detectable in the e tracellular pace. 
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Chapter 6 
Final discussion 
A huge variety of cargo proteins, in tenns of size and composition, is 
exported from the ER in a COPII dependent manner. A central question is 
whether they leave the ER using different types of carriers. The COPII 
complex is remarkably versatile and able to fonn assemblies with a variety 
of shapes and sizes (Stagg et al., 2008), but what regulates this differential 
assembly? 
A specific combination of Sec23 or Sec24 isofonns might favour a given 
COPII geometry, but there is space for yet undiscovered accessory proteins 
to regulate this event, the example of TANGO 1 for PCVII being one (Saito 
et aI., 2009; Wilson et al., 2011). Indeed a growing body of evidence 
indicates that different carriers fonn at the ER with differential molecular 
requirements. Studies in yeast have shown that different carriers can fonn in 
a COPII-dependent manner at the ER with differential molecular 
requirements. Two different types of carriers have been described: one 
containing GPI-anchored protein and another containing non GPI- anchored 
protein. Usolp, Sec34/35 and Yptlp are required for the fonnation of GPI-
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containing carriers, but are dispensable for the other carriers. Again, these 
findings support the hypothesis that different cargoes might use different 
machinery for exiting the ER. 
Manifold approaches have been undertaken to address this question m 
mammals but a definitive answer is still missing, with reports suggesting 
that PCI uses either distinct carriers or the same carriers used by "generic" 
cargo proteins. 
In fact, the strongest line of evidence that supports the existence of different 
molecular machinery that control ER exit of different cargoes comes from 
the identification of tissue-specific genetic diseases caused by mutations in 
components of the presumed general secretory transport machinery that, 
however, affect selected tissues, possibly because these tissues express 
special cargoes. 
For instance, mutations of COPII components cause tissue-specific 
pathology. SarlB if mutated leads to the onset of Chylomicron Retention 
Disease, characterized by the failure of enterocytes to secrete large 
lipoprotein particles, which in turn accumulate inside the ER. Cranio-
lenticulo sutural dysplasia is a rare genetic disease associated to mutations 
in the Sec23a gene. Why should widely expressed and highly conserved 
genes when mutated generate a tissue specific phenotype? A possible 
answer is that tissue-specific cargoes might be exquisitely sensitive to a 
defect in given components of the secretory machinery. 
Indeed, the study of monogenic diseases of membrane trafficking can be 
revealing in addressing the question as to whether special cargoes, in terms 
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of size or composition, do have special trafficking requirements in terms of 
molecular machinery, and I have provided here an example of how the 
study of the cellular pathogenesis of SEDT has revealed an unsuspected role 
for the TRAPP complex in the early secretory pathway .. 
So far, multiple trafficking steps in the exocytic, endocytic and autophagy 
pathways have been shown to be controlled by the TRAPP complex via the 
direct involvement of individual components of the complex. Here I report 
that TRAPP, through sedlin, intervenes in the earliest trafficking step along 
the exocytic pathway, i.e. the exit of (selected) cargoes from the ER, and I 
show that sedlin controls this step by modulating the residence time and 
concentration of Sar I-GTP at the ERES. 
I have provided several independent lines of evidence demonstrating that 
TRAPP, through sedlin, accelerates the membrane-cytosol cycle of Sar 1. 
Compared to control cells, sedliniTRAPP-depleted cells have I) a higher 
fraction of SarI associated with membranes, 2) a higher labelling density of 
SarI at the ERES membranes, 3) lower values of cytosolic SarI GAP 
activity, and 4) higher values for the membrane Koff of COPII components. 
Furthermore, this sedlin-mediated acceleration of SarI cycling is required 
for the export of PC, but not of many other cargoes, from the ER. 
These findings, together with the observation that the ER export of PC, but 
not of the reporter cargo VSV -G, is inhibited by low concentrations of the 
GTP-Iocked SarI mutant SarlH79G and the report that Sec13-31 (which 
enhances the SarI GAP activity of Sec23) is required for the ER export of 
PC but not of VSV-G (Townley et aI., 2008), converge on the conclusion 
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that the full-efficiency of the Sar 1 activation/inactivation cycle is required 
for PC but dispensable for VSV -G export from the ER (Stephens and 
Pepperkok, 2004). 
The activation of SarI at the ERES by Sec12 (leading to SarI-GTP) is 
required to initiate the recruitment of the Sec23-24 prebudding complex. 
However, Sec23-24 can temporarily remain associated with membranes 
once SarI is released from membranes (upon GTP hydrolysis promoted by 
Sec23 itself) thanks to the interaction of Sec24 with cargo through specific 
export signals (Barlowe, 2003; Miller et aI., 2003; Forster et aI., 2006). 
Thus, while the recruitment of "new" COPII invariably occurs with a 1: 1 
ratio between COPII and Sarl-GTP (which is continuously supplied by 
SecI2), the subsequent moulding of the COPII coat and the sculpting of the 
nascent bud proceeds under higher COPII:Sarl-GTP ratios. Indeed, Sarl-
GTP is efficiently and actively released from membranes through the GAP 
activity of Sec23/24, which is enhanced by Sec 13/31 (Bi et aI., 2007), by 
cargo (Sato and Nakano, 2004, 2005; Forster et al., 2006) and by TRAPP, as 
described in this Thesis. Given the flexibility of the COPII coat (Stagg et al., 
2008), its assembly in the presence of substoichiometric amounts of Sar 1-
GTP may allow the budding of carriers suitable for differently sized cargoes 
(Figure 6.1, upper panel). By contrast, higher local concentrations of SarI-
GTP during the budding process (as upon sedlinITRAPP depletion) induce 
constrictions along the nascent carriers, as Sarl-GTP, due to the insertion of 
its N-terminal alpha helix in the phospholipid bilayer, (Lee et al., 2005; 
Long et al., 2010) can bend membranes. 
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Sarl -GTP Sec23/ 24 
Sarl -GDP f Sec13/ 31 
sedlin/TRAPP depletion 
TRAPP complex ~ 
sedlin 
Sec12 
small soluble cargo 
membrane car~g 
large soluble cargo 
------
Figure 6.1 Model of the role of sedlinffRAPP in the budding of transport carriers from the 
ER. Upper panel: under control conditions the activation of Sar I by Sec 12 at the ERES initiate the 
recruitment of the COPTI complex. The inactivation of Sar I-GT? is tTiggered by ec23 and 
positively controlled by cargo and sed I inITRAPP. The release of Sar I-GOP from membrane i 
faster than the release of COPrI, which can remain temporarily bound to membrane through 
membrane cargo-Sec24 interaction. The carriers fonned under these conditions are competent for 
both small and large cargoes. Bottom: upon sedlinITRAPP depletion or edlin mutations the 
inactivation of Sarl-GTP is slowed down and its concentration in the na cent carrier increase . 
Higher local concentrations of Sar I-GTP induce membrane constrictions along the na cent carrier 
that are unsuited to host large cargoes, but are still able to accommodate small cargoes. See Final 
Discussion for details. 
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These "constricted" carriers may be unsuited to host large cargoes, but are 
still competent for smaller cargo (Figure 6.1, bottom panel). In this scenario, 
the dynamics of Sarl-GTP inactivation dictates the size and shape of the 
ER-derived carriers. 
In line with this, TRAPP depletion (which slows down the inactivation of 
Sarl-GTP) leads to the proliferation of membrane structures (tubules with 
constriction sites), which are inaccessible to the 300 nm PC triple helices 
but permissive for smaller cargoes (such as VSV-G, which is indeed found 
inside these membrane profiles, data not shown Mironov, personal 
communication). 
Interestingly, a higher concentration of Sar 1 and the presence of constricted 
tubular profiles at the ERES have been also observed in cells expressing 
mutant Sec23a, which is responsible for cranio-Ienticulo-sutural dysplasia 
(Fromme et al., 2007). This is another condition characterized by impaired 
PC secretion (Boyadjiev et al., 2011) in which a defective coupling between 
Sec23 and Sec31 slows down the rate of the SarI GTP/GDP cycle (Fromme 
et aI., 2007). All of the above conditions, i.e. sedlin depletion (this Thesis), 
Sec23a mutation (Fromme et aI., 2007; Boyadjiev S. et al 2011) and Sec13 
depletion (Townley et al., 2008), selectively affect PC export from the ER 
through a convergent mechanism involving a more stable association of 
Sarl-GTP with the ERES membranes. 
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Sedlin binds Sar 1, and this finding adds a further layer to the interactions 
between TRAPP and COPII, as Bet3 can bind Sec23 (Cai et aI., 2007). The 
Bet3-Sec23 interaction is reported to mediate the tethering of COPII 
vesicles, preceding their homotypic fusion in mammals and their heterotypic 
fusion with the Golgi complex in yeast (Cai et aI., 2007; Sacher et aI., 
2001). More recently, it has been shown that Bet3 competes with Sarl-GTP 
for its binding to Sec23 (Lord et aI., 2011), thus indicating that the Bet3-
Sec23-mediated interaction between TRAPP and COPII complexes can 
occur only after Sec23 is disengaged from SarI binding, i.e. only after SarI 
has been released from membranes and only after vesicles have detached 
from the donor ER membranes (Lord et aI., 20 II ). 
What I have reported here refers to an earlier interaction event between 
TRAPP and COPII complexes that involves sedlin and SarI. This 
interaction occurs at a transport step (i.e. budding) that precedes the release 
of COPII-coated vesicles and is required to accelerate the release of SarI 
from membranes, thus allowing the next layer of interaction between COPII 
and TRAPP involving Sec23 and Bet3. TRAPP would then remain 
associated with budded transport carriers to playa role in subsequent events, 
such as Rab 1 activation and the homotypic and heterotypic tethering of 
these carriers with the Golgi complex (Yu et al., 2006; Lord et aI., 2011). 
The TRAPP complex thus appears to be endowed with the ability to couple 
the cycles of two GTPases acting in series in ER-to-Golgi transport as it 
promotes the inactivation of SarI and the activation ofRabl, in line with the 
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proposal that the sequential activation of small GTPases acts as a switch 
controlling subsequent steps of intracellular trafficking (Segev, 2011 ; 
Poteryaev et al., 20 I 0). 
TRAPP mediates the first GTPase switch in the early secretory pathway: it 
deactivates SarI (acting as a co-GAP) and ensures Rabl activation 
(functioning as a GEF), providing a sequential control in different 
trafficking steps. Furthermore, this dual activity of TRAPP is exerted 
through distinct subunits, with sedlin mediating the inactivation of SarI but 
being dispensable for the activation of Rab 1. 
Finally, my findings provide important mechanistic insights into the 
pathophysiology of SEDT, as indicated by the observation that SEDT-
causing sedlin mutations shows defects in Sar 1 binding and that cells from 
SEDT patients have abnormal COPII dynamics and impaired PCII transport. 
While these results on the selective requirement of sedlin for the trafficking 
of PCII provide a possible explanation for the chondrocyte-restricted 
involvement in SEDT, additional factors may contribute to this selective 
sensitivity of chondrocytes to sedlin mutations. These include the possibility 
that the chondrocytes of SEDT male patients express lower levels of sedlin 
pseudogene products (Gecz et al., 2000; Scrivens et aI., 2009) or the ability 
of sedlin to exert "extra-TRAPP" and/or extra-trafficking functions, such as 
the regulation of transcription (Jeyabalan et al., 2010). 
The involvement of these factors in the pathogenesis of SEDT remains a 
topic for future investigation. Moreover, a demanding task at this stage is 
the generation of a SEDT animal model (Le. using Medaka animal model 
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system) to validate the identified molecular mechanism responsible for the 
onset of the disease and also to define therapeutic targets. 
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List of abbreviations 
ARF ADP-ribosylation factor 
ATP adenosine 5'-triphosphate 
BFA brefeldin A 
BSA bovine serum albumin 
eDNA complementary DNA 
CGN Cis-Golgi network 
COG Conserved oligomeric complex 
COPI/COPII coat protein IIII or coatomer 
CPY carboxypeptidase Y 
CS calf serum 
Cvt cytoplasm to vacuole targeting 
DAB 3 5' -diaminobenzidine 
DEAE diethylaminoethyl 
DMEM Dulbecco's modified minimal essential medium 
DNA deoxyribonucleasic acid 
DTT dithiothreitol 
ECM extracellular matrix 
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EDTA ethylenediamine tetraacetic acid 
EGC endoplasmic reticulum-to-Golgi carriers 
EGTA thyleneglycol-bis-(2-aminoethyllether)-N,N,N' ,N' -tetracetic acid 
EM electron microscopy 
ER endoplasmic reticulum 
ERES endoplasmic reticulum exit sites 
ERGIC ER-Golgi intermediate compartment 
FCS fetal calf serum 
FRAP fluorescence recovery after photobleaching 
GaiT galactosyl transferase 
GEF Guanine Exchange Factor 
GM Golgi matrix 
GFP green fluorescence protein 
GPC Golgi-to-plasma membrane carriers 
GST glutathione S-transferase 
GTP guanosine 5' -triphosphate 
GTPase guanosine triphosphatese 
HEPES N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 
Hfs Human fibroblast 
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HRP horseradish peroxidase 
IC Intermediate compartment 
IEM Immuno electron microscopy 
IF immunofluorescence 
IgG ImmunogIobuline G 
KD Knockdown 
kDa kilo Dalton 
LB Luria Broth 
LSCM laser scan confocal microscopy 
MannII mannosidase II 
MOPS 4-morpholinepropanesulfonic acid 
MW molecular weight 
NSF N-ethylmaleimide-sensitive fusion 
NZ nocodazole 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PAS pre-auto ph ago somal structure 
PBS phosphate buffered saline 
PCI procollagen type I 
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pcn procollagen type II 
PCR polymerase chain reaction 
PM plasma membrane 
rpm revolution per minute 
SDS Sodium dodecyl sulfate 
SEDL spondyloepiphyseal dysplasia late 
SNARE N-ethylmaleimide-sensitive fusion attachment protein 
receptor 
TBS 150 mM NaCI, 50 mM Tris-HCI pH 7.5 
tER transitional exit sites 
TGN trans-Golgi network 
TRIS tris(hydroxymethyl)aminomethane 
TRAPP Transport Protein Particles 
TTBS 0.05% Tween 20, 150 mM NaCI, 50 mM Tris-HCI pH 7.5 
VSV vesicular stomatitis virus 
VSV-G vesicular stomatitis virus G protein 
VTC vesicular-tubular cluster 
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